|
Mark Mandel, Esq.
Baker & McKenzie LLP 452 Fifth Avenue New York, New York 10018 (212) 626-4100 |
| |
Piotr Korzynski, Esq.
Baker & McKenzie LLP 300 East Randolph Street, Suite 5000 Chicago, IL 60601 (312) 861-8000 |
|
| | | | | 1 | | | |
| | | | | 1 | | | |
| | | | | 3 | | | |
| | | | | 13 | | | |
| | | | | 39 | | | |
| | | | | 40 | | | |
| | | | | 40 | | | |
| | | | | 41 | | | |
| | | | | 45 | | | |
| | | | | A-1 | | |
Name
|
| |
Position
|
|
Jon Heimer | | | Chief Executive Officer and Director | |
Oskar Hjelm | | | Chief Financial Officer | |
Rickard El Tarzi | | | Chief Strategy Officer | |
Ida Grundberg, PhD | | | Chief Scientific Officer | |
Carl Raimond | | | President | |
Anna Marsell | | | Chief Operating Officer | |
Elias Berglund | | | Chief People Officer | |
Linda Ramirez-Eaves, Esq. | | | General Counsel | |
Bruno Rossi | | | Chief Commercial Officer | |
Jon Hindar | | | Director | |
Solange Bullukian | | | Director | |
Johan Lund, PhD | | | Director | |
Nicolas Roelofs, PhD | | | Director | |
Gregory J. Moore | | | Director | |
Mary Reumuth | | | Director | |
Robert Schueren | | | Director | |
Tommi Unkuri | | | Director | |
Name
|
| |
Common
Shares (#) |
| |
Implied Cash
Consideration (U.S. $) |
| ||||||
Jon Heimer
|
| | | | 3,038,875 | | | | | $ | 79,010,750.00 | | |
Oskar Hjelm
|
| | | | 213,696 | | | | | $ | 5,556,096.00 | | |
Rickard El Tarzi
|
| | | | 339,396 | | | | | $ | 8,824,296.00 | | |
Ida Grundberg, PhD
|
| | | | 618,889 | | | | | $ | 16,091,114.00 | | |
Carl Raimond
|
| | | | 255,301 | | | | | $ | 6,637,826.00 | | |
Anna Marsell
|
| | | | 1,953 | | | | | $ | 50,778.00 | | |
Elias Berglund
|
| | | | 0 | | | | | $ | — | | |
Name
|
| |
Common
Shares (#) |
| |
Implied Cash
Consideration (U.S. $) |
| ||||||
Linda Ramirez-Eaves, Esq.
|
| | | | 16,432 | | | | | $ | 427,232.00 | | |
Jon Hindar
|
| | | | 153,034 | | | | | $ | 3,978,884.00 | | |
Solange Bullukian
|
| | | | 0 | | | | | $ | — | | |
Johan Lund, PhD
|
| | | | 40,845 | | | | | $ | 1,061,970.00 | | |
Nicolas Roelofs, PhD
|
| | | | 133,034 | | | | | $ | 3,458,884.00 | | |
Gregory J. Moore
|
| | | | 0 | | | | | $ | — | | |
Mary Reumuth
|
| | | | 0 | | | | | $ | — | | |
Robert Schueren
|
| | | | 0 | | | | | $ | — | | |
Tommi Unkuri
|
| | | | 0 | | | | | $ | — | | |
| | |
Company Stock Options
|
| |
Company RSUs
|
| |
Total
Consideration |
| |||||||||||||||||||||||||||||||||
| | |
Vested Options
|
| |
Unvested Options
|
| ||||||||||||||||||||||||||||||||||||
Name, Position
|
| |
#
|
| |
$(1)
|
| |
#
|
| |
$(2)
|
| |
#
|
| |
$(3)
|
| |
$
|
| |||||||||||||||||||||
Jon Heimer,
Chief Executive Officer and Director |
| | | | 46,273 | | | | | $ | 40,696 | | | | | | 74,468 | | | | | $ | 239,438 | | | | | | 81,991 | | | | | $ | 2,131,766 | | | | | $ | 2,459,918 | | |
Oskar Hjelm,
Chief Financial Officer |
| | | | 7,044 | | | | | $ | 13,604 | | | | | | 17,342 | | | | | $ | 55,972 | | | | | | 31,779 | | | | | $ | 826,254 | | | | | $ | 895,830 | | |
Rickard El Tarzi,
Chief Strategy Officer |
| | | | 4,472 | | | | | $ | 8,711 | | | | | | 9,247 | | | | | $ | 30,049 | | | | | | 19,899 | | | | | $ | 517,374 | | | | | $ | 556,133 | | |
Ida Grundberg, PhD,
Chief Scientific Officer |
| | | | 3,509 | | | | | $ | 6,690 | | | | | | 5,768 | | | | | | 18,447 | | | | | | 14,430 | | | | | $ | 375,180 | | | | | $ | 400,317 | | |
Carl Raimond,
President |
| | | | 8,254 | | | | | $ | 16,184 | | | | | | 20,701 | | | | | $ | 67,387 | | | | | | 48,519 | | | | | $ | 1,261,494 | | | | | $ | 1,345,064 | | |
Anna Marsell,
Chief Operating Officer |
| | | | — | | | | | | — | | | | | | 2,093 | | | | | $ | 6,719 | | | | | | 21,203 | | | | | $ | 551,278 | | | | | $ | 557,997 | | |
Elias Berglund,
Chief People Officer |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 7,479 | | | | | $ | 194,454 | | | | | $ | 194,454 | | |
Linda Ramirez-Eaves, Esq.,
General Counsel |
| | | | 7,057 | | | | | $ | 13,716 | | | | | | 11,617 | | | | | $ | 37,806 | | | | | | 29,151 | | | | | $ | 757,926 | | | | | $ | 809,447 | | |
Bruno Rossi,
Chief Commercial Officer |
| | | | — | | | | | | — | | | | | | 3,324 | | | | | $ | 10,760 | | | | | | 26,613 | | | | | $ | 691,938 | | | | | $ | 702,608 | | |
Jon Hindar,
Director |
| | | | 55,919 | | | | | $ | 73,757 | | | | | | 67,515 | | | | | $ | 136,920 | | | | | | — | | | | | | — | | | | | $ | 210,047 | | |
Solange Bullukian,
Director |
| | | | 19,859 | | | | | $ | 37,697 | | | | | | 31,454 | | | | | $ | 100,229 | | | | | | — | | | | | | — | | | | | $ | 137,926 | | |
Johan Lund, PhD,
Director |
| | | | 19,859 | | | | | $ | 37,697 | | | | | | 31,454 | | | | | $ | 100,229 | | | | | | — | | | | | | — | | | | | $ | 137,926 | | |
Nicolas Roelofs, PhD,
Director |
| | | | 19,859 | | | | | $ | 37,697 | | | | | | 31,454 | | | | | $ | 100,229 | | | | | | — | | | | | | — | | | | | $ | 137,926 | | |
Gregory J. Moore,
Director |
| | | | — | | | | | | — | | | | | | 6,909 | | | | | $ | 22,178 | | | | | | — | | | | | | — | | | | | $ | 22,178 | | |
Mary Reumuth,
Director |
| | | | 2,344 | | | | | $ | 20,182 | | | | | | 13,940 | | | | | $ | 82,715 | | | | | | — | | | | | | — | | | | | | — | | |
Robert Schueren,
Director |
| | | | 2,344 | | | | | $ | 20,182 | | | | | | 13,940 | | | | | $ | 82,715 | | | | | | — | | | | | | — | | | | | | — | | |
Tommi Unkuri,
Director |
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
| | |
2023E
|
| |
2024E
|
| |
2025E
|
| |
2026E
|
| |
2027E
|
| |
2028E
|
| |
2029E
|
| |
2030E
|
| |
2031E
|
| |
2032E
|
| |
2033E
|
| |||||||||||||||||||||||||||||||||
Revenue
|
| | | $ | 200 | | | | | $ | 276 | | | | | $ | 368 | | | | | $ | 481 | | | | | $ | 616 | | | | | $ | 751 | | | | | $ | 887 | | | | | $ | 1,023 | | | | | $ | 1,161 | | | | | $ | 1,300 | | | | | $ | 1,440 | | |
EBITDA (post-SBC)(1)
|
| | | $ | 5 | | | | | $ | 34 | | | | | $ | 67 | | | | | $ | 119 | | | | | $ | 214 | | | | | $ | 282 | | | | | $ | 340 | | | | | $ | 396 | | | | | $ | 453 | | | | | $ | 511 | | | | | $ | 572 | | |
Unlevered Free Cash Flow(2)
|
| | | $ | (25) | | | | | $ | (27) | | | | | $ | (4) | | | | | $ | 50 | | | | | $ | 102 | | | | | $ | 166 | | | | | $ | 209 | | | | | $ | 250 | | | | | $ | 293 | | | | | $ | 334 | | | | | $ | 377 | | |
Acquiror
|
| |
Target
|
| |
Date Announced
|
|
Danaher Corporation | | | Abcam plc | | | 08/28/23 | |
Waters Corporation | | | Wyatt Technology | | | 02/15/23 | |
Abcam plc | | | Biovision, Inc. | | | 08/02/21 | |
Danaher Corporation | | | Integrated DNA Technologies, Inc. | | | 03/09/18 | |
| | |
Selected Transactions
|
| |
EV/LTM Revenue
|
| |||
Announcement Date
|
| |
Acquiror
|
| |
Target
|
| |||
August 2023 | | | Danaher Corporation | | | Abcam plc | | |
12.1x
|
|
February 2023 | | | Waters Corporation | | |
Wyatt Technology Corp.
|
| |
12.4x
|
|
January 2022 | | | Thermo Fisher Scientific Inc. | | | PeproTech, Inc. | | |
18.5x
|
|
August 2021 | | | Abcam plc | | | BioVision Inc. | | |
10.1x
|
|
November 2019 | | | Astorg Advisory LLC and Cinven Limited | | | LGC Limited | | |
6.8x
|
|
July 2019 | | | Agilent Technologies, Inc. | | | BioTek Instruments, Inc. | | |
6.5x
|
|
November 2018 (not completed) | | | Illumina, Inc. | | | Pacific Biosciences of California, Inc. | | |
13.8x
|
|
March 2018 | | | Danaher Corporation | | | Integrated DNA Technologies, Inc. | | |
7.7x
|
|
|
Date: October 31, 2023
|
| | By: | | |
/s/ Jon Heimer
|
|
| | | | | | | Name: Jon Heimer | |
| | | | | | | Title: Chief Executive Officer | |
Exhibit (a)(5)(A)
October 17, 2023
The Board of Directors
Olink Holding AB (publ)
Uppsala Science Park
SE-751 83 Uppsala
Sweden
Members of the Board of Directors:
You have requested our opinion as to the fairness, from a financial point of view, to the holders of common shares, quota value SEK 2.431906612623020 per share (the “Company Common Shares”), and American depositary shares each representing one Company Common Share (the “ADSs”), of Olink Holding AB (publ) (the “Company”) of the consideration to be paid to such holders in the proposed Offer (as defined below) pursuant to the Purchase Agreement dated October 17, 2023 (the “Agreement”), between Thermo Fisher Scientific Inc. (the “Acquiror,” and together with its subsidiaries, the "Acquiror Group") and the Company. Pursuant to the Agreement, the Acquiror will, or will cause a direct or indirect wholly owned subsidiary of the Acquiror, to commence a tender offer to purchase any and all of the outstanding Company Commons Shares and the outstanding ADSs (the “Offer”) at a price for each Company Common Share equal to $26.00, representing $26.00 per ADS (such amount per Company Common Share or ADS, the “Offer Consideration”), payable in cash.
The Agreement further provides that, if the Minimum Tender Condition (as defined in the Agreement) is met and was not previously changed in accordance with Section 2.1(c) of the Agreement to below one Company Common Share more than 90%, then the Acquiror Group shall effectuate the Compulsory Redemption (as defined in the Agreement). The Offer and the Compulsory Redemption, together and not separately, are referred to herein as the “Transaction”.
In connection with preparing our opinion, we have (i) reviewed the Agreement; (ii) reviewed the Tender and Support Agreement; (iii) reviewed certain publicly available business and financial information concerning the Company and the industries in which it operates; (iv) compared the proposed financial terms of the
-2-
Transaction with the publicly available financial terms of certain transactions involving companies we deemed relevant and the consideration paid for such companies; (v) compared the financial and operating performance of the Company with publicly available information concerning certain other companies we deemed relevant and reviewed the current and historical market prices of the Company Common Shares and ADSs and certain publicly traded securities of such other companies; (vi) reviewed certain internal financial analyses and forecasts prepared by the management of the Company relating to its business; and (vii) performed such other financial studies and analyses and considered such other information as we deemed appropriate for the purposes of this opinion.
In addition, we have held discussions with certain members of the management of the Company and the Acquiror with respect to certain aspects of the Transaction, and the past and current business operations of the Company, the financial condition and future prospects and operations of the Company, and certain other matters we believed necessary or appropriate to our inquiry.
In giving our opinion, we have relied upon and assumed the accuracy and completeness of all information that was publicly available or was furnished to or discussed with us by the Company and the Acquiror or otherwise reviewed by or for us. We have not independently verified any such information or its accuracy or completeness and, pursuant to our engagement letter with the Company, we did not assume any obligation to undertake any such independent verification. We have not conducted or been provided with any valuation or appraisal of any assets or liabilities, nor have we evaluated the solvency of the Company or the Acquiror Group under any state or federal laws relating to bankruptcy, insolvency or similar matters. In relying on financial analyses and forecasts provided to us or derived therefrom, we have assumed that they have been reasonably prepared based on assumptions reflecting the best currently available estimates and judgments by management as to the expected future results of operations and financial condition of the Company to which such analyses or forecasts relate. We express no view as to such analyses or forecasts or the assumptions on which they were based. We have also assumed that the Transaction and the other transactions contemplated by the Agreement will be consummated as described in the Agreement, without reduction of the Minimum Tender Condition. We have also assumed that the representations and warranties made by the Company and the Acquiror in the Agreement and the related agreements are and will be true and correct in all respects material to our analysis. We are not legal, regulatory or tax experts and have relied on the assessments made by advisors to the Company with respect to such issues. We have further assumed that all material governmental, regulatory or other consents and approvals necessary for the consummation of the Transaction will be obtained without any adverse effect on the Company or on the contemplated benefits of the Transaction.
-3-
Our opinion is necessarily based on economic, market and other conditions as in effect on, and the information made available to us as of, the date hereof. It should be understood that subsequent developments may affect this opinion and that we do not have any obligation to update, revise, or reaffirm this opinion. Our opinion is limited to the fairness, from a financial point of view, of the Offer Consideration to be paid to the holders of the Company Common Shares and ADSs (other than the Acquiror Group and its affiliates) in the proposed Offer and we express no opinion as to the fairness of any consideration paid in connection with the Transaction to the holders of any other class of securities, creditors or other constituencies of the Company or as to the underlying decision by the Company to engage in the Transaction. Furthermore, we express no opinion with respect to the amount or nature of any compensation to any officers, directors, or employees of any party to the Transaction, or any class of such persons relative to the Offer Consideration to be paid to the holders of the Company Common Shares and ADSs in the Transaction or with respect to the fairness of any such compensation.
We have acted as financial advisor to the Company with respect to the proposed Transaction and will receive a fee from the Company for our services, a substantial portion of which will become payable only if the proposed Transaction is consummated. In addition, the Company has agreed to indemnify us for certain liabilities arising out of our engagement. During the two years preceding the date of this letter, we and our affiliates have had commercial or investment banking relationships with the Company and the Acquiror, for which we and such affiliates have received customary compensation. Such services during such period have included acting as joint lead bookrunner on the Company’s offering of equity securities in January 2023 and acting as joint lead arranger on the Acquiror’s credit facility in January 2022. During the two years preceding the date of this letter, neither we nor our affiliates have had any material financial advisory or other material commercial or investment banking relationships with Summa Equity AB (“Summa”), the majority shareholder of the Company, or Summa’s portfolio companies. In addition, we and our affiliates hold, on a proprietary basis, less than 1% of the outstanding common stock of each of the Company and the Acquiror. In the ordinary course of our businesses, we and our affiliates may actively trade the debt and equity securities or financial instruments (including derivatives, bank loans or other obligations) of the Company or the Acquiror for our own account or for the accounts of customers and, accordingly, we may at any time hold long or short positions in such securities or other financial instruments.
On the basis of and subject to the foregoing, it is our opinion as of the date hereof that the Offer Consideration to be paid to the holders of the Company Common Shares and ADSs (other than the Acquiror and its affiliates) in the proposed Offer is fair, from a financial point of view, to such holders.
-4-
The issuance of this opinion has been approved by a fairness opinion committee of J.P. Morgan Securities LLC. This letter is provided to the Board of Directors of the Company (in its capacity as such) in connection with and for the purposes of its evaluation of the Transaction. This opinion does not constitute a recommendation to any shareholder of the Company as to whether such shareholder should tender its shares into the Offer or how such shareholder should vote with respect to the Transaction or any other matter. This opinion may not be disclosed, referred to, or communicated (in whole or in part) to any third party for any purpose whatsoever except with our prior written approval. This opinion may be reproduced in full in any proxy or information statement mailed to shareholders of the Company but may not otherwise be disclosed publicly in any manner without our prior written approval.
Very truly yours,
J.P. MORGAN SECURITIES LLC
J.P. Morgan Securities LLC
Exhibit (a)(5)(B)
Goldman Sachs Bank Europe SE, Sweden Bankfilial
Blasieholmsgatan 7 I 111 48 Stockholm I Sweden
Tel: +46 (0)8 407 4900
PERSONAL AND CONFIDENTIAL
October 17, 2023
Board of Directors
Clink Holding AB (publ)
Uppsala Science Park
SE-751 83 Uppsala
Sweden
Ladies and Gentlemen:
Attached is our opinion letter, dated October 17, 2023 ("Opinion Letter''),with respect to the fairness from a financial point of view to the holders (other than Thermo Fisher Scientific Inc. ("Thermo Fisher") and its affiliates) of the outstanding common shares, quota value SEK 2.431906612623020 per share (the "Common Shares"), and the outstanding American depositary shares, each of which represents one Common Share (together with the Common Shares, the "Shares") of Olink Holding AB (publ) (the "Company") of the $26.00 in cash per Share for each Share accepted to be paid to such holders pursuant to the tender offer by Thermo Fisher, or a to-be-designated wholly owned subsidiary of Thermo Fisher in accordance with the Purchase Agreement, dated as of October 17, 2023, by and among Thermo Fisher and the Company (other than in the case of the Compulsory Redemption (as defined in the Agreement)).
The Opinion Letter is provided for the information and assistance of the Board of Directors of the Company in connection with its consideration of the transaction contemplated therein and is not to be used, circulated, quoted or otherwise referred to for any other purpose, nor is it to be filed with, included in or referred to in whole or in part in any registration statement, proxy statement or any other document, except in accordance with our prior written consent.
Very truly yours,
GOLDMAN SACHS EUROPE SE, SWEDEN BANKFILIAL
By: | ||
Managing Director |
By: | ||
Managing Director |
Goldman Sachs Bank Europe SE, Sweden Bankfilial
Blasieholmsgatan 7 1111 48 Stockholm I Sweden
Tel: +46 (0)8 407 4900
PERSONAL AND CONFIDENTIAL
October 17, 2023
Board of Directors
Olink Holding AB (publ)
Uppsala Science Park
SE-751 83 Uppsala
Sweden
Ladies and Gentlemen:
You have requested our opinion as to the fairness from a financial point of view to the holders (other than Thermo Fisher Scientific Inc. ("Thermo Fisher") and its affiliates) of the outstanding common shares, quota value SEK 2.431906612623020 per share (the "Common Shares"), and the outstanding American depositary shares, each of which represents one Common Share (the "ADSs", and together with the Common Shares, the "Shares") of Olink Holding AB (publ) (the "Company") of the $26.00 in cash per Share to be paid to such holders pursuant to the Tender Offer (as defined below) by Thermo Fisher, or a to-be-designated wholly owned subsidiary of Thermo Fisher (Thermo Fisher or such designee, "Buyer''), in accordance with the Purchase Agreement, dated as of October 17, 2023 (the "Agreement"), by and among Thermo Fisher and the Company. The Agreement provides for a tender offer for all of the Shares (the "Tender Offer") pursuant to which Buyer will pay $26.00 in cash per Share for each Share accepted. The Agreement further provides that, to the extent the Minimum Tender Condition (as defined in the Agreement) is met and not changed in accordance with the Agreement to below one Common Share more than 90%, Thermo Fisher and Buyer will effectuate the commencement and consummation by Buyer of the Compulsory Redemption (as defined in the Agreement), as to which Compulsory Redemption we express no opinion.
Goldman Sachs Bank Europe SE, Sweden Bankfilial and its affiliates (collectively, "Goldman Sachs") are engaged in advisory, underwriting, lending, and financing, principal investing, sales and trading, research, investment management and other financial and non-financial activities and services for various persons and entities. Goldman Sachs and its affiliates and employees, and funds or other entities they manage or in which they invest or have other economic interests or with which they co-invest, may at any time purchase, sell, hold or vote long or short positions and investments in securities, derivatives, loans, commodities, currencies, credit default swaps and other financial instruments of the Company, Thermo Fisher, any of their respective affiliates and third parties, including Summa Equity AB, a significant shareholder of the Company ("Summa Equity"), or any of its affiliates or portfolio companies or any currency or commodity that may be involved in the transaction contemplated by the Agreement (the "Transaction"). We have acted as financial advisor to the Company in connection with, and have participated in certain of the negotiations leading to, the Transaction. We expect to receive fees for our services in connection with the Transaction, the principal portion of which is contingent upon consummation of the Transaction, and the Company has agreed to reimburse certain of our expenses arising, and indemnify us against certain liabilities that may arise, out of our engagement. We have provided certain financial advisory and/or underwriting services to the Company and/or its affiliates from time to time for which Goldman Sachs Investment Banking has received, and may receive, compensation, including having acted as lead left bookrunner with respect to a public offering of the Company's ADSs in January 2023. We also have provided certain financial advisory and/or underwriting services to Thermo Fisher and/or its affiliates from time to time for which Goldman Sachs Investment Banking has received, and may receive, compensation, including having acted as joint bookrunner with respect to a public offering of Thermo Fisher's notes in November 2022 and as joint bookrunner with respect to a public offering of the Thermo Fisher's notes in August 2023. We may also in the future provide financial advisory and/or underwriting services to the Company, Thermo Fisher, Summa Equity and their respective affiliates and, as applicable, portfolio companies, for which Goldman Sachs Investment Banking may receive compensation. Affiliates of Goldman Sachs also may have co-invested with Summa Equity and its affiliates from time to time and may have invested in limited partnership units of affiliates of Summa Equity from time to time and may do so in the future.
Board of Directors
Olink Holding AB (publ)
October 17, 2023
Page 2
In connection with this opinion, we have reviewed, among other things, the Agreement; annual reports to shareholders and Annual Reports on Form 20-F of the Company for the two fiscal years ended December 31, 2022 and December 31, 2021; the Company's Registration Statement on Form F-1, including the prospectus contained therein dated March 3, 2021 relating to the initial public offering of the Company's ADSs; certain interim reports to shareholders of the Company; certain publicly available research analyst reports for the Company; and certain internal financial analyses and forecasts for the Company prepared by its management, as approved for our use by the Company (the "Forecasts"). We have also held discussions with members of the senior management of the Company regarding their assessment of the past and current business operations, financial condition and future prospects of the Company; reviewed the reported price and trading activity for the ADSs; compared certain financial and stock market information for the Company with similar information for certain other companies the securities of which are publicly traded; reviewed the financial terms of certain recent business combinations in the life sciences industry; and performed such other studies and analyses, and considered such other factors, as we deemed appropriate.
For purposes of rendering this opinion, we have, with your consent, relied upon and assumed the accuracy and completeness of all of the financial, legal, regulatory, tax, accounting and other information provided to, discussed with or reviewed by, us, without assuming any responsibility for independent verification thereof. In that regard, we have assumed with your consent that the Forecasts have been reasonably prepared on a basis reflecting the best currently available estimates and judgments of the management of the Company. We have not made an independent evaluation or appraisal of the assets and liabilities (including any contingent, derivative or other off-balance-sheet assets and liabilities) of the Company, and we have not been furnished with any such evaluation or appraisal. We have assumed that all governmental, regulatory or other consents and approvals necessary for the consummation of the Transaction will be obtained without any adverse effect on the expected benefits of the Transaction in any way meaningful to our analysis. We have assumed that the Transaction will be consummated on the terms set forth in the Agreement, without the waiver or modification of any term or condition the effect of which would be in any way meaningful to our analysis.
Board of Directors
Olink Holding AB {publ)
October 17, 2023
Page 3
Our opinion does not address the underlying business decision of the Company to engage in the Transaction, or the relative merits of the Transaction as compared to any strategic alternatives that may be available to the Company; nor does it address any legal, regulatory, tax or accounting matters. This opinion addresses only the fairness from a financial point of view to the holders (other than Thermo Fisher and its affiliates) of Shares, as of the date hereof, of the $26.00 in cash per Share to be paid to such holders pursuant to the Agreement {other than in the case of the Compulsory Redemption). We do not express any view on, and our opinion does not address, any other term or aspect of the Agreement, the Support Agreement (as defined in the Agreement) or Transaction or any term or aspect of any other agreement or instrument contemplated by the Agreement or the Support Agreement or entered into or amended in connection with the Transaction, including the fairness of the Transaction to, or any consideration received in connection therewith by, the holders of any other class of securities, creditors, or other constituencies of the Company; nor as to the fairness of the amount or nature of any compensation to be paid or payable to any of the officers, directors or employees of the Company, or class of such persons, in connection with the Transaction, whether relative to the $26.00 in cash per Share to be paid to the holders {other than Thermo Fisher and its affiliates) of Shares pursuant to the Agreement or otherwise. We are not expressing any opinion as to the prices at which the Shares will trade at any time or as to the potential effects of volatility in the credit, financial and stock markets on the Company, Thermo Fisher or the Transaction, or as to the impact of the Transaction on the solvency or viability of the Company or Thermo Fisher or the ability of the Company or Thermo Fisher to pay their respective obligations when they come due. Our opinion is necessarily based on economic, monetary, market and other conditions as in effect on, and the information made available to us as of, the date hereof and we assume no responsibility for updating, revising or reaffirming this opinion based on circumstances, developments or events occurring after the date hereof. Our advisory services and the opinion expressed herein are provided for the information and assistance of the Board of Directors of the Company in connection with its consideration of the Transaction and such opinion does not constitute a recommendation as to whether or not any holder of Shares should tender such Shares in connection the Tender Offer or any other matter. This opinion has been approved by a fairness committee of Goldman Sachs.
Based upon and subject to the foregoing, it is our opinion that, as of the date hereof, the $26.00 in cash per Share to be paid to the holders {other than Thermo Fisher and its affiliates) of Shares pursuant to the Agreement {other than in the case of the Compulsory Redemption) is fair from a financial point of view to such holders.
Very truly yours,
GOLDMAN SACHS EUROPE SE, SWEDEN BANKFILIAL
By: | ||
Managing Director |
By: | ||
Managing Director |
Exhibit (a)(5)(H)
Olink Tender Offer Launch Employee Letter from Olink CEO
Dear Colleagues,
I am writing to share an update on the next step in our agreement to combine with Thermo Fisher Scientific.
Today Thermo Fisher announced here that it has commenced the tender offer, which means that shareholders can officially begin submitting or “tendering” their shares into Thermo Fisher’s offer.
As you know, our Board recommends that all Olink shareholders tender their shares into the offer. If you are an Olink shareholder, you can reach out with any questions and requests about the tender offer to Georgeson LLC at +1 866-821-2550 (U.S. toll-free), +1-781-222-0033 (outside U.S. & Canada) or +46-846-007-389 (Sweden), or via email at olink@georgeson.com. A copy of the tender offer materials may be obtained at the website maintained by the U.S. Securities and Exchange Commission at www.sec.gov.
The current deadline for the tender offer is 6:00 p.m., New York time, on November 30, 2023. That said, if certain of the conditions to closing the tender offer, including obtaining the required regulatory approvals, are not satisfied as of the current deadline, the tender offer will be extended to permit such conditions to be satisfied.
We remain excited about the transaction with Thermo Fisher and the benefits we expect this combination will provide for our stakeholders – including Olink employees. We remain on track to close the transaction by mid-2024. Until then, we remain separate companies, and it is business as usual.
You may get questions from people outside our organization regarding today’s announcement. If you receive inquiries from the media, please do not comment and direct them to Jan Medina. If you’re contacted by an investor or other outside party, please do not respond and forward to olink@georgeson.com.
We will continue to keep you updated as we work towards close. As always, thank you for your dedication and focus.
Sincerely,
Jon Heimer
Chief Executive Officer
Forward-looking Statements
This communication contains forward-looking statements that involve a number of risks and uncertainties. Words such as “believes,” “anticipates,” “plans,” “expects,” “seeks,” “estimates,” and similar expressions are intended to identify forward-looking statements, but other statements that are not historical facts may also be deemed to be forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the COVID-19 pandemic, the need to develop new products and adapt to significant technological change; implementation of strategies for improving growth; general economic conditions and related uncertainties; dependence on customers’ capital spending policies and government funding policies; the effect of economic and political conditions and exchange rate fluctuations on international operations; use and protection of intellectual property; the effect of changes in governmental regulations; any natural disaster, public health crisis or other catastrophic event; and the effect of laws and regulations governing government contracts, as well as the possibility that expected benefits related to recent or pending acquisitions, including the proposed acquisition, may not materialize as expected; the proposed acquisition not being timely completed, if completed at all; regulatory approvals required for the transaction not being timely obtained, if obtained at all, or being obtained subject to conditions; prior to the completion of the transaction, Olink’s business experiencing disruptions due to transaction-related uncertainty or other factors making it more difficult to maintain relationships with employees, customers, licensees, other business partners or governmental entities; difficulty retaining key employees; the outcome of any legal proceedings related to the proposed acquisition; and the parties being unable to successfully implement integration strategies or to achieve expected synergies and operating efficiencies within the expected time-frames or at all. Additional important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in Thermo Fisher’s Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q, which are on file with the U.S. Securities and Exchange Commission (“SEC”) and available in the “Investors” section of Thermo Fisher’s website, ir.thermofisher.com, under the heading “SEC Filings”, and in any subsequent documents Thermo Fisher files or furnishes with the SEC, and in Olink’s Annual Report on Form 20-F and subsequent interim reports on Form 6-K, which are on file with the SEC and available in the “Investor Relations” section of Olink’s website, https://investors.olink.com/investor-relations, under the heading “SEC Filings”, and in any subsequent documents Olink files or furnishes with the SEC. While Thermo Fisher or Olink may elect to update forward-looking statements at some point in the future, Thermo Fisher and Olink specifically disclaim any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing either Thermo Fisher’s or Olink’s views as of any date subsequent to today.
Additional Information and Where to Find It
This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any common shares or American Depositary Shares of Olink or any other securities, nor is it a substitute for the tender offer materials that Thermo Fisher or the Buyer has filed with the SEC. The terms and conditions of the tender offer are published in, and the offer to purchase common shares and American Depositary Shares of Olink is made only pursuant to, the offer document and related offer materials prepared by Thermo Fisher and the Buyer and is filed with the SEC in a tender offer statement on Schedule TO. In addition, Olink has filed a solicitation/recommendation statement on Schedule 14D-9 with the SEC with respect to the tender offer.
THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A ADS LETTER OF TRANSMITTAL, ACCEPTANCE FORM FOR SHARES AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9, AS THEY MAY BE AMENDED FROM TIME TO TIME, CONTAIN IMPORTANT INFORMATION. INVESTORS AND SHAREHOLDERS OF OLINK ARE URGED TO READ THESE DOCUMENTS CAREFULLY BECAUSE THEY, AND NOT THIS DOCUMENT, GOVERN THE TERMS AND CONDITIONS OF THE TENDER OFFER, AND BECAUSE THEY CONTAIN IMPORTANT INFORMATION THAT SUCH PERSONS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR COMMON SHARES AND AMERICAN DEPOSITARY SHARES.
The tender offer materials, including the offer to purchase, the related ADS letter of transmittal and acceptance form for shares and certain other tender offer documents, and the solicitation/recommendation statement and other documents filed with the SEC by Thermo Fisher or Olink, may be obtained free of charge at the SEC's website at www.sec.gov, at Olink’s website https://investors.olink.com/investor-relations, at Thermo Fisher's website at www.thermofisher.com or by contacting Thermo Fisher's investor relations department at 781-622-1111. In addition, Thermo Fisher's tender offer statement and other documents it will file with the SEC will be available at https://ir.thermofisher.com/investors.
Exhibit (e)(8)
Olink Holding AB, reg. no 559189-7755, Uppsala (the "Company") and Jon Heimer, personal identity number, Stockholm, (the "Executive"), have today concluded the following
EXECUTIVE AGREEMENT
1. | Position and Start Date |
1.1 | The Executive is hereby employed as Chief Executive Officer/President (CEO) of the Company. This Agreement is effective as of 1 February 2022. The parties acknowledge that the employment began on 1 January 2015. |
1.2 | The primary place of employment is the Company's place of business in Uppsala, Sweden. In accordance with the instructions which the Company issues from time to time, the position includes an obligation to work at all of the Company's places of business or at another location. Permanent change of primary place of employment to a place that is not in an area in relation to the current place of employment requires that the parties agree on the change. The position includes an obligation to undertake business travel, both within and outside of Sweden. |
1.3 | The Executive may from time to time be appointed as board member or managing director of not only the Company but also other companies in the Company Group (as defined below). This agreement governs all such appointments and is valid until further notice in accordance with the conditions stated below. |
1.4 | The term "Company Group" in this agreement includes any legal entity which, directly or indirectly, controls, is controlled by or is under common control with the Company, regardless of which country such legal entity is registered in. |
1.5 | The parties agree that the Executive holds a managerial position and that the Swedish Employment Protection Act (1982:80) does not apply to the Executive's employment hereunder. |
1.6 | The Executive shall at all times meet the requirements of Fit & Proper standards as, at any time, stipulated by Nasdaq. Failure to do so is considered a major breach of this agreement. |
2. | Responsibilities and Duties |
The Executive is responsible for all activities of the Company in accordance with Swedish law and practices and within the guidelines and instructions as decided by the board of directors and the Company Group management. The Executive shall carry out all decisions made by the board of directors and shall comply with all guidelines and instructions given to the Executive during the term of the employment hereunder. The Executive shall report to the chairman of the board of directors of the Company.
3. | Working Hours, External Functions and Activities |
3.1 | The normal working time is 40 hours a week but the Executive recognizes that additional hours may be needed depending on the needs of the Company. |
3.2 | The Executive shall devote all of the Executive's working time and capacity to the employment with the Company. The Executive may not conduct business on his own or through representatives, receive assignments or in any other way conduct business, without the prior written approval from the Company. |
4. | Salary |
4.1 | The Executive is entitled to an annual base salary of SEK 3,870,000 payable at the end of each month. |
4.2 | In addition to the annual fixed salary, the Executive shall be entitled to participate in a bonus scheme, as defined by the Company's board of directors. The bonus scheme will consist of a maximum obtainable annual bonus, equal to 100 % of annual base salary, based on predefined financial-, operational-, and personal goals. The annual bonus payment to be made to the Executive is intended to be a reflection of his achievements relative to the goals set by the board of directors from year to year. The bonus scheme will be included in an addendum to this Agreement, which may therefore be updated and amended on an annual basis at the discretion of the board of directors. |
4.3 | The Executive shall be offered ownership or participation in a management incentive scheme. |
4.4 | The salary includes compensation for any other appointments and board assignments that the Executive may have within the Company or the Company Group. The Executive shall not be compensated for overtime or travel time. |
5. | Vacation |
5.1 | The Executive is entitled to 30 vacation days per vacation year. Vacation scheduling is to be approved in advance by the Company. The Executive may carry forward a maximum of five days per year. |
5.2 | The vacation year coincides with the qualifying year, being the same as the calendar year. The Executive hereby gives the Company a right to deduct any advanced vacation pay from any monies due to the Executive when the employment ends. |
6. | Pension |
The Company shall each month pay an amount corresponding to 15 percent of the Executive's monthly base salary to an occupational pension insurance for which the Executive is the beneficiary.
7. | Insurances |
7.1 | The Company shall take out and pay for relevant insurance policies in accordance with the Company's general policy for the benefit of the Executive, including insurances for illness, health, accident, travel, death, inability, as resolved on board meeting held in the Company from time to time. To the extent the Executive will serve on the board of directors of the Company, there will also be an insurance coverage relevant for the board assignment. |
8. | Expenses |
8.1 | The Executive is entitled to reimbursement for reasonable travel costs and other expenses in accordance with the Company's guidelines in force at each time. |
8.2 | Amounts which pertain to purchases using the Company's credit card at the Executive's disposal and which the Executive has failed to report in accordance with the Company's regulations within three (3) months from the credit card the Company's invoice due date may be set off by the Company against such net salary the Executive is to receive from the Company. |
2
9. | Termination |
9.1 | Termination of the employment by the Executive shall be subject to a notice period of six (6) months and termination of the employment by the Company shall be subject to a notice period of twelve (12) months. Notice of termination shall be in writing. |
9.2 | During the notice period the Company has the right to relieve the Executive from the Executive's duties and stop the Executive's access to the Company's premises or property with immediate effect. However, the Executive shall remain available to the Company to respond to any questions and to perform such work as the board of directors may require. The Executive shall remain completely bound by his duty of good faith and loyalty during the entire notice period (regardless of whether or not he has been relieved of his job responsibilities). Any variable compensation shall not be payable for such time when the Executive was relieved of job responsibilities or otherwise released from his position. Otherwise compensation shall be paid pursuant to the Agreement during the notice of termination period. |
9.3 | Upon termination of the employment, regardless of the reason therefore, the Executive shall be obligated to resign from all board appointments and such like which the Executive holds in the Company and/or Group Company without any claim for compensation. |
9.4 | With the Company's prior consent the Executive may commence new employment or start his own business. Deductions will be made from the payments and employment benefits made to the Executive during the notice period to reflect any income gained or which ought to have been gained through the Executive's new employment or business. |
9.5 | The employment ends without notice at the end of the calendar month when the Executive turns 65 years old. |
10. | Termination for Breach |
The Company has the right to dismiss the Executive with immediate effect if the Executive has grossly neglected the Executive's obligations towards the Company or otherwise has committed a major breach of agreement. The Executive will not be entitled to receive any compensation during the normal period of notice or any severance pay at the end of the employment if the Executive is dismissed for any of these reasons.
11. | Non-competition Clause |
11.1 | Restrictions |
The parties agree that the Executive will have access to and gain insight into trade secrets relating and belonging to the Company. Furthermore, the parties agree that, in the event of termination of the employment, the Executive would be able to use these trade secrets in a manner detrimental to the Company. The Executive further acknowledges that the disclosure of such information would cause irreparable harm to the Company.
In view thereof, the parties agree that regardless of whether the notice of termination is given by the Company or the Executive, the Executive undertakes for a period of twelve (12) months after the expiration of the employment not to directly or indirectly:
(i) | take employment in a business competing with the Company or the Company Group; |
(ii) | be an owner of a competing enterprise or in any other way assist a competing enterprise; or |
3
(iii) | self or through other start or carry on a competing business to the Company or the Company Group; |
11.2 | Compensation |
If the termination of agreement is made by the Company the severance pay shall be considered adequate compensation for the restrictions hereunder. If the termination of this agreement is made by the Executive and if the Executive is not relieved by the Company from the competition restrictions above, the Company is liable to compensate the Executive for the restraint laid down in this section by each month paying the Executive the difference between the Executive's average monthly income with the Company at the time the employment expired and the (lower) income the Executive hereafter earns or ought to have earned in a new employment or business. The compensation shall, however, not exceed 60 percent of the average monthly income from the Company at the expiration of employment with the Company and shall only be paid for the period during which the limitation in competition applies. The Executive's average monthly income will be calculated based on the average amount that the Executive has received per month as base salary and variable compensation (including any commission and bonus) during the previous twelve months of employment with the Company. In order to establish the level of compensation, the Executive shall keep the Company continuously informed of the Executive's salaries in any new employment or business as well as for estimated compensation which the Executive ought to have procured.
Should the Executive be dismissed immediately because of a major breach of agreement, the right to compensation as above is forfeited. No compensation is due when the employment ends due to the Executive's retirement.
11.3 | Release of Restrictions |
The Company may through notice to the Executive relieve the Executive from the limitation in competition at which the Company's obligation to compensate the Executive in accordance with this section 11 expires three months from the time notice was given.
11.4 | Damages |
Should the Executive commit a breach of the limitation in competition, the Executive is liable upon each occasion to pay the Company fixed damages with an amount corresponding to six times the Executive's average monthly income while employed with the Company. The Executive's average monthly income will be calculated based on the average amount that the Executive has received per month as base salary and variable compensation (including any commission and bonus) during the previous twelve months of employment with the Company. Should the breach be of an ongoing nature, each new month shall be deemed to constitute a new breach. The Company is also entitled to claim actual damages if the damage exceeds the fixed damages.
12. | Non-solicitation Clause |
12.1 | The Executive may not, during the term of this agreement or for a period of twelve (12) months after the expiration of the employment, directly or indirectly: |
(i) | solicit or attempt to solicit, (or assist in such activities) in competition with the Company the business or custom of any of the Company's or the Company Group's customers, prospective customers or business partners; or |
(ii) | entice, induce, solicit, or procure, ( or attempt to do so or assist in such activities) any person who is an employee, director or consultant of the Company or of any other company in the Company Group to leave that employment or assignment. |
4
12.2 | Should the Executive commit a breach of the limitation in solicitation, the Executive is liable upon each occasion to pay the Company fixed damages with an amount corresponding to six times the Executive's average monthly income while employed with the Company. The Executive's average monthly income will be calculated based on the average amount that the Executive has received per month as base salary and variable compensation (including any commission and bonus) during the previous twelve months of employment with the Company (not including any period of approved leave of absence). The Company is also entitled to claim actual damages if the damage exceeds the fixed damages. |
13. | Confidentiality |
The Executive is at all times - during the term of employment and thereafter - under the obligation to protect the interests of the Company, the Company Group and the shareholders and may not disclose to any third party any information regarding the Company's, the Company Group or the shareholders' respective businesses, except in the proper performance of the Executive's duties hereunder. This restriction does not apply to information that is already publicly available or becomes publicly available without the Executive's participation. |
14. | Obligation to Return Company Property |
If the Executive should leave his position as CEO of the Company, he will immediately return all property (including but not limited to documents and disks, mobile telephone, including the SIM-card, laptop computer, credit cards, equipment, keys and passes) belonging to the Company or the Company Group that is or has been in the Executive's possession or under the Executive's control. Documents and disks shall include but not be limited to correspondence, files, e-mails, memos, reports, minutes, plans, records, surveys, software, diagrams, computer print-outs, manuals, customer documentation or any other medium for storing information. The Executive's obligations in this respect shall include the return of all copies, drafts, reproductions, notes, extracts or summaries (howsoever made) of the foregoing. |
15. | Intellectual Property Rights |
15.1 | All intellectual property rights and know-how, worldwide, including rights to inventions, patentable or not, works protected by copyright and neighbouring rights, databases, computer software, designs, trademarks or other intellectual property rights and know-how, made or created by the Executive in the Executive's employment or during the term of the employment or subsequent to the termination of the employment (with respect to patentable inventions, up to one (1) year after the termination of the employment), in substance as a result of the Executive's employment with the Company, shall exclusively belong to the Company. For the avoidance of doubt, the Company's rights include, without limitation, the right to use, alter, develop, grant licenses, transfer and assign any inventions, solutions and all other intellectual property, material or documents. Unless otherwise provided by mandatory law, the Executive shall not receive any special compensation, in addition to salary and other employment benefits, for the creation of intellectual property rights and know-how referred to in this clause. |
15.2 | The Executive hereby waives any moral rights granted by the Act on Copyright in Literary and Artistic Works (1960:729) that vest in the Executive (whether before, on or after the date hereof) in connection with his authorship of any copyright works in the course of the employment with the Company, namely the right to be identified as the author of the works and the right not to have any such works subjected to derogatory treatment. |
15.3 | The Executive agrees not to copy for private purposes or otherwise use works protected by copyright or computer programs belonging to the Company or the Company Group without the Company's prior written consent for each individual case, and not to use know-how or material protected by intellectual property rights outside of the Executive's ordinary duties or after termination of the employment without the Company's prior written consent in each individual case. |
5
16. | Processing of Personal Data |
16.1 | In order to be able to perform the obligations under this agreement, comply with its legal obligations as an employer and in order to establish a safe and efficient administration, the Company needs to collect, enter, process and store personal data regarding its employees within the Company Group. Such information concerns, inter alia, identification details, contact details, period of employment, form of employment, working hours, wages and benefits, vacation and vacation benefits, work duties and work environment etc. The Company does not retain the personal data longer than necessary for in order to exercise or defend against any legal claims. The Company may also need to transfer personal data to third party service providers that provide services related to administration, technical issues and advisory issues. Moreover, the Company needs to transfer personal data to companies within the Company Group. |
16.2 | In accordance with the applicable personal data regulations, the Executive is entitled to request information regarding the Executive's personal data processed by the Company. In case of incorrect data or data processed incorrectly, the Executive may request that this is rectified, erased or restricted. The Executive may request that the Company provides a copy of the data concerned in a structured, commonly used, and machine-readable format. The Executive may also lodge a complaint with a supervisory authority. |
17. | Deductions |
The Company shall be entitled at any time during the employment, or in any event on termination, to deduct from the remuneration hereunder any monies owed by the Executive to the Company, including but not limited to any outstanding loans, advances, taxes, the cost of repairing any damage or loss to the Company's property caused by the Executive (and of recovering the same), and any other monies owed by the Executive to the Company. The Executive shall be notified before such deduction is made. |
18. | Entire Agreement and Amendments |
This agreement constitutes the entire agreement between the parties and supersedes any written or oral agreement between the Company and the Executive on the matters dealt with in this agreement. Amendments to this agreement shall be in writing and signed by both parties to be valid. |
19. | Governing Law |
This agreement shall be governed by Swedish law.
20. | Dispute Resolution |
20.1 | Any dispute, controversy or claim arising out of or in connection with this agreement, or the breach, termination or invalidity thereof, shall be finally settled by arbitration in accordance with the Arbitration Rules of the Arbitration Institute of the Stockholm Chamber of Commerce. The arbitral tribunal shall be composed of a sole arbitrator. The seat of arbitration shall be in Stockholm, Sweden. The language to be used in the arbitral proceedings shall be English. However, evidence may be presented in English or Swedish as the case may be. |
20.2 | If the aggregate costs for the arbitrator and the Stockholm Chamber of Commerce exceed three times the "base amount" (Sw. prisbasbelopp) under the Social Insurance Code (2010:110), the excess amount shall, irrespective of the outcome, be paid by the Company. |
6
20.3 | The parties undertake and agree that all arbitral proceedings conducted with reference to this arbitration clause will be kept strictly confidential. This confidentiality undertaking shall cover all information disclosed in the course of such arbitral proceedings, as well as any decision or award that is made or declared during the proceedings. Information covered by this confidentiality undertaking may not, in any form, be disclosed to a third party without the written consent of the other party. This notwithstanding, a party shall not be prevented from disclosing such information if such a right exists pursuant to statute, regulation, a decision by an authority, a stock exchange contract or similar. |
This agreement has been made in duplicate, one original to each party.
Date: | 1/2/2022 | Date: | 1/2/2022 |
Olink Holding AB
/s/ Jon Hindar | /s/ Jon Heimer | |
Jon Hindar | Jon Heimer | |
Chairman of the Board |
7
Exhibit (e)(9)
Oskar Hjelm
Confirmation of new compensation
This letter is to confirm the changes to your employment with Olink Proteomics AB effective 1 April 2021
New Salary: | 215 000 SEK per month |
Bonus | 50% of your base salary |
All other employment conditions will stay the same.
On behalf of Olink Holding AB
2021-04-15
/s/ Johana Isander | |
Johanna Isander | |
Chief People Officer |
www.olink.com | |
Olink Proteomics, Dag Hammarskjölds väg 52B | |
Uppsala Science Park, SE-751 83 Uppsala, Sweden | |
Phone: +46 (0)18 444 39 70, info@olink.com, Re no: 559046-8632 | 1 |
Anställningsavtal
Mellan Knilo Holdco AB 559189-7755 Uppsala (nedan kallat "Bolaget") och 0skar Hjelm (nedan kallad den"Anställde") har denna dag träffats följande villkor för anställning i bolaget.
Personuppgifter för den Anställde:
Namn: | Oskar Hjelm | |
Personnummer: | ||
Adress: | ||
Postnr + ort |
1. | Anstallning |
1.1 | Oskar Hjelms anställning som "CFO" i Knilo BidCo AB övergår fran 2020-12-01 till Knilo Holdco AB. Placeringsort ar Uppsala. |
1.2 | Anstallningen gaiter tillsvidare och avser heltid (100%). |
2. | Rapportering |
Den Anställde rapporterar till Jon Heimer.
3. | Lojalitet |
3.1 | Den Anställde är skyldig att ägna hela sin arbetstid, omsorg och skicklighet åt skötseln av sina åligganden enligt detta Avtal samt att vid alla tillfällen noga bevaka och tillvarataga Bolagets intressen. Den Anställde får inte medvetet vidta någon åtgärd som kan leda till skada för Bolaget. |
3.2 | Den Anställde får inte, utan Bolagets skriftliga godkännande, utföra annat arbete eller, direkt eller indirekt, åta sig uppdrag, bedriva verksamhet eller ha andra engagemang vid sidan av Anställningen. Den Anställde har dock rätt att, för investeringsändamål, äga en andel om maximalt fem (5) procent av aktierna eller andra säkerheter i börsnoterade bolag. |
4. | Arbetstider |
Normal arbetstid är 40 timmar/per helgfri vecka. Den Anställde har möjlighet till flexibel arbetstid i enlighet med bolagets policy.
5. | Lön och andra förmåner |
5.1 | Den Anställde uppbär en månadslön om 95 000 sek, Grundlön, per månad (avseende 100% tjänst) som utbetalas den 25:e varje månad. Lönen avser 2020 års lönerevision. |
5.2 | Den Anställde har rätt till bonus enligt vid varje tid gällande bonusplan beslutad av Bolagets styrelse. |
5.3 | Den Anställde är berättigad till pension och försäkring enligt bolagets Försäkringspolicy. |
6. | Semester |
Den Anställde är berättigad till en årlig semester om 30 arbetsdagar per semesterår. Semesteråret är den 1 januari till och med den 31 december. Intjänandeår är lika med semesterår.
7. | Övertids- och restidsersättning |
Övertids- eller restidsersättning utgår inte särskilt utan kompenseras genom den fasta månadslönen samt i enlighet med bolagets semesterpolicy där den anställde får fem (5) extra dagar, dvs totalt 30 semesterdagar.
8. | Arbetsmiljöpolicy |
Den Anställde förbinder sig att följa de ordnings-, miljö- och arbetsmiljöregler som gäller på Bolaget. Den närmare innebörden av dessa åtaganden preciseras av den Anställdes närmaste chef.
9. | IT-säkerhet och personuppgifter |
9.1 | Den Anställde åtar sig att följa Bolagets policy rörande användning av Bolagets datorer, epostsystem, internettjänster och andra programvaror. Den Anställde är medveten om och samtycker till att Bolaget har full tillgång till alla uppgifter, filer och all e-postkorrespondens samt att Bolaget har en fullständig överblick över Internetanvändningen som lagras i, eller överförs genom, Bolagets IT-system. |
9.2 | Den anställde är medveten om att Bolaget behandlar personuppgifter i enlighet med Bilaga 1. |
10. | Immateriella rättigheter |
10.1 | Samtliga immateriella rättigheter, inklusive all tillhörande know-how, som har framställts eller skapats av, eller på initiativ av, den Anställde, oavsett om detta skett under eller utanför arbetstid och/eller Bolagets eller dess Närstående bolags lokaler, innan undertecknandet av detta Avtal eller i samband med Anställningen eller under anställningstiden eller efter Anställningens upphörande (upp till ett år efter Anställningens upphörande beträffande patenterbara uppfinningar) som ett resultat av den Anställdes arbete hos Bolaget ("Rättigheterna") ska uteslutande tillhöra Bolaget eller – i förekommande fall – ett Närstående bolag. Med "Närstående bolag" avses en juridisk person som direkt eller indirekt kontrollerar eller kontrolleras av Bolaget eller som står under samma kontroll som Bolaget. Om inte annat framgår av tvingande lagstiftning eller tillämpligt kollektivavtal, ska den Anställde inte ha rätt till någon ersättning i förhållande till Rättigheterna, annat än lön och andra förmåner som anges i detta Avtal. |
10.2 | Bolaget äger rätt att modifiera, ändra, överlåta, upplåta och licensiera Rättigheterna, inklusive allt därtill hänförligt material, till tredje part. |
10.3 | Den Anställde är skyldig att, såväl under detta Avtal som efter dess upphörande, samarbeta och vidta alla åtgärder som Bolaget anser vara nödvändiga för att bland annat överföra Rättigheterna till Bolaget eller registrera Rättigheterna hos behöriga myndigheter (inklusive t.ex. patentansökningar) samt vidta åtgärder mot eventuella intrång. |
11. | Sekretess |
11.1 | Den Anställde får inte (bortsett från när det krävs för utförandet av arbetet), varken under eller efter Anställningen, kopiera, använda eller för tredje part yppa företagshemligheter eller annan Konfidentiell Information beträffande Bolagets eller dess Närstående bolagsverksamheter. Den Anställde ska vidare efter bästa förmåga förhindra obehörig kopiering, användning eller yppande av sådan information. |
11.2 | "Konfidentiell Information" innefattar, men är inte begränsad till, information hänförlig till Bolagets och/eller Närstående bolags tekniska information, metoder, processer, know-how, uppfinningar, mönster, program, tekniker, databassystem, formler och idéer, finansiella information, prislistor, kund- och leverantörslistor samt information om deras nuvarande och framtida affärsbehov, information om anställda och deras anställningsvillkor, information som angivits såsom konfidentiell och annan information hänförlig till Bolagets och/eller Närstående bolags verksamheter och affärsförhållanden, strategier, marknadsföring, finanser, utveckling, affärer, transaktioner, avtal och företagshemligheter. |
11.3 | Förbudet i punkten 0 gäller dock inte i de fall det enligt detta Avtal eller tillämplig lag eller författning krävs att Konfidentiell Information avslöjas eller om Parterna skriftligen har överenskommit att den Konfidentiella Informationen får avslöjas eller om den Konfidentiella Informationen är allmänt känd och har kommit till allmänhetens kännedom på annat sätt än genom överträdelse av förbuden i punkten 11. |
11.4 | Enligt lag (2018:558) om företagshemligheter får den Anställde inte angripa företags- hemligheter som den Anställde tagit del av hos Bolaget, vilket innefattar men inte är begränsat till information i punkten 0. Förbudet innefattar bland annat att den Anställde varken under eller efter Anställningen får kopiera, utnyttja eller röja Bolagets företagshemligheter utan Bolagets samtycke. |
12. | Konkurrens- och värvningsförbud |
12.1 | Under Anställningen, inklusive uppsägningstiden, är den Anställde bunden av en lojalitetsplikt. |
12.2 | Den Anställde åtar sig att, under Anställningen och under en period om [sex] månader efter Anställningens upphörande (dvs. från slutet av eventuell uppsägningstid) ("Förbudstiden"), varken direkt eller indirekt, engagera sig i eller ta anställning inom sådant verksamhetsområde som direkt eller indirekt konkurrerar med Bolagets eller dess Närstående bolags verksamhet eller handla med eller driva verksamhet med, värva eller försöka att värva affärer, beställningar, kunder eller klienter från Bolaget eller dess Närstående bolag. |
12.3 | Om detta Avtal upphör, av annan anledning än den Anställdes pensionering eller Bolagets hävning av Avtalet enligt punkten 13.4, ska Bolaget under Förbudstiden utge en ersättning till den Anställde motsvarande skillnaden mellan den Anställdes Grundlön vid tidpunkten för Anställningens upphörande och den lön eller annan ersättning som den Anställde är berättigad till i en ny anställning eller nytt åtagande. Ersättningen ska dock inte överstiga 60 procent av den Anställdes Grundlön vid tidpunkten för Anställningens upphörande. Den Anställde är därför skyldig att fortlöpande under Förbudstiden hålla Bolaget skriftligen informerad om eventuell ny anställning eller nytt åtagande samt vilken inkomst eller annan ersättning som den Anställde uppbär från ny anställning eller nytt åtagande. Den Anställde är också skyldig att visa att den lägre inkomsten eller ersättningen från ny anställning eller nytt åtagande är orsakad av restriktionerna som anges i punkt 12.2. Den Anställde har inte rätt till ersättning enligt denna punkt 12.3 under tid, om någon, som den Anställde erhåller avgångsvederlag, om något. |
12.4 | Bolaget får ensidigt besluta om att begränsa tillämpningsområdet för de åtaganden som angivits ovan i punkten 12.2. Bolaget får också, helt eller delvis, befria den Anställde från åtagandena i punkten 12.2. Om den Anställde befrias från åtagandena i punkt 12.2 har Bolaget ingen skyldighet att betala ersättningen till den Anställde enligt punkten 12.3 ovan. |
13. | Anställningens upphörande |
13.1 | För båda parter gäller en ömsesidig uppsägningstid om 6 månader. |
13.2 | Om Anställningen upphör fortsätter dock detta Avtal att gälla i tillämpliga delar. |
13.3 | Om Bolaget förklarar att den Anställde inte behöver stå till Bolagets förfogande under hela eller delar av uppsägningstiden, har Bolaget rätt att från förmåner enligt detta Avtal avräkna inkomster som den Anställde förvärvar i annan anställning eller näringsverksamhet. |
13.4 | Om en Part grovt åsidosätter någon av sina skyldigheter enligt detta Avtal har den andra Parten rätt att säga upp detta Avtal med omedelbar verkan och utan att vidare förpliktelser enligt detta Avtal gäller. |
14. | Återlämnande av bolagets egendom |
Vid Anställningens upphörande (vid slutet av eventuell uppsägningstid), eller vid den tidigare tidpunkt som Bolaget begär, ska den Anställde till en av Bolaget utsedd person återlämna alla register, rapporter, dokument och annat material som den Anställde har skapat, försetts eller betrotts med eller som den Anställde har fått i sin besittning i samband med Anställningen samt all utrustning och annan egendom som tillhör Bolaget eller dess Närstående bolag. Den Anställde får inte behålla kopior av den nämnda egendomen eller informationen.
15. | Vite |
Om den Anställde bryter mot någon av bestämmelserna i punkt 10 (Immateriella rättigheter), 11 (Sekretess) och/eller 12 (Konkurrens- och värvningsförbud) är den Anställde, till följd av varje enskild överträdelse, skyldig att utge vite till Bolaget med ett belopp motsvarande tre gånger den Anställdes Grundlön vid tidpunkten för överträdelsen, eller om Anställningen har upphört, vid tidpunkten för Anställningens upphörande. Om överträdelsen är pågående är den Anställde skyldig att utge det överenskomna vitet för varje månad som överträdelsen består. Om Bolagets faktiska skada överstiger det överenskomna vitet har Bolaget rätt att kräva ytterligare ersättning motsvarande Bolagets skada.
16. | Kvittningsmedgivande |
Den Anställde samtycker till attvBolaget har rätt att kvitta fordringar som Bolaget har gentemot den Anställde , oavsett om dessa fordringar foljer av detta Avtal eller inte, mot sådan ersättning som Bolaget enligt detta Avtal är skyldig att utge till den Anställde.
17. | Tillägg och ändringar |
Tillagg till eller ändringar av detta Avtal får endast ske genom Parternas skriftliga överenskommelse.
Detta avtal har upprättats i tva exemplar varav parterna tagit va
Uppsala den | Uppsala den | |
Date: 1-12-2020 | Date: 1-12-2020 | |
/s/ Johan Pietila Holmner | /s/ Oskar Hjelm | |
Johan Pietila Holmner | Oskar Hjelm |
Exhibit (e)(10)
Employment Contract
Olink Proteomics AB 559046-8632 Uppsala (the "Company") and Rickard El Tarzi (the "Employee") have today entered into the following agreement regarding an employment at the Company.
PERSONAL INFORMATION
Name: | Rickard El Tarzi | |
Personal id #: |
The Company and the Employee are referred to individually as "Party" and collectively as the "Parties".
1. | COMMENCEMENT DATE, FORM OF EMPLOYMENT AND POSITION |
1.1 | The Employee is employed by the Company as Chief Strategy Officer on the terms and conditions of this Agreement (the "Employment"). The Employment commenced on 10 February 2020 and last until further notice. |
1.2 | This Agreement cancels, replaces and is in substitution of all prior agreements and arrangements, oral or written, between the Parties regarding the Employee's services and terms and conditions of employment. |
2. | LOYALTY |
2.1 | During the Employment, the Employee will work in a loyal and diligent manner for the Company and devote all care and skill to fulfilling the obligations under this Agreement as well as at all times promoting, observing and protecting the Company's interests and maintaining the Company's goodwill and not knowingly do or willingly permit to be done anything that may result in prejudice, loss or injury to the Company. |
2.2 | The Employee may not without the prior written consent of the Company be directly or indirectly involved or engaged, in any capacity, in any activity, assignment, business, trade, profession or occupation beside the Employment, save that the Employee may hold for bona fide investment purposes not more than 5 per cent of any class of shares or other securities which are listed on a recognised stock exchange. |
3. | PLACE AND HOURS OF WORK |
3.1 | The Employee shall have the principal place of work at the Company's premises currently in Uppsala, or at other locations in Sweden or abroad where the Company from time to time may conduct business. For the fulfilment of the duties under this Agreement, the Employee is obliged to travel within as well as outside Sweden. |
1
3.2 | The Employment is a full time position and the normal working hours are 40 hours per week. The Employee is obliged to work overtime when needed. |
4. | BASE SALARY |
4.1 | For the services rendered by the Employee in accordance with this Agreement, the Company shall pay to the Employee a gross monthly salary of SEK 136 167 salary year 2021 (the "Base Salary"). The Base Salary is paid in accordance with the Company's at each time applicable salary payment routines. |
4.2 | The Employee's Base Salary shall be reviewed annually. The undertaking of a salary review does not confer a contractual right (whether expressed or implied) to any increase in salary and the Employee acknowledges that any salary increase is at the discretion of the Company. |
4.3 | The Employee is not entitled to any additional compensation for overtime work. |
5. | VARIABLE REMUNERATION |
5.1 | The Employee may, at the Company's sole discretion, be eligible to participate in bonus arrangements established by the Company from time to time. Any bonus, if awarded, will primarily be based on individual, business unit and Company performance. The maximum amount of any bonus in any year shall be 30 per cent of the annual Base Salary. |
5.2 | If the Employment has been terminated during the year for which bonus is calculated, any bonus entitlement shall be reduced to a pro-rated amount based on days worked up to the date of the termination of the Employment. |
6. | PENSION AND INSURANCE |
6.1 | The Employee is entitled to pension benefits, calculated on the Employee's Base Salary, in accordance with Company policy from time to time. For more information see "Olinks Fo rsa kri ngs policy" |
6.2 | The Employee is entitled to insurance coverage in accordance with Company policy from time to time. |
7. | VACATION |
7.1 | The Employee is entitled to thirty (30) days' paid annual vacation in accordance with the Swedish Annual Leave Act (Sw. Semester/agen {1977:480}). The vacation is planned and decided by the Company. |
2
8. | WORK EQUIPMENT |
The Company shall, from time to time, supply the Employee with such equipment that the Company considers appropriate for the performance of the Employee's duties in accordance with this Agreement. Currently, this means that the Employee, for the purpose of performing the duties, shall have access to free mobile telephone and laptop computer and other relevant equipment.
9. | EXPENSES |
The Employee shall be reimbursed for reasonable expenses (travel costs, hotel charges, entertainment and similar expenses) which the Employee has incurred in connection with the proper performance of the duties. The Employee shall specify and verify the expenses in accordance with the Company's policy.
10. | PERSONAL DATA AND IT SECURITY |
10.1 | The Employee acknowledges that the Company will process personal data relating to the Employee. Such data will include the Employee's employment application, address, references, bank details, performance appraisals, work-, vacation-, and sickness records, next of kin, salary reviews, remuneration details, and other data (which may, where necessary, include sensitive personal data relating to the Employee's health, and data held for equal opportunities purposes). The Company will process such personal data for personnel administration and management purposes, to fulfil its obligations with regard to pension and insurance benefits, and to fulfil its obligations with regard to the Employment. The Employee acknowledges that the Employee's right of access, objection, correction, limitation and transferal and other rights in connection to processing of such data is prescribed by law. |
10.2 | The Employee further acknowledges that the Company may hold and process personal data relating to personnel administration and management purposes, and may, when necessary for those purposes, make such data available (in Sweden or third countries) to its advisers, to third parties providing products and/or services to the Company (such as IT systems suppliers, pensions, benefits and payroll administrators) and as required by law. Furthermore, the Employee acknowledges that the Company may transfer such data to and from any Affiliates for the purposes described above. In this Agreement, an "Affiliate" shall mean any legal body which directly or indirectly controls or is controlled by the Company or which is under the same control as the Company. |
10.3 | The Employee undertakes to comply with the Company policies regarding the use of Company computers, e-mail systems, Internet services and other software programs. The Employee acknowledges and agrees that the Company shall have full access to all data, files and e-mail correspondence as well as full overview of the Internet usage which is stored in or carried out through the Company's IT system. |
3
11. | INTELLECTUAL PROPERTY RIGHTS |
11.1 | All intellectual property rights (the "Rights"), including all know-how related thereto, which are made, created or initiated by the Employee, whether within or outside working hours and/or the facilities of the Company or its Affiliates in the course of employment or during the term of the employment or subsequent to the termination of the employment (with respect to patentable inventions, up to one year after the termination of this Agreement) as a result of the employment with the Company shall belong exclusively to the Company or- as the case may be - to an Affiliate. Unless stipulated in mandatory law, the Employee shall not be entitled to any compensation in relation to the Rights, apart from salary and other employment benefits granted under this Agreement. |
11.2 | The Company shall have the right to modify, amend, transfer, assign and license to any third party the Rights, including any material related thereto or based thereon. |
11.3 | The Employee is obliged, both during and after the termination of this Agreement, to fully cooperate and take all measures that the Company considers to be necessary in order to inter alia transfer the Rights to the Company, or register the Rights with relevant government authorities (including, without limitation, patent filings) and take actions against potential infringers. |
12. | CONFIDENTIALITY |
12.1 | Except in the proper performance of the Employee's duties, the Employee may not during or after the Employment copy, use or disclose any information which the Company or an Affiliate may reasonably consider to be of a confidential nature ("Confidential Information"). The Employee shall use the Employee's best endeavours to prevent the unauthorised copying, use or disclosure of Confidential Information. |
12.2 | Confidential Information includes, but is not limited to, information concerning the Company's or Affiliates' technical information, methods, processes, procedures, know-how, inventions, designs, programs, techniques, database systems, formulae and ideas, financial information, price lists, customer and supplier lists, details in relation to agreements with customers, clients and suppliers and their current or future business requirements, details in relation to agreements with employees and their terms and conditions of employment, information designated as confidential and other not publicly known information concerning the business or business relationships, strategies, marketing, development, finances, dealings, transactions, affairs or trade secrets of the Company or Affiliates. |
12.3 | The prohibition in clause 12.1 shall, however, not apply in cases where this Agreement or applicable law or regulation require that the Confidential Information is disclosed or where the Parties have agreed in writing that the Confidential Information may be disclosed or where the Confidential Information is publicly known and has come to public knowledge in any other way than by breach of the prohibition in this clause 12. |
4
12.4 | The Employee undertakes that, upon expiry of the Employment or on the earlier date as may be requested by the Company, the Employee shall return to the person designated by the Company all files, reports, documents, correspondence and other memoranda or materials which have come into the Employee's possession or control due to the Employment, whether or not the memoranda or materials contain Confidential Information and irrespective of the circumstances or conditions under which it may be in the Employee's possession or under the Employee's control and the Employee shall not retain any copies of or access to the memoranda or materials. |
12.5 | The Employee acknowledges that the Swedish Act on Trade Secrets (Sw. Lag (2018:558) om foretagshemligheter) prohibits attacks on trade secrets that the Employee has access to due to the Employment, including but not limited to Confidential Information. The Employee further acknowledges that this prohibition includes that the Employee may not, during or after the Employment, without the Company's consent copy, use or disclose trade secrets of the Company. |
13. | NON-SOLICITATION |
The Employee undertakes that, during the Employment and for a period of six (6) months following its expiry or termination (i.e. the end of the notice period, if any), the Employee will not directly or indirectly solicit, entice or encourage or attempt to encourage any of the Company's or its Affiliates' employees with whom the Employee has had a close professional relationship due to professional dealings within the twelve {12) months preceding the expiry or termination of the Employment, to leave his or her employment and the Employee will not directly or indirectly engage, employ or offer any such employee any employment or other engagement or agreement regarding services.
14. | NON-COMPETION AND NON-SOLICITATION |
14.1 | During the term of this Agreement, including any notice period, the Employee's duty of loyalty and fidelity is continuous. |
14.2 | The Employee undertakes that, during the Employment and for a period of six (6) months following the termination of the Employment (i.e., the end of the notice period, if any) (the "Restricted Period"), the Employee will not directly or indirectly, engage in or be employed by any person or entity which directly or indirectly is engaged in any business which competes with the Company's or its Affiliates' business or canvass, solicit or entice away business, orders, customers or clients from the Company or its Affiliates. |
14.3 | If this Agreement is terminated on other grounds than the Employee's retirement or the Company's termination of the Agreement in accordance with clause 17.3, the Company will, during the Restricted Period, pay the Employee a compensation equivalent to the difference between the Employee's Base Salary at the end of the Employment and the lower salary to which the Employee is entitled under any new employment or engagement. However, the compensation shall not exceed 60 per cent of the Employee's Base Salary at the end of Employment. In order for the Employee to receive the compensation, the Employee is obliged to keep the Company continuously informed in writing of any new employment or engagement and of the amount of income ensuing from such employment or engagement during the Restricted Period. Further, the Employee is obliged to show that the lower income from new employment or engagement during the Restricted Period is caused by the restrictions set forth in clause 14.2. The Employee shall not be entitled to compensation in accordance with this clause 14.3 during any period when the Employee receives severance pay, if any. |
5
14.4 | The Company may, at its sole discretion, limit the scope of any of the undertakings in clause 14.2 above. The Company may also wholly or partially release the Employee from any of the obligations in clause 14.2. If the Employee is released from the undertakings in clause 14.2, the Company will have no obligation to pay any compensation to the Employee pursuant to clause 14.3 above. |
15. | LIQUIDATED DAMAGES |
If the Employee violates any of the provisions of clauses lll(lntellectual Property Rights), 12(Confidentiality), 13 (Non-Recruitment) and/or 144 (Non-Competition and Non-Solicitation), the Employee shall, in respect of each and every violation, pay liquidated damages to the Company amounting to three (3) times the Employee's Base Salary preceding the violation or, if the Employment has terminated, as at the end date of the Employment. If the violation is on-going, the Employee will be liable to pay the agreed liquidated damages for each month during which the violation subsists. Should the actual loss caused to the Company exceed the agreed liquidated damages, the Company will be entitled to receive additional compensation in respect of such additional damage suffered by the Company.
16. | SET-OFF |
If at any time money is owed and payable by the Employee to the Company, whether under the provisions of this Agreement or otherwise, the Employee agrees and accepts that the Company deducts the sum or sums from time to time owing to the Company from any payment due to the Employee from the Company under this Agreement.
17. | TERMINATION |
17.1 | The Company may terminate the Employment by observing 6 months' notice or the longer notice period set forth in the Employment Protection Act (Sw. Lag {1982:80) om anstiillningsskydd). The Employee may terminate the employment by observing 6 months' notice. During any notice period, the terms of this Agreement shall continue to apply. |
6
17.2 | If the Company declares that the Employee does not have to be at the Company's disposal during the notice period, or part of the notice period, the Company has the right to deduct any income that the Employee earns either directly or indirectly from other employment or business activity from the remuneration received in accordance with this Agreement. |
17.3 | If a Party commits a gross violation of its obligations under this Agreement, the other Party will be entitled to terminate this Agreement with immediate effect and with no further obligations under this Agreement. |
17.4 | The expiry or termination of this Agreement (for any reason) will not operate to affect any of its provisions which, in accordance with their terms, are expressed to operate or have effect after such expiry or termination, such as the Employee's obligations under clauses 11 (Intellectual Property Rights), 12 (Confidentiality), 15 (Liquidated Damages), 18 (Return of Company Property) and 20 (Governing Law and Dispute Resolution). |
18. | RETURN OF COMPANY PROPERTY |
Upon termination of the Employment or on the earlier date as may be requested by the Company, the Employee will return to the person designated by the Company all files, reports, documents and other materials which the Employee has produced or been supplied or entrusted with or which have come into the Employee's possession in connection with the Employment and all equipment and other property belonging to the Company or its Affiliates and the Company's or its Affiliates' business. The Employee must not retain any copies of any property or information referred to in this clause 18.
19. | AMENDMENT AND MODIFICATION |
This Agreement may not be amended nor modified unless agreed in writing between the Parties.
20. | GOVERNING LAW AND DISPUTE RESOLUTION |
20.1 | This Agreement shall be governed by and construed in accordance with the laws of Sweden. |
20.2 | Any dispute, controversy or claim arising out of or in connection with the Employment or this Agreement shall be settled by the courts of competent jurisdiction in Sweden. |
[signatory page follows]
7
This Agreement has been executed in two (2) originals of which each Party has taken one (1) each.
Uppsala | Uppsala | |
Date: | Date: 2/11/2022 | |
/s/ Johanna sander | /s/ Rickard El Tarzi | |
Johanna sander |
Rickard El Tarzi | |
Olink Proteomics AB |
8
Exhibit (e)(11)
Sidan 1 av 5 |
Anställningsavtal
Mellan Olink Proteomics AB 559046–8632 Uppsala (nedan kallat ”Bolaget”) och Ida Grundberg (nedan kallad den ”Anställde”) har denna dag träffats följande villkor för anställning i bolaget.
Personuppgifter för den Anställde:
Namn: | Ida Grundberg |
Personnummer: | |
Adress: | |
Postnr + ort | |
Mobil telefon: |
1. | Anställning |
1.1 | Ida Grundberg anställs som CSO i Olink Proteomics AB. Placeringsort är Uppsala. |
1.2 | Anställningen gäller tillsvidare och avser heltid (100%) från och med 2020-04-01. |
2. | Rapportering |
Den Anställde rapporterar till CEO.
3. | Lojalitet |
3.1 | Den Anställde är skyldig att ägna hela sin arbetstid, omsorg och skicklighet åt skötseln av sina åligganden enligt detta Avtal samt att vid alla tillfällen noga bevaka och tillvarataga Bolagets intressen. Den Anställde får inte medvetet vidta någon åtgärd som kan leda till skada för Bolaget. |
3.2 | Den Anställde får inte, utan Bolagets skriftliga godkännande, utföra annat arbete eller, direkt eller indirekt, åta sig uppdrag, bedriva verksamhet eller ha andra engagemang vid sidan av Anställningen. Den Anställde har dock rätt att, för investeringsändamål, äga en andel om maximalt fem (5) procent av aktierna eller andra säkerheter i börsnoterade bolag. |
4. | Arbetstider |
Normal arbetstid är 40 timmar/per helgfri vecka. Den Anställde har möjlighet till flexibel arbetstid i enlighet med bolagets policy.
5. | Lön och andra förmåner |
5.1 | Den Anställde uppbär en månadslön om 95 000 sek, Grundlön, per månad (avseende 100% tjänst) som utbetalas den 25:e varje månad. Lönen avser 2020 års lönerevision. |
5.2 | Den Anställde har rätt till bonus enligt vid varje tid gällande bonusplan beslutad av Bolagets styrelse. |
Olink Proteomics AB | Phone | +46 18 477 3970 |
Uppsala Science Park | Fax: | +46 18 50 93 00 |
SE-751 83 Uppsala | Reg no: | 559046-8632 |
Sweden | Reg Office: | Uppsala |
Sidan 1 av 5 |
5.3 | Den Anställde är berättigad till pension och försäkring enligt bolagets Försäkringspolicy. |
6. | Semester |
Den Anställde är berättigad till en årlig semester om 30 arbetsdagar per semesterår. Semesteråret är den 1 januari till och med den 31 december. Intjänandeår är lika med semesterår.
7. | Övertids- och restidsersättning |
Övertids- eller restidsersättning utgår inte särskilt utan kompenseras genom den fasta månadslönen samt i enlighet med bolagets semesterpolicy där den anställde får fem (5) extra dagar, dvs totalt 30 semesterdagar.
8. | Arbetsmiljöpolicy |
Den Anställde förbinder sig att följa de ordnings-, miljö- och arbetsmiljöregler som gäller på Bolaget. Den närmare innebörden av dessa åtaganden preciseras av den Anställdes närmaste chef.
9. | IT-säkerhet och personuppgifter |
9.1 | Den Anställde åtar sig att följa Bolagets policy rörande användning av Bolagets datorer, epostsystem, internettjänster och andra programvaror. Den Anställde är medveten om och samtycker till att Bolaget har full tillgång till alla uppgifter, filer och all e-postkorrespondens samt att Bolaget har en fullständig överblick över Internetanvändningen som lagras i, eller överförs genom, Bolagets IT-system. |
9.2 | Den anställde är medveten om att Bolaget behandlar personuppgifter i enlighet med Bilaga 1. |
10. | Immateriella rättigheter |
10.1 | Samtliga immateriella rättigheter, inklusive all tillhörande know-how, som har framställts eller skapats av, eller på initiativ av, den Anställde, oavsett om detta skett under eller utanför arbetstid och/eller Bolagets eller dess Närstående bolags lokaler, innan undertecknandet av detta Avtal eller i samband med Anställningen eller under anställningstiden eller efter Anställningens upphörande (upp till ett år efter Anställningens upphörande beträffande patenterbara uppfinningar) som ett resultat av den Anställdes arbete hos Bolaget ("Rättigheterna") ska uteslutande tillhöra Bolaget eller – i förekommande fall – ett Närstående bolag. Med "Närstående bolag" avses en juridisk person som direkt eller indirekt kontrollerar eller kontrolleras av Bolaget eller som står under samma kontroll som Bolaget. Om inte annat framgår av tvingande lagstiftning eller tillämpligt kollektivavtal, ska den Anställde inte ha rätt till någon ersättning i förhållande till Rättigheterna, annat än lön och andra förmåner som anges i detta Avtal. |
10.2 | Bolaget äger rätt att modifiera, ändra, överlåta, upplåta och licensiera Rättigheterna, inklusive allt därtill hänförligt material, till tredje part. |
10.3 | Den Anställde är skyldig att, såväl under detta Avtal som efter dess upphörande, samarbeta och vidta alla åtgärder som Bolaget anser vara nödvändiga för att bland annat överföra Rättigheterna till Bolaget eller registrera Rättigheterna hos behöriga myndigheter (inklusive t.ex. patentansökningar) samt vidta åtgärder mot eventuella intrång. |
Olink Proteomics AB | Phone | +46 18 477 3970 |
Uppsala Science Park | Fax: | +46 18 50 93 00 |
SE-751 83 Uppsala | Reg no: | 559046-8632 |
Sweden | Reg Office: | Uppsala |
Sidan 1 av 5 |
11. | Sekretess |
11.1 | Den Anställde får inte (bortsett från när det krävs för utförandet av arbetet), varken under eller efter Anställningen, kopiera, använda eller för tredje part yppa företagshemligheter eller annan Konfidentiell Information beträffande Bolagets eller dess Närstående bolagsverksamheter. Den Anställde ska vidare efter bästa förmåga förhindra obehörig kopiering, användning eller yppande av sådan information. |
11.2 | "Konfidentiell Information" innefattar, men är inte begränsad till, information hänförlig till Bolagets och/eller Närstående bolags tekniska information, metoder, processer, know-how, uppfinningar, mönster, program, tekniker, databassystem, formler och idéer, finansiella information, prislistor, kund- och leverantörslistor samt information om deras nuvarande och framtida affärsbehov, information om anställda och deras anställningsvillkor, information som angivits såsom konfidentiell och annan information hänförlig till Bolagets och/eller Närstående bolags verksamheter och affärsförhållanden, strategier, marknadsföring, finanser, utveckling, affärer, transaktioner, avtal och företagshemligheter. |
11.3 | Förbudet i punkten 0 gäller dock inte i de fall det enligt detta Avtal eller tillämplig lag eller författning krävs att Konfidentiell Information avslöjas eller om Parterna skriftligen har överenskommit att den Konfidentiella Informationen får avslöjas eller om den Konfidentiella Informationen är allmänt känd och har kommit till allmänhetens kännedom på annat sätt än genom överträdelse av förbuden i punkten Error! Reference source not found.1. |
11.4 | Enligt lag (2018:558) om företagshemligheter får den Anställde inte angripa företags- hemligheter som den Anställde tagit del av hos Bolaget, vilket innefattar men inte är begränsat till information i punkten 0. Förbudet innefattar bland annat att den Anställde varken under eller efter Anställningen får kopiera, utnyttja eller röja Bolagets företagshemligheter utan Bolagets samtycke. |
12. | Konkurrens- och värvningsförbud |
12.1 | Under Anställningen, inklusive uppsägningstiden, är den Anställde bunden av en lojalitetsplikt. |
12.2 | Den Anställde åtar sig att, under Anställningen och under en period om [sex] månader efter Anställningens upphörande (dvs. från slutet av eventuell uppsägningstid) ("Förbudstiden"), varken direkt eller indirekt, engagera sig i eller ta anställning inom sådant verksamhetsområde som direkt eller indirekt konkurrerar med Bolagets eller dess Närstående bolags verksamhet eller handla med eller driva verksamhet med, värva eller försöka att värva affärer, beställningar, kunder eller klienter från Bolaget eller dess Närstående bolag. |
12.3 | Om detta Avtal upphör, av annan anledning än den Anställdes pensionering eller Bolagets hävning av Avtalet enligt punkten 13.4, ska Bolaget under Förbudstiden utge en ersättning till den Anställde motsvarande skillnaden mellan den Anställdes Grundlön vid tidpunkten för Anställningens upphörande och den lön eller annan ersättning som den Anställde är berättigad till i en ny anställning eller nytt åtagande. Ersättningen ska dock inte överstiga 60 procent av den Anställdes Grundlön vid tidpunkten för Anställningens upphörande. Den Anställde är därför skyldig att fortlöpande under Förbudstiden hålla Bolaget skriftligen informerad om eventuell ny anställning eller nytt åtagande samt vilken inkomst eller annan ersättning som den Anställde uppbär från ny anställning eller nytt åtagande. Den Anställde är också skyldig att visa att den lägre inkomsten eller ersättningen från ny anställning eller nytt åtagande är orsakad av restriktionerna som anges i punkt 12.2. Den Anställde har inte rätt till ersättning enligt denna punkt 12.3 under tid, om någon, som den Anställde erhåller avgångsvederlag, om något. |
Olink Proteomics AB | Phone | +46 18 477 3970 |
Uppsala Science Park | Fax: | +46 18 50 93 00 |
SE-751 83 Uppsala | Reg no: | 559046-8632 |
Sweden | Reg Office: | Uppsala |
Sidan 1 av 5 |
12.4 | Bolaget får ensidigt besluta om att begränsa tillämpningsområdet för de åtaganden som angivits ovan i punkten 12.2. Bolaget får också, helt eller delvis, befria den Anställde från åtagandena i punkten 12.2. Om den Anställde befrias från åtagandena i punkt 12.2 har Bolaget ingen skyldighet att betala ersättningen till den Anställde enligt punkten 12.3 ovan. |
13. | Anställningens upphörande |
13.1 | För båda parter gäller en ömsesidig uppsägningstid om 6 månader. |
13.2 | Om Anställningen upphör fortsätter dock detta Avtal att gälla i tillämpliga delar. |
13.3 | Om Bolaget förklarar att den Anställde inte behöver stå till Bolagets förfogande under hela eller delar av uppsägningstiden, har Bolaget rätt att från förmåner enligt detta Avtal avräkna inkomster som den Anställde förvärvar i annan anställning eller näringsverksamhet. |
13.4 | Om en Part grovt åsidosätter någon av sina skyldigheter enligt detta Avtal har den andra Parten rätt att säga upp detta Avtal med omedelbar verkan och utan att vidare förpliktelser enligt detta Avtal gäller. |
14. | Återlämnande av bolagets egendom |
Vid Anställningens upphörande (vid slutet av eventuell uppsägningstid), eller vid den tidigare tidpunkt som Bolaget begär, ska den Anställde till en av Bolaget utsedd person återlämna alla register, rapporter, dokument och annat material som den Anställde har skapat, försetts eller betrotts med eller som den Anställde har fått i sin besittning i samband med Anställningen samt all utrustning och annan egendom som tillhör Bolaget eller dess Närstående bolag. Den Anställde får inte behålla kopior av den nämnda egendomen eller informationen.
15. | Vite |
Om den Anställde bryter mot någon av bestämmelserna i punkt 10 (Immateriella rättigheter), Error! Reference source not found.1 (Sekretess) och/eller Error! Reference source not found. (Konkurrens- och värvningsförbud) är den Anställde, till följd av varje enskild överträdelse, skyldig att utge vite till Bolaget med ett belopp motsvarande tre gånger den Anställdes Grundlön vid tidpunkten för överträdelsen, eller om Anställningen har upphört, vid tidpunkten för Anställningens upphörande. Om överträdelsen är pågående är den Anställde skyldig att utge det överenskomna vitet för varje månad som överträdelsen består. Om Bolagets faktiska skada överstiger det överenskomna vitet har Bolaget rätt att kräva ytterligare ersättning motsvarande Bolagets skada.
Olink Proteomics AB | Phone | +46 18 477 3970 |
Uppsala Science Park | Fax: | +46 18 50 93 00 |
SE-751 83 Uppsala | Reg no: | 559046-8632 |
Sweden | Reg Office: | Uppsala |
Sidan 1 av 5 |
16. | Kvittningsmedgivande |
Den Anställde samtycker till att Bolaget har rätt att kvitta fordringar som Bolaget har gentemot den Anställde, oavsett om dessa fordringar följer av detta Avtal eller inte, mot sådan ersättning som Bolaget enligt detta Avtal är skyldig att utge till den Anställde.
17. | Tillägg och ändringar |
Tillägg till eller ändringar av detta Avtal får endast ske genom Parternas skriftliga överenskommelse.
Detta avtal har upprättats i två exemplar varav parterna tagit var sitt
Uppsala 4/23/2020 | Uppsala 4/23/2020 | |
/s/ Eva Svahn | /s/ Ida Grundberg | |
Eva Svahn | Ida Grundberg | |
Head of Human Resources |
Olink Proteomics AB | Phone | +46 18 477 3970 |
Uppsala Science Park | Fax: | +46 18 50 93 00 |
SE-751 83 Uppsala | Reg no: | 559046-8632 |
Sweden | Reg Office: | Uppsala |
Exhibit (e)(12)
June 24, 2020
Carl Raimond
Re: Offer of Employment
Dear Carl:
On behalf of Clink Proteomics, Inc. (the "Company"), I am pleased to offer you a position as Sr VP Global Sales reporting to Jon Heimer, CEO Clink Proteomics. The role is based at our office in Watertown, MA and your responsibilities will, among other things, encompass responsibility for global sales for all the territories in which the Company, its parent, subsidiaries, and affiliates conduct business.
The following sets forth the compensation and benefit provisions of this offer.
Base Salary
You will be paid $13 333,33 twice a month, which is equivalent to an annual amount of $320 000. You will be eligible for annual merit increases based on your performance, which might lead to increases in your compensation, in each case, as determined by the Company in its sole discretion.
Bonus Plan
During your employment with the Company, you will be eligible to receive a certain bonus payment of 50% of base salary if 100% of your annual targets are met. The bonus targets will be set on an annual basis by the CEO. As a "Signing Bonus" the Company will pre-pay 2020 years bonus at the starting date ($320,000/2/12x5=$66,666,67).
Employee Health and Welfare Benefits
· | Health Insurance. Employees have the opportunity to enroll for health insurance coverage, if desired, including spouses, domestic partners and children under age 26. Health coverage becomes effective the first day of employment. Employees can select either an Aetna Point of Service Plan with no annual deductible or a Health Savings Account (H.S.A.) qualified High Deductible Health Plan . Both Aetna plans offer nationwide access to participating healthcare providers. Health Savings Accounts are with Bank of America and include a monthly employer contribution of $125 . To assist you in your selection, Aetna's Schedule of Benefits and Summary of Benefits & Coverage for each of the two plans, along with the employee's semi-monthly payroll contributions, will be provided. | |
· | Dental & Vision Insurance. Clink offers generous group dental and vision insurance. Dental coverage is through Delta Dental while Sun Life provides vision coverage through the VSP national provider network. Employee contributions are very competitive for both plans and allow participating employees to include coverage for their spouse/partner and child(ren) under age 26. Eligibility for coverage begins the first day of employment. |
· | Life/AD&D Insurance, Short Term and Long-Term Disability. All full-time employees are automatically enrolled in the Clink Proteomics' employer paid group Basic Life/AD&D, Short Term Disability and Long Term disability programs insured by Sun Life. The Basic Life/AD&D benefit is $50,000 while both the Short and Long Term Disability plans provide up to 60% income replacement subject to specified maximums. in addition, employees can purchase additional life insurance in $10,000 increments up to the lesser of SX annual earnings or $500,000. Participating employees can also purchase Voluntary Life/AD&D for their dependents. |
· | 40l(k) Pension Plan. The Company offers a voluntary pre-tax salary reduction plan In which regular full - time and regular active part-time employees (scheduled work a minimum of 20 hours per week) who are 21 years of age or older may elect to participate beginning the first of the month following one full month of employment. The Company contributes a 3% safe harbor and matches 100% of the first 2% for all active employees as of December 31" each year. |
· | Other Benefits. Company laptop will be provided. Cell phone and/or internet as a reimbursable expense. Health and fitness expenses (e.g. gym and health club memberships) up to $600/year. A car allowance of $600/month will be paid. |
· | General. Notwithstanding anything to the contrary contained herein, the Company may amend, revise, or terminate any of the plans, programs, policies, or arrangements listed under the heading "Employee Health and Welfare Benefits" of this offer letter at any time. |
Paid Time Off
The Company will grant you 15 vacation days per year, in accordance with the Company's paid time off policy In effect from time to time.
Observed Paid Holidays
The Company will observe 10 company holidays per year (of which the Company will notify you each calendar year), and for calendar year 2020, shall be as follows:
· | New Years' Day, January 1; | |
· | Presidents' Day, February 17; | |
· | Memorial Day, May 25; | |
· | Independence Day, July 3; | |
· | Labor Day, September 7; | |
· | Thanksgiving, November 26; | |
· | Christmas Day, December 25; and | |
· | Three (3) discretionary holidays to be determined by the Company each year (e.g. the days after Christmas and Thanksgiving). | |
· | For 2020 these will be: |
o | Monday July 6 | |
o | Friday November 27 | |
o | Thursday December 24 |
Termination
Your employment may be terminated by the Company In the event of the following circumstances : (1) your death; (2) if, as a result of your physical or mental disability (which cannot be reasonably accommodated), you cannot perform all of the essential functions of your position for a period of not less than ninety (90) days; or (3) upon notice to you, with or without Cause. For purposes of this Agreement, the Company shall have "Cause" to terminate your employment in the event of: (a) fraud, embezzlement, or theft; (b) your commission of any act which the Company, in its reasonable discretion, determines constitutes dishonest behavior or misconduct (including, but not limited to, any action that may or does result In embarrassment or harm to the Company; (c) your malfeasance; (d) failure to follow any material rule, policy, or procedure; or (e) your conviction of a crime or the filing of criminal charges against you.
You may terminate your employment hereunder upon forty-five (45) days prior written notice to the Company. In the event of such notice, the Company may, at its option, advance the date of your termination to a date earlier than that specified by you if the Company determines that such is consistent with its business and transition needs. In such cases, you may be paid for the remainder of the forty-five (45) days' notice period and the parties agree that under these circumstances, you shall not receive any separation payment as described in the Compensation Upon Termination section below.
The Company may terminate your employment hereunder upon two (2) weeks prior written notice. In the event of such notice, the Company may, at its option, advance the date of your termination to a date earlier than that specified if the Company determines that such is consistent with its business and transition needs. In such cases, you may be paid for the remainder of the two (2) weeks' notice period.
Notice and Date of Termination
Any termination of your employment by the Company or by you (other than termination by reason of your death) shall be communicated by written Notice of Termination to the other party. The "Date of Termination" shall mean : (a) if your employment is terminated by your death, the date of your death; (b) if your employment is terminated for Cause, the date on which the Notice of Termination is given or such other date specified in the Notice of Termination; or (c) if you terminate your employment, or if the Company terminates your employment but not for Cause, the date specified in the Notice of Termination (which shall be subject to advancement at the option of the Company, as described in the Termination section above).
Compensation Upon Termination
If your employment is terminated by reason of your death or disability, the Company shall pay to such person as you designate in writing filed with the Company, or if no such person shall be designated, to your duly-qualified estate (and as otherwise provided by law) your unpaid Base Salary earned through the Date of Termination, at the rate in effect at the Date of Termination, along with any unused vacation, in each case, earned or accrued through your Date of Termination. Such payment shall fully discharge the Company's obligations to you and your estate with respect to your employment with the Company.
If your employment is terminated for Cause as described in the Termination section above, or if you terminate your employment, the Company shall pay you your unpaid Base Salary earned through the Date of Termination, at the rate in effect at the time Notice of Termination is given, along with any unused vacation, in each case, earned or accrued through your Date of Termination, and the Company shall have no further obligations to you with respect to your employment with the Company.
If the Company terminates your employment, other than for Cause as described in the Termination section above, your death or disability, or other than as a result of your termination of employment, then the Company shall pay you your unpaid Base Salary earned through the Date of Termination, at the rate in effect at the time Notice of Termination is given, along with any unused vacation, in each case, earned or accrued through your Date of Termination . In addition, in the event of such termination, the Company shall provide you an opportunity to execute a Separation Agreement and Release of Claims, to be prepared by the Company, which shall include a provision for monthly salary continuation of your annual Base Salary in effect as of the Date of Termination, for a period of six months. At the conclusion of the six month period, if you have found employment your severance will end. If at the end of the six month period you remain unemployed, as certified by you, you will be eligible for additional salary continuation payments for a period of time equal to the lesser of: (i) three (3) months; or (ii) the period of time you remain without employment as certified by you. In no event will the Company be obligated to pay you severance payments for a period greater than nine (9) months. This separation payment shall be in lieu of any further obligations to you, including, but not limited to, any arising under this Offer of Employment.
Non-Disclosure, Non-Compete, Non-Solicitation
This offer of employment is contingent upon your execution of the Company's standard Key Employment Agreement regarding non-competition, confidentiality and inventions, and non-solicitation, attached hereto as Exhibit A.
1-9 Documentation
During your first day of employment, it will be required for you to provide proof that you are presently eligible to work in the United States for 1-9 purposes. Failure to provide appropriate documentation within 3 days of hire will result in immediate termination of employment in accordance with the terms of the Immigration Reform and Control Act.
Taxes
All amounts payable and benefits provided to you shall be subject to any and all applicable taxes, as required by applicable federal, state, local and foreign laws and regulations.
Severability; Amendment; Governing Law
In the event that any one or more of the provisions of this letter shall be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not be affected thereby. This letter may not be amended or modified except by an express written agreement signed by you and the Company. This letter shall be governed in all respects, including as to interpretation, substantive effect and enforceability, by the internal laws of the Commonwealth of Massachusetts, without regard to conflicts of laws provisions thereof that would require application to the laws of another jurisdiction other than those that mandatorily apply.
Agreement
This letter (along with Exhibit A attached hereto) constitutes the entire agreement between the Company and you with respect to your employment by the Company, and supersedes all undertakings and agreements, whether oral or in writing, previously entered into by the Company and you with respect to any services you may have provided or will provide in the future. If you have any questions regarding the terms of this letter of understanding or employment, I will be happy to discuss them further.
/s/ Jon Heimer | Date: June 24, 2020 |
Jon Heimer, President & CEO, Olink Proteomics AB
I agree to the terms of the employment set forth above. This offer shall remain open until June 25th, 2020. Any acceptance after this date will be considered invalid. The starting date for employment is proposed to be August
10th, 2020.
AGREED TO:
/s/ Carl Raimond | 6/24/2020 | |
Carl Raimond | Date |
Exhibit A
Key Employee Agreement
In view of the highly competitive nature of the business of Clink Proteomics Inc. (together with its parent, affiliates and subsidiaries, the "Company"), the need of the Company to maintain its competitive position through the protection of its goodwill, trade secrets and confidential and proprietary information, and in consideration for being provided with access to certain trade secrets and/or confidential and proprietary information in conjunction with your employment with the Company, you agree as follows:
1. Non-Competition. You hereby agree that in consideration for your employment with the Company, and/or payment of the Signing Bonus to you by the Company, you shall not, during the period of your employment and for a period of twelve (12) months following your last day of employment with the Company, directly or indirectly, within any county (or adjacent county), in any State within the United States, or within any country outside of the United States, in which the Company is engaged in business during the period of your employment or on the date of termination of your employment, do the following: engage with, have an interest in, or render any services to any business (whether as owner, manager, operator, licensor, licensee, lender, partner, stockholder, joint venturer, employee, consultant or otherwise) which is competitive with the Company's business activities, in any territory in which such activities are carried on within the United States and/or outside of the United States.
2. Customer and Vendor Confidentiality. You recognize that it is essential to the Company's success that all customer and vendor information be deemed to be confidential and be properly treated as a confidential trade secret. Therefore, you agree not to use or disclose any such customer or vendor information except as may be necessary in the normal conduct of the Company's business for the specific customer or vendor, and after the end of your employment with the Company, you will return all materials containing any such information and all copies to the Company.
3. Confidentiality of Company Materials. You agree that both during your employment with the Company and thereafter you will not use for your own benefit, divulge or disclose to anyone except to persons within the Company whose positions require them to know it, any information not already readily and lawfully available to the public concerning the Company or any of its customers or suppliers ("Confidential Information"), including but not limited to any products, product development, business strategy, financial information or customer, supplier or employee lists. Confidential Information also includes, without limitation, any technical data, design, pattern, formula, computer program, source code, object code, algorithm, subroutine, manual, product specification, or plan for a new, revised or existing product; any business, marketing, financial or sales order; and any information concerning the present or future business or products of the Company.
4. All Developments the Property of the Company. All confidential, proprietary or other trade secret information and all other discoveries, inventions, processes, methods and improvements, conceived, developed, or otherwise made by you, alone or with others, and in any way relating to the Company's present or planned business or products, whether or not reduced to tangible form or reduced to practice during the period of your employment with the Company ("Developments") shall be the sole property of the Company. You agree to disclose all Developments promptly, fully and in writing to the Company promptly after development of the same, and at any time upon request. You agree to, and hereby do assign to the Company all your right, title and interest throughout the world in and to all Developments. You agree that all Developments shall constitute "Works for Hire" (as such are defined under the U.S. Copyright Laws) and hereby assign to the Company all copyrights, patents and other proprietary rights you may have in any Developments without any obligation on the part of the Company to pay royalties or any other consideration to you in respect of such Developments. You agree to assist the Company (without charge, but at no cost to you) to obtain and maintain for itself such rights.
You will, within two weeks from the date of the Agreement, submit to the Company a signed schedule of all inventions, processes, methods or improvements conceived or made by you prior to employment by the Company (hereinafter "Prior Developments"). It is understood that such Prior Developments are not subject to the provisions of this Agreement and, further, that not describing in your schedule any alleged Prior Development shall be conclusive evidence of the fact that it had not been conceived by you prior to employment by the Company.
5. Recruiting Company Employees. During your employment and for the twelve month period following the effective date of your termination, for any reason, from the Company, whether voluntary or involuntary (the "Restriction Period" ), you agree not to (a) directly or indirectly recruit, solicit or induce, help to recruit, solicit or induce, or attempt to recruit, solicit or induce any employees, consultants or independent contractors of the Company to terminate, alter or modify their employment relationship with the Company; or (b) hire or otherwise engage any such persons or participate in any such hiring or engagement, whether on your own behalf or on behalf of any other entity.
6. Non-Solicitation of Business Relationships. During the Restriction Period, you shall not, directly or indirectly, for your own account or for the account of any other person or entity, solicit, interfere with, or otherwise attempt to establish any business relationship of a nature that is competitive with the business of the Company, or with any person or entity throughout the world which is or was a customer, client, distributor, supplier or vendor of the Company at any time during your employment with the Company, other than any such activity on behalf of or at the request of the Company during your employment with the Company.
7. Return of Company Materials. At the time of your termination, for any reason, from the Company, you agree to return to the Company all Company materials, documents and property, in your possession or control relating to work done for the Company or relating to the processes and materials of the Company, including all copies. You also agree to return to the Company all materials concerning past, present and future or potential clients, customers, products and/or services, including all copies. You also agree to return to the Company all materials provided by customers of the Company and all teaching materials provided by the Company, including all copies. Such materials include, but are not limited to, customer and/or vendor lists, customer and/or vendor prospect material, price lists, rate structures, and software owned or developed by the Company for any purpose in any form, as well as all materials containing Confidential Information. You also agree to attend and participate cooperatively in an exit interview if so requested by the Company.
8. Non-Disclosure of Third Party Confidential Information. In your work for the Company, you will be expected and required not to use or disclose any confidential information, including trade secrets, of any former employer or other person to whom you have an obligation of confidentiality. Rather, you will be expected and required to use only that information which is generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry or otherwise legally in the public domain, or which is otherwise provided or developed by the Company. You agree that you will not bring onto Company premises any unpublished documents or property belonging to any former employer or other person to whom you have an obligation of confidentiality. You hereby represent that you have disclosed to the Company any contract you have signed that may restrict or purport to restrict any of your activities on behalf of the Company and that you have not taken any legally protectable confidential information belonging to a former employer. You may not under any circumstance use for the benefit of the Company, or disclose to any Company employee, any legally protectable confidential information belonging to your former employer.
Additionally, you represent and warrant that (i) you are voluntarily entering into this agreement and the letter to which this agreement is attached, and that your obligations hereunder and employment thereunder and compliance with the terms and conditions hereof will not conflict with or result In the breach by you of any agreement to which you are a party or by which you may be bound; and {Ii) you have not violated, and in connection with your employment with the Company will not violate, any non-competition, non-solicitation or other similar covenant or agreement by which you are or may be bound.
9. Non-Disparagement. You agree that while you are employed by the Company, and for a period of ten (10) years following your termination of employment with the Company, you will not, directly or indirectly, engage in any conduct or make any statement (including through social media) disparaging or criticizing In any way the Company, or any of their personnel, or engage in any other conduct or make any other statement (including through social media) that could be reasonably expected to Impair the goodwill or reputation of the Company, in each case, except to the extent required by law, and then only after consultation with the Company to the extent possible.
10. Miscellaneous:
(a) This agreement (together with the letter to which this agreement is attached) contains the entire agreement between you and the Company with respect to the subject matter hereof, superseding any previous oral or written agreements with the Company or any officer or representative thereof. In the event of any inconsistency between this agreement and any other contract between you and the Company, the provisions of this agreement shall prevail.
(b) Your obligations under this agreement shall survive the termination of your employment with the Company regardless of the manner of or reasons for such termination, and regardless of whether such termination constitutes a breach of any other agreement you may have with the Company. Your obligations under this Agreement shall be binding upon your heirs, assigns, executors, administrators and representatives, and the provisions of this Agreement shall inure to the benefit of and be binding on the successors and assigns of the Company.
(c) You agree that the terms of this agreement are reasonable and properly required for the adequate protection of the Company's legitimate business interests and do not prevent you from making a living in your profession. You agree that in the event that any of the provisions of this agreement arc determined by a court of competent jurisdiction to be contrary to any applicable statute, law, rule, or policy or for any reason unenforceable as written, then such court may modify any of such provisions so as to permit enforcement thereof to the maximum extent permissible as thus modified. Further, you agree that any finding by a court of competent jurisdiction that any provision of this agreement is contrary to any applicable statute, law, rule, or policy or for any reason unenforceable as written shall have no effect upon any other provisions and all other provisions shall remain in full force and effect.
(d) You agree that any material breach by you of this agreement will cause immediate and irreparable harm to the Company not compensable by monetary damages and that the Company will be entitled to obtain injunctive relief, in addition to all other relief, in any court of competent jurisdiction, to enforce the terms of this agreement, without having to prove or show any actual damage to the Company and without posting any bond. For purposes of such enforcement and injunctive relief, you hereby consent to the jurisdiction and venue of the Courts of the Commonwealth of Massachusetts.
(e) No failure by the Company to insist upon strict compliance with any of the terms, covenants, or conditions hereof, and no delay or omission by the Company in exercising any right under this agreement, will operate as a waiver of such terms, covenants, conditions or rights. A waiver or consent given by the Company on any occasion is effective only in that instance and will not be construed as a bar to or waiver of any right on any other occasion.
(f) You agree that this agreement may be amended or modified only by a written agreement of yourself and an authorized representative of the Company.
(g) This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts, without regard to the doctrine of conflicts of law. If any one or more provisions contained in this agreement is determined to be invalid, illegal or unenforceable in any respect under any applicable law, the validity, legality and enforceability of the remaining provisions contained in this agreement shall not be affected or impaired and in any such case the parties agree that they will in good faith agree to be bound by any revised provision that as far as legally permissible accomplishes the purposes and intentions of the stricken provision or provisions.
(h) This agreement does not create any obligation on the Company or any other person or entity to continue your employment. Your employment is "at will", meaning either the Company or you may terminate your employment at any time and for any reason or no reason at all.
(i) You agree that any change in your duties, roles, or reporting lines at the Company will not invalidate this Agreement or constitute any abandonment of it.
(j) Notwithstanding anything to the contrary contained in this agreement, this agreement does not limit your ability to communicate with any government agency or otherwise participate in any investigation or proceeding that may be conducted by any government agency, including providing documents or other information, without notice to the Company. This agreement does not limit your right to receive an award for information provided to any government agencies.
11. Arbitration. You and the Company agree that, subject to paragraph l0(d) above, binding arbitration shall be the sole and exclusive remedy for resolving any legal dispute arising out of or relating to your employment by the Company, including but not limited to all claims relating to your compensation, the termination of your employment, all claims of discrimination, including under Title VII of the Civil Rights Act, the Age Discrimination in Employment Act, the Older Workers Benefits Protection Act, and all other local, state, or federal discrimination or civil rights laws, all claims for severance, for reinstatement, attorneys' fees or costs, and any other employment-related legal claim; provided, however, that this shall in no way limit the Company's ability to commence litigation with regard to any breach of this agreement. Any such arbitration shall be conducted in Boston, Massachusetts under applicable AAA rules of arbitration. You will be responsible for all of your own costs and expenses and legal fees in connection with any such arbitration.
ACCEPTED AND AGREED TO:
Date: 6/24/2020 | ||||
/s/ Carl Raimond | ||||
Employee Signature | ||||
ACCEPTED ON BEHALF OF: | ||||
OLINK PROTEOMICS, AB | ||||
Date: | 6/24/20 | By: | /s/ Jon Heimer | |
Its: | President & CEO |
Exhibit (e)(13)
Employment Contract
Olink Proteomics AB 559046-8632 Uppsala (the “Company”) and Anna Marsell (the “Employee”) have today entered into the following agreement regarding an employment at the Company.
PERSONAL INFORMATION
Name: | Anna Marsell |
Personal id #: |
The Company and the Employee are referred to individually as "Party" and collectively as the "Parties".
1. | COMMENCEMENT DATE, FORM OF EMPLOYMENT AND POSITION |
1.1 | The Employee is employed by the Company as Chief Operating Officer on the terms and conditions of this Agreement (the "Employment"). The Employment will commence no later than 1 December 2022 and last until further notice. |
1.2 | This Agreement cancels, replaces and is in substitution of all prior agreements and arrangements, oral or written, between the Parties regarding the Employee's services and terms and conditions of employment. |
2. | LOYALTY |
2.1 | During the Employment, the Employee will work in a loyal and diligent manner for the Company and devote all care and skill to fulfilling the obligations under this Agreement as well as at all times promoting, observing and protecting the Company's interests and maintaining the Company's goodwill and not knowingly do or willingly permit to be done anything that may result in prejudice, loss or injury to the Company. |
2.2 | The Employee may not without the prior written consent of the Company be directly or indirectly involved or engaged, in any capacity, in any activity, assignment, business, trade, profession or occupation beside the Employment, save that the Employee may hold for bona fide investment purposes not more than 5 per cent of any class of shares or other securities which are listed on a recognised stock exchange. |
3. | PLACE AND HOURS OF WORK |
3.1 | The Employee shall have the principal place of work at the Company's premises currently in Uppsala, or at other locations in Sweden or abroad where the Company from time to time may conduct business. For the fulfilment of the duties under this Agreement, the Employee is obliged to travel within as well as outside Sweden. |
1
3.2 | The Employment is a full time position and the normal working hours are 40 hours per week. The Employee is obliged to work overtime when needed. |
4. | BASE SALARY |
4.1 | For the services rendered by the Employee in accordance with this Agreement, the Company shall pay to the Employee a gross monthly salary of SEK 170 000 salary year 2023 (the "Base Salary"). The Base Salary is paid in accordance with the Company's at each time applicable salary payment routines. |
4.2 | The Employee's Base Salary shall be reviewed annually. The undertaking of a salary review does not confer a contractual right (whether expressed or implied) to any increase in salary and the Employee acknowledges that any salary increase is at the discretion of the Company. |
4.3 | The Employee is not entitled to any additional compensation for overtime work. |
5. | VARIABLE REMUNERATION |
5.1 | The Employee may, at the Company's sole discretion, be eligible to participate in bonus arrangements established by the Company from time to time. Any bonus, if awarded, will primarily be based on individual, business unit and Company performance. The maximum amount of any bonus in any year shall be 30 per cent of the annual Base Salary and is paid on an annual basis two months trailing. |
5.2 | If the Employment has been terminated during the year for which bonus is calculated, any bonus entitlement shall be reduced to a pro-rated amount based on days worked up to the date of the termination of the Employment. |
5.3 | The employee is eligible to participate in the LTI program decided by the terms and conditions approved by the board each year starting 2023. |
5.4 | The employee is entitled to a sign on RSU allocation of 15 714 RSUs on start date. |
6. | PENSION AND INSURANCE |
6.1 | The Employee is entitled to pension benefits, calculated on the Employee's Base Salary, in accordance with Company policy from time to time. For more information see “Olinks Försäkringspolicy” |
6.2 | The Employee is entitled to insurance coverage in accordance with Company policy from time to time. |
2
7. | VACATION |
7.1 | The Employee is entitled to thirty (30) days' paid annual vacation in accordance with the Swedish Annual Leave Act (Sw. Semesterlagen (1977:480)). The vacation is planned and decided by the Company. |
8. | WORK EQUIPMENT |
The Company shall, from time to time, supply the Employee with such equipment that the Company considers appropriate for the performance of the Employee's duties in accordance with this Agreement. Currently, this means that the Employee, for the purpose of performing the duties, shall have access to free mobile telephone and laptop computer and other relevant equipment.
9. | EXPENSES |
The Employee shall be reimbursed for reasonable expenses (travel costs, hotel charges, entertainment and similar expenses) which the Employee has incurred in connection with the proper performance of the duties. The Employee shall specify and verify the expenses in accordance with the Company's policy.
10. | PERSONAL DATA AND IT SECURITY |
10.1 | The Employee acknowledges that the Company will process personal data relating to the Employee. Such data will include the Employee's employment application, address, references, bank details, performance appraisals, work-, vacation-, and sickness records, next of kin, salary reviews, remuneration details, and other data (which may, where necessary, include sensitive personal data relating to the Employee's health, and data held for equal opportunities purposes). The Company will process such personal data for personnel administration and management purposes, to fulfil its obligations with regard to pension and insurance benefits, and to fulfil its obligations with regard to the Employment. The Employee acknowledges that the Employee's right of access, objection, correction, limitation and transferal and other rights in connection to processing of such data is prescribed by law. |
10.2 | The Employee further acknowledges that the Company may hold and process personal data relating to personnel administration and management purposes, and may, when necessary for those purposes, make such data available (in Sweden or third countries) to its advisers, to third parties providing products and/or services to the Company (such as IT systems suppliers, pensions, benefits and payroll administrators) and as required by law. Furthermore, the Employee acknowledges that the Company may transfer such data to and from any Affiliates for the purposes described above. In this Agreement, an "Affiliate" shall mean any legal body which directly or indirectly controls or is controlled by the Company or which is under the same control as the Company. |
3
10.3 | The Employee undertakes to comply with the Company policies regarding the use of Company computers, e-mail systems, Internet services and other software programs. The Employee acknowledges and agrees that the Company shall have full access to all data, files and e-mail correspondence as well as full overview of the Internet usage which is stored in or carried out through the Company's IT system. |
11. | INTELLECTUAL PROPERTY RIGHTS |
11.1 | All intellectual property rights (the "Rights"), including all know-how related thereto, which are made, created or initiated by the Employee, whether within or outside working hours and/or the facilities of the Company or its Affiliates in the course of employment or during the term of the employment or subsequent to the termination of the employment (with respect to patentable inventions, up to one year after the termination of this Agreement) as a result of the employment with the Company shall belong exclusively to the Company or – as the case may be – to an Affiliate. Unless stipulated in mandatory law, the Employee shall not be entitled to any compensation in relation to the Rights, apart from salary and other employment benefits granted under this Agreement. |
11.2 | The Company shall have the right to modify, amend, transfer, assign and license to any third party the Rights, including any material related thereto or based thereon. |
11.3 | The Employee is obliged, both during and after the termination of this Agreement, to fully cooperate and take all measures that the Company considers to be necessary in order to inter alia transfer the Rights to the Company, or register the Rights with relevant government authorities (including, without limitation, patent filings) and take actions against potential infringers. |
12. | CONFIDENTIALITY |
12.1 | Except in the proper performance of the Employee's duties, the Employee may not during or after the Employment copy, use or disclose any information which the Company or an Affiliate may reasonably consider to be of a confidential nature ("Confidential Information"). The Employee shall use the Employee's best endeavours to prevent the unauthorised copying, use or disclosure of Confidential Information. |
12.2 | Confidential Information includes, but is not limited to, information concerning the Company's or Affiliates' technical information, methods, processes, procedures, know-how, inventions, designs, programs, techniques, database systems, formulae and ideas, financial information, price lists, customer and supplier lists, details in relation to agreements with customers, clients and suppliers and their current or future business requirements, details in relation to agreements with employees and their terms and conditions of employment, information designated as confidential and other not publicly known information concerning the business or business relationships, strategies, marketing, development, finances, dealings, transactions, affairs or trade secrets of the Company or Affiliates. |
4
12.3 | The prohibition in clause 12.1 shall, however, not apply in cases where this Agreement or applicable law or regulation require that the Confidential Information is disclosed or where the Parties have agreed in writing that the Confidential Information may be disclosed or where the Confidential Information is publicly known and has come to public knowledge in any other way than by breach of the prohibition in this clause 12. |
12.4 | The Employee undertakes that, upon expiry of the Employment or on the earlier date as may be requested by the Company, the Employee shall return to the person designated by the Company all files, reports, documents, correspondence and other memoranda or materials which have come into the Employee's possession or control due to the Employment, whether or not the memoranda or materials contain Confidential Information and irrespective of the circumstances or conditions under which it may be in the Employee's possession or under the Employee's control and the Employee shall not retain any copies of or access to the memoranda or materials. |
12.5 | The Employee acknowledges that the Swedish Act on Trade Secrets (Sw. Lag (2018:558) om företagshemligheter) prohibits attacks on trade secrets that the Employee has access to due to the Employment, including but not limited to Confidential Information. The Employee further acknowledges that this prohibition includes that the Employee may not, during or after the Employment, without the Company's consent copy, use or disclose trade secrets of the Company. |
13. | NON-SOLICITATION |
The Employee undertakes that, during the Employment and for a period of six (6) months following its expiry or termination (i.e. the end of the notice period, if any), the Employee will not directly or indirectly solicit, entice or encourage or attempt to encourage any of the Company's or its Affiliates' employees with whom the Employee has had a close professional relationship due to professional dealings within the twelve (12) months preceding the expiry or termination of the Employment, to leave his or her employment and the Employee will not directly or indirectly engage, employ or offer any such employee any employment or other engagement or agreement regarding services.
14. | NON-COMPETION AND NON-SOLICITATION |
14.1 | During the term of this Agreement, including any notice period, the Employee's duty of loyalty and fidelity is continuous. |
14.2 | The Employee undertakes that, during the Employment and for a period of six (6) months following the termination of the Employment (i.e., the end of the notice period, if any) (the "Restricted Period"), the Employee will not directly or indirectly, engage in or be employed by any person or entity which directly or indirectly is engaged in any business which competes with the Company's or its Affiliates' business or canvass, solicit or entice away business, orders, customers or clients from the Company or its Affiliates. |
5
14.3 | If this Agreement is terminated on other grounds than the Employee's retirement or the Company's termination of the Agreement in accordance with clause 17.3, the Company will, during the Restricted Period, pay the Employee a compensation equivalent to the difference between the Employee's Base Salary at the end of the Employment and the lower salary to which the Employee is entitled under any new employment or engagement. However, the compensation shall not exceed 60 per cent of the Employee's Base Salary at the end of Employment. In order for the Employee to receive the compensation, the Employee is obliged to keep the Company continuously informed in writing of any new employment or engagement and of the amount of income ensuing from such employment or engagement during the Restricted Period. Further, the Employee is obliged to show that the lower income from new employment or engagement during the Restricted Period is caused by the restrictions set forth in clause 14.2. The Employee shall not be entitled to compensation in accordance with this clause 14.3 during any period when the Employee receives severance pay, if any. |
14.4 | The Company may, at its sole discretion, limit the scope of any of the undertakings in clause 14.2 above. The Company may also wholly or partially release the Employee from any of the obligations in clause 14.2. If the Employee is released from the undertakings in clause 14.2, the Company will have no obligation to pay any compensation to the Employee pursuant to clause 14.3 above. |
15. | LIQUIDATED DAMAGES |
If the Employee violates any of the provisions of clauses 111(Intellectual Property Rights), 12(Confidentiality), 13 (Non-Recruitment) and/or 144 (Non-Competition and Non-Solicitation), the Employee shall, in respect of each and every violation, pay liquidated damages to the Company amounting to three (3) times the Employee's Base Salary preceding the violation or, if the Employment has terminated, as at the end date of the Employment. If the violation is on-going, the Employee will be liable to pay the agreed liquidated damages for each month during which the violation subsists. Should the actual loss caused to the Company exceed the agreed liquidated damages, the Company will be entitled to receive additional compensation in respect of such additional damage suffered by the Company.
16. | SET-OFF |
If at any time money is owed and payable by the Employee to the Company, whether under the provisions of this Agreement or otherwise, the Employee agrees and accepts that the Company deducts the sum or sums from time to time owing to the Company from any payment due to the Employee from the Company under this Agreement.
6
17. | TERMINATION |
17.1 | The Company may terminate the Employment by observing 6 months' notice or the longer notice period set forth in the Employment Protection Act (Sw. Lag (1982:80) om anställningsskydd). The Employee may terminate the employment by observing 4 months' notice. During any notice period, the terms of this Agreement shall continue to apply. |
17.2 | If the Company declares that the Employee does not have to be at the Company's disposal during the notice period, or part of the notice period, the Company has the right to deduct any income that the Employee earns either directly or indirectly from other employment or business activity from the remuneration received in accordance with this Agreement. |
17.3 | If a Party commits a gross violation of its obligations under this Agreement, the other Party will be entitled to terminate this Agreement with immediate effect and with no further obligations under this Agreement. |
17.4 | The expiry or termination of this Agreement (for any reason) will not operate to affect any of its provisions which, in accordance with their terms, are expressed to operate or have effect after such expiry or termination, such as the Employee's obligations under clauses 11 (Intellectual Property Rights), 12 (Confidentiality), 15 (Liquidated Damages), 18 (Return of Company Property) and 20 (Governing Law and Dispute Resolution). |
18. | RETURN OF COMPANY PROPERTY |
Upon termination of the Employment or on the earlier date as may be requested by the Company, the Employee will return to the person designated by the Company all files, reports, documents and other materials which the Employee has produced or been supplied or entrusted with or which have come into the Employee's possession in connection with the Employment and all equipment and other property belonging to the Company or its Affiliates and the Company's or its Affiliates' business. The Employee must not retain any copies of any property or information referred to in this clause 18.
19. | AMENDMENT AND MODIFICATION |
This Agreement may not be amended nor modified unless agreed in writing between the Parties.
20. | GOVERNING LAW AND DISPUTE RESOLUTION |
20.1 | This Agreement shall be governed by and construed in accordance with the laws of Sweden. |
7
20.2 | Any dispute, controversy or claim arising out of or in connection with the Employment or this Agreement shall be settled by the courts of competent jurisdiction in Sweden. |
[signatory page follows]
This Agreement has been executed in two (2) originals of which each Party has taken one (1) each.
Uppsala | Uppsala | |
Date: 5/25/2022 | Date: 5/25/2022 |
/s/ Johana Isander | /s/ Anna Marsell | |
Johanna Isander | Anna Marsell | |
Olink Proteomics AB |
8
Exhibit (e)(14)
Employment Contract
Olink Proteomics AB 559046-8632 Uppsala (the “Company”) and Elias Berglund the “Employee”) have today entered into the following agreement regarding an employment at the Company.
PERSONAL INFORMATION
Name: | Elias Berglund |
Personal id #: |
The Company and the Employee are referred to individually as "Party" and collectively as the "Parties".
1. | COMMENCEMENT DATE, FORM OF EMPLOYMENT AND POSITION |
1.1 | The Employee is employed by the Company as Chief People Officer on the terms and conditions of this Agreement (the "Employment"). The Employment will commence on 8 May 2023 and last until further notice. |
1.2 | This Agreement cancels, replaces and is in substitution of all prior agreements and arrangements, oral or written, between the Parties regarding the Employee's services and terms and conditions of employment. |
2. | LOYALTY |
2.1 | During the Employment, the Employee will work in a loyal and diligent manner for the Company and devote all care and skill to fulfilling the obligations under this Agreement as well as at all times promoting, observing and protecting the Company's interests and maintaining the Company's goodwill and not knowingly do or willingly permit to be done anything that may result in prejudice, loss or injury to the Company. |
2.2 | The Employee may not without the prior written consent of the Company be directly or indirectly involved or engaged, in any capacity, in any activity, assignment, business, trade, profession or occupation beside the Employment, save that the Employee may hold for bona fide investment purposes not more than 5 per cent of any class of shares or other securities which are listed on a recognised stock exchange. |
3. | PLACE AND HOURS OF WORK |
3.1 | The Employee shall have the principal place of work at the Company's premises currently in Uppsala, or at other locations in Sweden or abroad where the Company from time to time may conduct business. For the fulfilment of the duties under this Agreement, the Employee is obliged to travel within as well as outside Sweden. |
1
3.2 | The Employment is a full time position and the normal working hours are 40 hours per week. The Employee is obliged to work overtime when needed. |
4. | BASE SALARY |
4.1 | For the services rendered by the Employee in accordance with this Agreement, the Company shall pay to the Employee a gross monthly salary of SEK 135 000 salary year 2023 (the "Base Salary"). The Base Salary is paid in accordance with the Company's at each time applicable salary payment routines. |
4.2 | The Employee's Base Salary shall be reviewed annually. The undertaking of a salary review does not confer a contractual right (whether expressed or implied) to any increase in salary and the Employee acknowledges that any salary increase is at the discretion of the Company. |
4.3 | The Employee is not entitled to any additional compensation for overtime work. |
5. | VARIABLE REMUNERATION |
5.1 | The Employee may, at the Company's sole discretion, be eligible to participate in bonus arrangements established by the Company from time to time. Any bonus, if awarded, will primarily be based on individual, business unit and Company performance. The target amount shall be 30 per cent of the annual Base Salary. |
5.2 | If the Employment has been terminated during the year for which bonus is calculated, any bonus entitlement shall be reduced to a pro-rated amount based on days worked up to the date of the termination of the Employment. |
5.3 | The employee is eligible to participate in the Long Term incentive program as set out each year and approved by the board of Directors and the AGM. Your allocation in 2023 is set to be equivalent to 100% of your base salary and granted upon joining Olink. |
6. | PENSION AND INSURANCE |
6.1 | The Employee is entitled to pension benefits, calculated on the Employee's Base Salary, in accordance with Company policy from time to time. For more information see “Olinks Försäkringspolicy” |
6.2 | The Employee is entitled to insurance coverage in accordance with Company policy from time to time. |
2
7. | VACATION |
7.1 | The Employee is entitled to thirty (30) days' paid annual vacation in accordance with the Swedish Annual Leave Act (Sw. Semesterlagen (1977:480)). The vacation is planned and decided by the Company. |
8. | WORK EQUIPMENT |
The Company shall, from time to time, supply the Employee with such equipment that the Company considers appropriate for the performance of the Employee's duties in accordance with this Agreement. Currently, this means that the Employee, for the purpose of performing the duties, shall have access to free mobile telephone and laptop computer and other relevant equipment.
9. | EXPENSES |
The Employee shall be reimbursed for reasonable expenses (travel costs, hotel charges, entertainment and similar expenses) which the Employee has incurred in connection with the proper performance of the duties. The Employee shall specify and verify the expenses in accordance with the Company's policy.
10. | PERSONAL DATA AND IT SECURITY |
10.1 | The Employee acknowledges that the Company will process personal data relating to the Employee. Such data will include the Employee's employment application, address, references, bank details, performance appraisals, work-, vacation-, and sickness records, next of kin, salary reviews, remuneration details, and other data (which may, where necessary, include sensitive personal data relating to the Employee's health, and data held for equal opportunities purposes). The Company will process such personal data for personnel administration and management purposes, to fulfil its obligations with regard to pension and insurance benefits, and to fulfil its obligations with regard to the Employment. The Employee acknowledges that the Employee's right of access, objection, correction, limitation and transferal and other rights in connection to processing of such data is prescribed by law. |
10.2 | The Employee further acknowledges that the Company may hold and process personal data relating to personnel administration and management purposes, and may, when necessary for those purposes, make such data available (in Sweden or third countries) to its advisers, to third parties providing products and/or services to the Company (such as IT systems suppliers, pensions, benefits and payroll administrators) and as required by law. Furthermore, the Employee acknowledges that the Company may transfer such data to and from any Affiliates for the purposes described above. In this Agreement, an "Affiliate" shall mean any legal body which directly or indirectly controls or is controlled by the Company or which is under the same control as the Company. |
3
10.3 | The Employee undertakes to comply with the Company policies regarding the use of Company computers, e-mail systems, Internet services and other software programs. The Employee acknowledges and agrees that the Company shall have full access to all data, files and e-mail correspondence as well as full overview of the Internet usage which is stored in or carried out through the Company's IT system. |
11. | INTELLECTUAL PROPERTY RIGHTS |
11.1 | All intellectual property rights (the "Rights"), including all know-how related thereto, which are made, created or initiated by the Employee, whether within or outside working hours and/or the facilities of the Company or its Affiliates in the course of employment or during the term of the employment or subsequent to the termination of the employment (with respect to patentable inventions, up to one year after the termination of this Agreement) as a result of the employment with the Company shall belong exclusively to the Company or – as the case may be – to an Affiliate. Unless stipulated in mandatory law, the Employee shall not be entitled to any compensation in relation to the Rights, apart from salary and other employment benefits granted under this Agreement. |
11.2 | The Company shall have the right to modify, amend, transfer, assign and license to any third party the Rights, including any material related thereto or based thereon. |
11.3 | The Employee is obliged, both during and after the termination of this Agreement, to fully cooperate and take all measures that the Company considers to be necessary in order to inter alia transfer the Rights to the Company, or register the Rights with relevant government authorities (including, without limitation, patent filings) and take actions against potential infringers. |
12. | CONFIDENTIALITY |
12.1 | Except in the proper performance of the Employee's duties, the Employee may not during or after the Employment copy, use or disclose any information which the Company or an Affiliate may reasonably consider to be of a confidential nature ("Confidential Information"). The Employee shall use the Employee's best endeavours to prevent the unauthorised copying, use or disclosure of Confidential Information. |
12.2 | Confidential Information includes, but is not limited to, information concerning the Company's or Affiliates' technical information, methods, processes, procedures, know-how, inventions, designs, programs, techniques, database systems, formulae and ideas, financial information, price lists, customer and supplier lists, details in relation to agreements with customers, clients and suppliers and their current or future business requirements, details in relation to agreements with employees and their terms and conditions of employment, information designated as confidential and other not publicly known information concerning the business or business relationships, strategies, marketing, development, finances, dealings, transactions, affairs or trade secrets of the Company or Affiliates. |
4
12.3 | The prohibition in clause 12.1 shall, however, not apply in cases where this Agreement or applicable law or regulation require that the Confidential Information is disclosed or where the Parties have agreed in writing that the Confidential Information may be disclosed or where the Confidential Information is publicly known and has come to public knowledge in any other way than by breach of the prohibition in this clause 12. |
12.4 | The Employee undertakes that, upon expiry of the Employment or on the earlier date as may be requested by the Company, the Employee shall return to the person designated by the Company all files, reports, documents, correspondence and other memoranda or materials which have come into the Employee's possession or control due to the Employment, whether or not the memoranda or materials contain Confidential Information and irrespective of the circumstances or conditions under which it may be in the Employee's possession or under the Employee's control and the Employee shall not retain any copies of or access to the memoranda or materials. |
12.5 | The Employee acknowledges that the Swedish Act on Trade Secrets (Sw. Lag (2018:558) om företagshemligheter) prohibits attacks on trade secrets that the Employee has access to due to the Employment, including but not limited to Confidential Information. The Employee further acknowledges that this prohibition includes that the Employee may not, during or after the Employment, without the Company's consent copy, use or disclose trade secrets of the Company. |
13. | NON-SOLICITATION |
The Employee undertakes that, during the Employment and for a period of six (6) months following its expiry or termination (i.e. the end of the notice period, if any), the Employee will not directly or indirectly solicit, entice or encourage or attempt to encourage any of the Company's or its Affiliates' employees with whom the Employee has had a close professional relationship due to professional dealings within the twelve (12) months preceding the expiry or termination of the Employment, to leave his or her employment and the Employee will not directly or indirectly engage, employ or offer any such employee any employment or other engagement or agreement regarding services.
14. | NON-COMPETION AND NON-SOLICITATION |
14.1 | During the term of this Agreement, including any notice period, the Employee's duty of loyalty and fidelity is continuous. |
14.2 | The Employee undertakes that, during the Employment and for a period of six (6) months following the termination of the Employment (i.e., the end of the notice period, if any) (the "Restricted Period"), the Employee will not directly or indirectly, engage in or be employed by any person or entity which directly or indirectly is engaged in any business which competes with the Company's or its Affiliates' business or canvass, solicit or entice away business, orders, customers or clients from the Company or its Affiliates. |
5
14.3 | If this Agreement is terminated on other grounds than the Employee's retirement or the Company's termination of the Agreement in accordance with clause 17.3, the Company will, during the Restricted Period, pay the Employee a compensation equivalent to the difference between the Employee's Base Salary at the end of the Employment and the lower salary to which the Employee is entitled under any new employment or engagement. However, the compensation shall not exceed 60 per cent of the Employee's Base Salary at the end of Employment. In order for the Employee to receive the compensation, the Employee is obliged to keep the Company continuously informed in writing of any new employment or engagement and of the amount of income ensuing from such employment or engagement during the Restricted Period. Further, the Employee is obliged to show that the lower income from new employment or engagement during the Restricted Period is caused by the restrictions set forth in clause 14.2. The Employee shall not be entitled to compensation in accordance with this clause 14.3 during any period when the Employee receives severance pay, if any. |
14.4 | The Company may, at its sole discretion, limit the scope of any of the undertakings in clause 14.2 above. The Company may also wholly or partially release the Employee from any of the obligations in clause 14.2. If the Employee is released from the undertakings in clause 14.2, the Company will have no obligation to pay any compensation to the Employee pursuant to clause 14.3 above. |
15. | LIQUIDATED DAMAGES |
If the Employee violates any of the provisions of clauses 111(Intellectual Property Rights), 12(Confidentiality), 13 (Non-Recruitment) and/or 144 (Non-Competition and Non-Solicitation), the Employee shall, in respect of each and every violation, pay liquidated damages to the Company amounting to three (3) times the Employee's Base Salary preceding the violation or, if the Employment has terminated, as at the end date of the Employment. If the violation is on-going, the Employee will be liable to pay the agreed liquidated damages for each month during which the violation subsists. Should the actual loss caused to the Company exceed the agreed liquidated damages, the Company will be entitled to receive additional compensation in respect of such additional damage suffered by the Company.
6
16. | SET-OFF |
If at any time money is owed and payable by the Employee to the Company, whether under the provisions of this Agreement or otherwise, the Employee agrees and accepts that the Company deducts the sum or sums from time to time owing to the Company from any payment due to the Employee from the Company under this Agreement.
17. | TERMINATION |
17.1 | The Company may terminate the Employment by observing 6 months' notice or the longer notice period set forth in the Employment Protection Act (Sw. Lag (1982:80) om anställningsskydd). The Employee may terminate the employment by observing 6 months' notice. During any notice period, the terms of this Agreement shall continue to apply. |
17.2 | If the Company declares that the Employee does not have to be at the Company's disposal during the notice period, or part of the notice period, the Company has the right to deduct any income that the Employee earns either directly or indirectly from other employment or business activity from the remuneration received in accordance with this Agreement. |
17.3 | If a Party commits a gross violation of its obligations under this Agreement, the other Party will be entitled to terminate this Agreement with immediate effect and with no further obligations under this Agreement. |
17.4 | The expiry or termination of this Agreement (for any reason) will not operate to affect any of its provisions which, in accordance with their terms, are expressed to operate or have effect after such expiry or termination, such as the Employee's obligations under clauses 11 (Intellectual Property Rights), 12 (Confidentiality), 15 (Liquidated Damages), 18 (Return of Company Property) and 20 (Governing Law and Dispute Resolution). |
18. | RETURN OF COMPANY PROPERTY |
Upon termination of the Employment or on the earlier date as may be requested by the Company, the Employee will return to the person designated by the Company all files, reports, documents and other materials which the Employee has produced or been supplied or entrusted with or which have come into the Employee's possession in connection with the Employment and all equipment and other property belonging to the Company or its Affiliates and the Company's or its Affiliates' business. The Employee must not retain any copies of any property or information referred to in this clause 18.
19. | AMENDMENT AND MODIFICATION |
This Agreement may not be amended nor modified unless agreed in writing between the Parties.
7
20. | GOVERNING LAW AND DISPUTE RESOLUTION |
20.1 | This Agreement shall be governed by and construed in accordance with the laws of Sweden. |
20.2 | Any dispute, controversy or claim arising out of or in connection with the Employment or this Agreement shall be settled by the courts of competent jurisdiction in Sweden. |
[signatory page follows]
8
This Agreement has been executed in two (2) originals of which each Party has taken one (1) each.
Uppsala | Uppsala | |
Date: 2/6/2023 | Date: 2/6/2023 | |
/s/ Johanna Isander | /s/ Elias Berglund | |
Johanna Isander | Elias Berglund | |
Olink Proteomics AB |
9
Exhibit (e)(15)
INDEFINITE-TERM
EMPLOYMENT |
CONTRAT
DE TRAVAIL A DUREE |
BETWEEN THE UNDERSIGNED : | ENTRE : |
⮚ | Olink Proteomics SAS, Single-member simplified joint stock company with the SIREN number 919 080 143, Having its registered office at 9 rue du 4 septembre – 75002 Paris (France), | ⮚ | Olink Proteomics SAS, Société par actions simplifiée unipersonnelle dont le numéro SIREN est le 919 080 143, Ayant son siège social 9 rue du 4 septembre –75002 Paris (France), | |
⮚ | ||||
Represented for the purpose hereof by Oskar Hjelm, President | Représentée par M Oskar Hjelm. President | |||
Hereinafter referred as to “Olink Proteomics SAS” or “the Company” | Ci-après dénommée « Olink Proteomics SAS » ou «la Société» |
OF THE FIRST PART | D’UNE PART | |
AND : | ET : | |
Mr Bruno Rossi, a French citizen, born on 04/02/1972 residing at, registered under the social security number |
M Bruno Rossi, de nationalité française, né le 04/02/1972, demeurant, immatriculation à la Sécurité Sociale sous le numéro |
Hereinafter referred as to “M Bruno Rossi ” or “the Employee” |
Ci-après dénommé « M Bruno Rossi » ou « le Salarié » |
OF THE OTHER PART | D’AUTRE PART | |
Hereinafter together referred as to “the Parties”. |
Ci-après dénommés ensemble « les Parties ». |
Preamble : | Préambule : | |
Olink Proteomics SAS is a company engaged in the biotechnology and pharmaceutic industry. | Olink Proteomics SAS est une société spécialisée dans la recherche biotechnologique et pharmaceutique. | |
The parties have agreed that M Bruno Rossi will be employed at Olink Proteomics SAS, in France for the position of Chief Commercial Officer. |
Les Parties ont convenu que M Bruno Rossi sera employé par Olink Proteomics SAS, en France pour le poste de Chief Commercial Officer. |
Therefore, the Parties have agreed as follows: |
En conséquence, il a été convenu et arrêté ce qui suit : |
Article 1: Title and Status | Article 1 : Titre et statut | |
M Bruno Rossi will perform in France the duties of Chief Commercial Officer and will start in this position no later than 23 March 2023. | M Bruno Rossi exercera les fonctions de Chief Commercial Offier, à compter au plus tard le 23 mars 2023 | |
The contract is subject to the provisions of the French Legislation and of the metropolitan collective agreement of pharmaceutic industry of 6th April 1956. | Le présent contrat est régi par les dispositions de la législation française et de la convention collective Nationale de l’industrie pharmaceutique du 6 avril 1956. | |
Pursuant to this Agreement, M Bruno Rossi will be listed as a “Cadre” XI | En application de cette convention collective, M Bruno Rossi sera classé cadre, XI | |
This contract is subject to a medical examination as per the provisions of law. | Le présent contrat est conclu sous réserve de la visite médicale d’embauche. | |
This contract will become permanent after a probation period of 3 months. | Ce contrat deviendra permanent après une période d'essai de 3 mois. | |
During the probationary period, the contract may be ended at any time without reason. | Pendant la période d'essai, le contrat peut être rompu à tout moment sans raison. | |
If any party ends the contract during the probation period, it must respect a notice period of 24 hours if the Employee has been in the company less than 8 days, 48 hours between 8 days and 2 weeks of presence in the Company, two weeks between 2 weeks and one month of presence in the company, 1 month between 1 and 3 months of presence. After the probation period, this contract may be terminated by either of the parties subject to a period set by the Collective agreement, except in the event of serious misconduct. | Si l'une des parties met fin au contrat pendant la période d'essai, elle doit respecter un délai de préavis de 24 heures si le salarié est présent dans l'entreprise depuis moins de 8 jours, de 48 heures entre 8 jours et 2 semaines de présence dans l'entreprise, de deux semaines entre 2 semaines et un mois de présence dans l'entreprise, de 1 mois entre 1 et 3 mois de présence. Après la période d'essai, le présent contrat peut être rompu par l'une ou l'autre des parties sous réserve d'un délai fixé par la Convention collective, sauf en cas de faute grave | |
Notice Period will be 3 months. | Le délai de préavis sera de trois mois. |
2
Article 2: Duties | Article 2 : Fonctions et attributions | |
As Chief Commercial M Bruno Rossi is mainly in charge of the following duties: | En qualité de Chief Commercial Officer M Bruno Rossi est notamment chargé d’exécuter les fonctions suivantes : |
· | Deliver strategic leadership for defining the Company’s commercial path to continued, sustainable growth and profitability and the establishment of an effective growth process and infrastructure. Develop collaborative working relationships within the organisation in pursuit of the Company’s overall business goals. |
· | Lead development of the Company’s marketing strategy with an emphasis on achieving further market penetration and sales growth. Oversee the company’s communications and PR activities. |
· | Develop a strategy and provide leadership for company-wide business development opportunities that are consistent with the Company’s strategy for revenue growth. Creating relationships with major industry partners in order to build alliances and partnerships that best exploit Olink's products and offerings. |
· | Manage and optimize the sales operations, customer care and training functions, creating professionalized processes and a reputation of operational excellence within the industry. |
· | Develop the sales strategy of the company across direct sales and partnerships to exceed revenue growth and profit targets. |
· | Work with a cross-functional team to define country specific marketing strategy and plans globally. |
· | Assurer un leadership stratégique pour définir la trajectoire commerciale de la Société vers une croissance et une rentabilité continues et durables et la mise en place d'un processus et d'une infrastructure de croissance efficaces. Développer des relations de travail collaboratives au sein de l'organisation dans la poursuite des objectifs commerciaux globaux de l'entreprise. | |
· | Diriger le développement de la stratégie marketing de la société en mettant l'accent sur la pénétration du marché et la croissance des ventes. Superviser les activités de communication et de relations publiques de l'entreprise. | |
· | Élaborer une stratégie et développer les opportunités commerciales en accord avec la stratégie de croissance de l'entreprise. Créer des relations avec les principaux partenaires de l'industrie afin de créer des alliances et des partenariats servant au mieux les produits et les offres d'Olink. | |
· | Gérer et optimiser les opérations de vente, le service à la clientèle et les fonctions de formation, créant des processus professionnalisés et une réputation d'excellence opérationnelle au sein de l'industrie. | |
· | Développer la stratégie de vente de l'entreprise à travers les ventes directes et les partenariats pour dépasser les objectifs de croissance des revenus et de profit. | |
· | Travailler avec une équipe interfonctionnelle pour définir une stratégie et des plans marketing spécifiques à chaque pays à l'échelle mondiale. |
Article 3: Conditions of the performance of duties | Article 3 : Conditions d’exécution des fonctions | |
M Bruno Rossi undertakes to devote all his time, attention and abilities to the business of Olink Proteomics SAS. | M Bruno Rossi s’engage à consacrer tout son temps productif, toutes ses capacités et toute son attention aux affaires de la Société. | |
M Bruno Rossi undertakes to perform his duties and responsibilities in compliance with the internal instructions and policies given by Olink Proteomics SAS | M Bruno Rossi s’engage à exécuter ses fonctions et ses responsabilités dans le respect des directives internes et des politiques définies par la Société. | |
During the term of this contract, M Bruno Rossi shall not perform any other business activity of any kind, whether on his own account or on behalf of a third party, and also shall not take any interest, active or passive, with another company whatever it may be, without Olink Proteomics SAS’s prior written authorization. | M Bruno Rossi s’interdira pendant la durée du présent contrat d’exercer toute activité professionnelle de quelque nature que ce soit, pour son compte personnel ou pour le compte d’un tiers, ainsi que d’avoir une prise d’intérêt active ou passive auprès d’une société quelle qu’elle soit, sans autorisation écrite de la Société | |
Article 4: Place of work – travels – Training |
Article 4 : Lieu de travail – déplacements – Formation professionnelle | |
4.1 M Bruno Rossi will work from home in France | 4.1 M Bruno Rossi travaillera depuis son bureau à domicile en France. |
3
4.2 M Bruno Rossi may be called to do travel in France and abroad. Consequently, he accepts to be away from his home for short periods. | 4.2 M Bruno Rossi pourra être amené à se déplacer sur l’ensemble du territoire national et à l’étranger. Aussi, il accepte d’être éloignée de son domicile pendant des périodes de courte durée. | |
Article 5: Remuneration | Article 5 : Rémunération | |
As full consideration of the performance of his duties, M Bruno Rossi will receive an annual gross remuneration of 320 000€ over 12 months. | En contrepartie de l’accomplissement de ses fonctions, M Bruno Rossi percevra un salaire annuel brut de 320 000 € sur 12 mois. | |
The Employee is also eligible to a variable yearly remuneration target (Bonus) of 50% based of the annual gross remuneration. The bonus will subject to fulfillment of specified company objectives and will be paid annually. | Le Salarié pourra en outre bénéficier d’une rémunération annuelle variable cible (bonus) égale à 50% de son salaire brut annuel. Ce bonus sera versé à la réalisation d'objectifs spécifiques de l'entreprise et sera versée annuellement. | |
Article 6: Duration of work | Article 6 : Durée du travail | |
In accordance with the collective agreement applicable, the functions of the Employee and the responsibilities which they comprise make it possible for him to benefit from a convention of annual fixed price in days, the duration of work the Employee cannot be predetermined. | Conformément à la convention collective applicable, les fonctions du Salarié et les responsabilités qu’elles comportent permettent de lui faire bénéficier d’une convention de forfait annuel en jours, la durée de travail du Salarié ne pouvant être prédéterminée. | |
Given the day of solidarity and legal and contractual leave, the annual working time of the Employee is fixed at 218 days for a calendar year workload and calculated on the basis of a full entitlement to leave. | Compte tenu de la journée de solidarité et des congés légaux et conventionnels, la durée annuelle de travail du Salarié est fixée à 218 jours pour une année civile complète de travail et calculée sur la base d’un droit intégral à congés. | |
The exercise of the missions of the Employee will be done according to a weekly distribution of his working time on all the days worked in the company. | L'exercice des missions du Salarié s'effectuera selon une répartition hebdomadaire de son temps de travail sur l'ensemble des jours travaillés dans l'entreprise. | |
The Employee being subject to a fixed-day, he can not under any circumstances claim to the payment of overtime, his salary being fixed. | Le Salarié étant soumis à un forfait-jours, il ne pourra en aucun cas prétendre au paiement d’heures supplémentaires, son salaire étant forfaitaire. | |
The pay slip of the Employee will be established without any hourly reference, with the only mention "annual fee in days" followed by the precision of the number of days provided for the year. | Le bulletin de paie du Salarié sera établi sans aucune référence horaire, avec la seule mention « forfait mensuel en jours » suivie de la précision du nombre de jours prévu pour l'année. | |
The Employee will make a monthly declaration of his days worked and not worked for the months passed. An annual summary will be sent to him at the end so that it can be verified that the ceiling is not reached at the end of the month | Le Salarié fera une déclaration mensuel de ses jours travaillés et non travaillés pour la semaines échues. Un récapitulatif annuel lui sera adressé afin qu'il puisse être vérifié que le plafond n'est pas atteint. |
4
This summary will be kept 5 years. | Ce récapitulatif sera conservé 5 années. | |
The effects of exceeding the aforementioned ceiling of days or, on the other hand, the non-fulfillment of the number of days fixed in this clause are dealt with in the collective agreement. | Les effets d'un dépassement du plafond de jours susmentionné ou, au contraire, du non- accomplissement du nombre de jours fixé dans la présente clause sont traités dans la convention collective. | |
Given the autonomy that the Employee has in the organization of his working time, he undertakes to respect in all circumstances the rest daily minimum of 11 consecutive hours, the amplitude of the working day defined in the agreement, as well as the weekly rest. | Compte tenu de l’autonomie dont le Salarié dispose dans l’organisation de son temps de travail, il s’engage à respecter en toutes circonstances le repos minimal quotidien de 11 heures consécutives, l’amplitude de la journée de travail dans l’accord, ainsi que le repos hebdomadaire. | |
An annual meeting will take place with the Employee to control his load of work and eventually reduce it. | Un entretien annuel sera réalisé avec le Salarié pour évaluer sa charge de travail et éventuellement la réduire. | |
Article 8: Professional expenses – Use of home office | Article 8 - Frais professionnels – home office | |
The professional expenses, including business travels in France and outside France, reasonably incurred by M Bruno Rossi and justified by the performance of his duties will be reimbursed to him, on presentation of receipts, and in accordance with the rules in effect in the Company. | Les frais professionnels, y compris les voyages d’affaires, raisonnablement engagés par M Bruno Rossi et justifiés par l’exercice de ses fonctions lui seront remboursés, sur présentation de justificatifs, et conformément aux règles en vigueur au sein de la Société. | |
M Bruno Rossi will sometimes work from home. The parties agree that an amount of € 100 per month will be awarded as compensation for the professional use of a room in his accommodation. | M Bruno Rossi sera parfois amené à travailler à partir de son domicile. Les parties conviennent qu’il sera alloué une somme de 100 € par mois à titre d’indemnisation pour l’usage à titre professionnel d’une pièce de son logement. | |
Article 9: Use of car | Article 9 : Usage d’un Véhicule | |
Since the Employee may use his personal car for professional travels, the Company grants him an allowance of 1200 € per month as indemnity for such use and will reimburse cost of gas or petrol, insurance and repairs as a result of the professional travels. | Dans la mesure où le Salarié pourra être amenée à utiliser son véhicule personnel pour des déplacements professionnels, la Société lui accorde une indemnité de 1200 € par mois pour cet usage et lui remboursera le coût de l'essence, de l'assurance et des réparations résultants de l'usage professionnel du véhicule | |
Article 10: Communication devices | Article 10 : Outils de communication | |
The Company provides M Bruno Rossi with a phone mobile and a laptop. | La Société fournit à M Bruno Rossi un téléphone portable et un ordinateur portable. |
5
M Bruno Rossi undertakes to return these devices to the Company if it should so request, in the event that a prolonged absence by M Bruno Rossi should constitute a suspension of his employment agreement, or if his employment agreement is terminated for any reason whatsoever. | M Bruno Rossi s’engage à remettre ces équipements à la Société dans le cas où celle-ci en ferait la demande, dans le cas où l’absence prolongée de M Bruno Rossi constituerait une suspension de son contrat de travail, ou lors de la rupture de son contrat de travail, pour quelque raison que ce soit. | |
Article 11: Absence and non-availability | Article 11 : Absence et indisponibilité | |
If M Bruno Rossi should be absent by cause of illness or accident, he shall immediately notify the Company thereof, and give evidence of it within 48 hours by producing a medical certificate. | En cas d’absence pour maladie ou accident, M Bruno Rossi devra immédiatement en aviser la Société, et en justifier par la production d’un certificat médical dans les 48 heures. | |
Article 12: Welfare and Benefits | Article 12 : Protection sociale et avantages Sociaux | |
M Bruno Rossi will benefit from all retirement and pension scheme and welfare scheme granted by the Company according to the law and the Collective agreement applicable. | M Bruno Rossi bénéficiera de tous les avantages de retraite et de prévoyance accordés par la Société du fait de la loi et de la convention collective. | |
The complementary pension scheme is managed by AGIRC ARRCO. | Le régime de retraite complémentaire est géré par AGIRC ARRCO. | |
Article 13: Paid holidays | Article 13 : Congés payés | |
M Bruno Rossi will be entitled to the benefit of paid holidays under the conditions specified by law ie 25 business days. | M Bruno Rossi bénéficiera des congés payés conformément à la législation soit 25 jours ouvrés. | |
The period at which these holidays will be taken is jointly determined between the Parties, in light of operational requirements. | La période de ces congés sera déterminée en accord entre les Parties, compte tenu des nécessités de l’entreprise. | |
Article 14: Confidentiality and intellectual property | Article 14 : Confidentialité et propriété intellectuelle | |
14.1 M Bruno Rossi agrees not to make use of, or disclose or divulge to any third party, without the prior written consent of the Company, any information of a confidential nature relating to the business or the affairs of the Company or any of its affiliates or clients. M Bruno Rossi agrees to, if so requested by the Company, sign a non disclosure agreement which, agreement will in detail (in addition to the above) regulate the confidentiality obligations. | 14.1 M Bruno Rossi s’engage à ne pas utiliser ou dévoiler ou divulguer à aucun tiers, sans le consentement préalable écrit de la Société, aucune information de nature confidentielle concernant l’activité ou les affaires de la Société ou toute entité qui lui est liée. A ce titre, le Salarié s’engage à signer un accord de confidentialité si la Société le requiert et qui régira l’obligation de confidentialité. |
6
In “Confidential information” as used in this provision, is included any information – technical, commercial or of any other nature – regardless of whether or not the information is documented, with exception of information which is or becomes generally known or which has come or comes to general knowledge other than through M Bruno Rossi’s employment. | Par « Information Confidentielle », il est entendu toute information – technique, commerciale ou de toute nature – peu importe que l’information soit ou non détaillée, à l’exception des informations relevant du domaine public ou venant à tomber dans le domaine public dès lors que cela n’est pas dû à une violation de la confidentialité par M Bruno Rossi. | |
M Bruno Rossi shall take all reasonable steps to minimize the risk of disclosure of confidential information to any third party. All reasonable precautions shall be taken to prevent unauthorized use thereof or any persons getting access to secret or confidential information. | M Bruno Rossi devra prendre toutes les précautions requises pour éviter tout risque de connaissance d’informations confidentielles par des tiers. Toutes les précautions raisonnables devront être prises pour empêcher toute utilisation non autorisée ou l’accès à des informations secrètes ou confidentielles. | |
M Bruno Rossi is aware of and acknowledges that especially all business and strategic information of the Company and their customers, with no limitation intended, is extremely sensitive and any disclosure or unauthorized use of such information is likely to materially harm the Company. | M Bruno Rossi reconnaît être conscient que toutes les informations techniques et scientifiques relatives à la Société et à ses clients, sans aucune limite, sont extrêmement sensibles et que toute révélation ou utilisation non autorisée de telles informations porterait préjudice à la Société. | |
14.2 M Bruno Rossi acknowledges and accepts that all inventions, including, but not limited to development, discoveries, concepts, ideas, processes, and products as well as improvements or know-how concerning them (whether these are patentable inventions or protected by copyright or not or inventions that provide entitlement to royalties, and collectively referred to as “the inventions”), relating to all the activities of M Bruno Rossi’s duties or performances according to this Contract shall be the exclusive property of the Company (without limitation) as the case may be. | 14.2 M Bruno Rossi reconnaît et accepte que toutes les inventions, y compris, notamment, le développement, les découvertes, les concepts, les idées, les processus, les logiciels, les techniques, les formules et les produits ainsi que les améliorations ou le savoir-faire les concernant (qu’il s’agisse ou non d’inventions brevetables ou donnant droit à des droits d’auteur), se rapportant à toutes les activités de la Société pendant sa durée de service sont la propriété exclusive de la Société. | |
M Bruno Rossi acknowledges and accepts that all inventions and copyright that have to do with the Company’s products and services manufactured, created or designed by M Bruno Rossi , alone or with others, during the employment, shall be the exclusive property of the Company (without limitation in time). | M Bruno Rossi reconnaît et accepte que toutes les inventions ayant trait aux produits de la Société, fabriqués ou conçus par lui, seul ou avec d’autres, pendant sa période de service au sein de la Société, ou en utilisant les installations, le matériel ou le personnel de la Société, que l’invention ait été conçue, développée ou mise en pratique pendant la durée du travail de M Bruno Rossi , ou qui ont été suggérées par lui ou qui résultent ou proviennent d’une manière ou d’une autre du travail de M Bruno Rossi au sein de la Société, sont la propriété exclusive de la Société. | |
M Bruno Rossi agrees to sign any form or document to help to protect all the intellectual property rights of the Company if so requested by the Company. | M Bruno Rossi devra apporter son concours afin de préserver l’ensemble des droits de propriété intellectuelle de la Société. | |
M Bruno Rossi agrees and acknowledges that he can be liable and obliged to pay indemnities to the Company if she should be or act in violation with this article. | M Bruno Rossi pourra être tenue responsable et condamnée au paiement de dommages et intérêts en cas de violation de la présente clause. |
7
Article 15: Return of property | Article 15 : Restitution | |
M Bruno Rossi undertakes explicitly, on the day that his duties according to this contract cease, without any further steps needing to be taken and without any prior notice from the Company, to return any property or documents (whether physical or in electronic form) belonging to the Company. | M Bruno Rossi’s engage expressément à restituer, le jour même de la cessation effective de ses fonctions dans la Société, et ce sans qu’il soit besoin d’aucune démarche ou d’une mise en demeure préalable de la Société, ou préalablement sur demande de la Société, tout bien et/ou document appartenant à la Société. | |
Article 16: Termination of the agreement | Article 16 : Rupture du contrat | |
Save dismissal for gross or willful misconduct (“faute grave ou lourde”), either party may terminate this agreement, subject to providing prior notice as set by the Law and/or the applicable collective bargaining agreement. | Sauf licenciement pour faute grave ou lourde, ou cas de force majeure, chacune des parties pourra mettre fin au contrat de travail, sous réserve du préavis prévu par la loi et/ou la convention collective applicable. | |
By gross or willful misconduct, the Company and the Employee recognize that breach of confidentiality, competing business with another company, secret information or documents of the Company transmitted to a third party without the agreement of the Company from the Employee shall constitute major situations leading to the immediate lay-off of the Employee. In such cases, the Employee shall be obliged and liable to pay indemnities to the Company. | Par faute grave ou lourde, les parties reconnaissent que le défaut de confidentialité, le fait d’être en relation d'affaires concurrentielle avec une autre société, la divulgation de secret ou de documents à un tiers par le Salarié constituent des fautes majeures devant mener au licenciement immédiat du Salarié. Dans de telles circonstances, le Salarié pourra être tenu d’indemniser la Société pour le préjudice subi. | |
Article 17 : Non-Compete | Article 17 : Non-concurrence | |
In the event that the Employee leaves the Company for any reason, the Employee undertakes, not to enter the service of another firm manufacturing or selling products or services that could compete with those of the company, to create a firm of the same type or participate directly or indirectly in any capacity. | En cas de départ de la Société, quels qu'en soient la cause et l'auteur, le Salarié s'engage expressément à ne pas entrer au service d’une entreprise fabriquant ou vendant des produits ou services susceptibles de concurrencer ceux de la Société, de créer pour son propre compte une entreprise du même genre ou d’y participer directement ou indirectement, en quelque qualité que ce soit. | |
For this purpose, the employee undertake in particular, for any products or service that might compete with the products or services of the company, not to visit or contact the Company’s clients or to deal with any individual or company that was a client of the company with whom the Employee was in contact at any time during the years preceding your actual departure of the company. | A ce titre, le Salarié s'interdit notamment, s’agissant de tout produit ou service susceptible de concurrencer les produit ou services de la Société, de prospecter la clientèle de la Société et de traiter avec toute personne physique ou morale qui aura été le client de la Société et avec lequel le Salarié aurez été en relation pendant les années précédant votre départ effectif de la Société. | |
It is expressly agreed that the performance of this clause is limited to a period of one (1) year as from the date of the employee actual departure from the company and applies to all geographies. | Il est expressément convenu que l’exécution de la présente clause est limitée à une période d’un (1) an à compter de la date de votre départ effectif de la Société, et s'applique à toutes les zones géographiques. |
8
During this period of non-compete and under the condition that the employee comply with this non-competition obligation, the employee will receive a monthly indemnity provided by the collective bargaining agreement applicable to the company, it being understood that this indemnity will be subject to social security deductions. | Pendant toute cette période de non-concurrence et sous réserve du respect de l'obligation du Salarié obligation de non-concurrence, la Société versera au Salarié une indemnité mensuelle telle que prévue par la Convention Collective applicable à la Société, étant entendu que cette indemnité sera assujettie aux contributions sociales. | |
It is agreed that, in any case, the company shall be entitled to reduce the duration of the period of application of the non-compete clause, or to waive this clause, provided however that it informs the employee thereof by registered letter with return receipt requested in accordance with the provisions of the collective bargaining agreement applicable to the company. | Il est entendu qu’en toutes circonstances, la Société aura la possibilité soit de réduire la durée de la période d’application de la clause de non-concurrence, sout de renoncer à cette dernière à condition d'en informer le Salarié par lettre recommandée avec accusé de réception conformément aux dispositions de la Convention Collective applicable à la Société. | |
Any violation of the present non-competition clause will automatically make you liable to a flat-rate penalty fixed at the net amount of your salary received during the last 6 months of activity due for each infringement found. | Compte tenu de l’extrême sensibilité des connaissance et informations techniques et commerciales auxquelles vous avez accès dans l’exercice des fonctions du Salarié dans le cadre du présent contrat, et de la nature excessivement concurrentielle et sensible des activités de la Société, les parties conviennent expressément de la nécessité d’une clause de non-concurrence pour protéger les intérêts légitimes de la Société. | |
This penalty is due notwithstanding any damages that may be claimed by the company due to the damage suffered by the company as a result of the non-respect of tour non-competition clause. | ||
Article 18 : Non sollicitation | Article 18 : Non sollicitation | |
In the event that the Employee leaves the Company for any reason, the Employee undertakes, for a period of 12 months immediately following the date the termination letter is first presented, not to directly or indirectly solicit, induce, or recruit any of the Company's employees either directly or indirectly, or encourage them to leave their employment. | En cas de départ de la Société, quels qu'en soient la cause et l'auteur, le Salarié s'engage à ne pas faire appel et à n'engager directement, indirectement ou par personne interposée ou à inciter à quitter la Société, aucun personnel de la Société et ceci pour une durée de 12 mois, à compter de la date de première présentation de la lettre notifiant la rupture du contrat de travail. |
9
Clause 19 : Liquidated damages | Article 19 : Clause pénale | |
Any breach to the prohibitions referred to in clauses 14 (confidentiality and Intellectual property), and 17 and 18 of the present contract, shall make the Employee automatically liable for liquidated damages defined herein as a lump sum corresponding to the salary paid over the last 6 months of the contract's existence. The Company reserves the right to claim for compensation in addition to the abovementioned amount if the Company could demonstrate that the said amount is not sufficient for covering the damages suffered by the Company due to such breach. These damages shall be due for each breach noted, without formal notice to cease the activity resulting in the breach being required. | Toute infraction aux interdictions stipulées à l'article 14 (confidentialité et propriété intellectuelle), ou à l'article 17 & 18 du présent contrat rendra le Salarié automatiquement redevable d'une pénalité fixée dès à présent et forfaitairement au montant des salaires, qu'elle aura encaissés pendant les 6 derniers mois de l'existence du contrat, pénalité due pour chaque infraction constatée sans qu'il soit besoin d'une mise en demeure de faire cesser l'activité interdite et sans préjudice de toute autre action de la Société visant à la réparation de son entier préjudice causé par le Salarié. | |
The Company expressly reserves the right to file proceedings to obtain the reimbursement of the effective damage from the Employee, and to order them to cease all activity resulting in the breach subject to penalties for delay, by any legal means. | La présente pénalité ne porte pas atteinte au droit, que la Société se réserve expressément, de poursuivre le Salarié en remboursement du préjudice effectivement subi et de faire ordonner sous astreinte la cessation du trouble par toutes voies et moyens de droit. | |
Article 20 : Applicable Law and special provisions | Article 20 : Loi applicable et dispositions particulières | |
This agreement and the rights and obligations of the parties arising out of it shall be governed by and interpreted according to French law. | Le présent contrat ainsi que les droits et obligations des parties en découlant seront régis et interprétés en conformité avec la loi française. | |
French courts are the only ones with jurisdiction in relation to the performance, interpretation and termination of this employment agreement. | Les juridictions françaises sont les seules compétentes quant à l’exécution, l’interprétation et la rupture du présent contrat de travail. | |
If a clause of this agreement should be deemed to be illegal, unfounded or invalid for any reason whatsoever, this will not affect the validity of the other provisions of the agreement. | Au cas où une clause du présent contrat serait réputée illégale, sans effet ou non valable pour quelque raison que ce soit, cela n’affecterait pas la validité des autres dispositions du contrat. |
10
Executed at OTTROTT | Fait à OTTROTT | ||
On 12/19/ 2022 | Le 12/19/2022 | ||
In two copies | En deux exemplaires originaux | ||
M Bruno Rossi | M Bruno Rossi | ||
Signature: | /s/ Bruno Rossi | Signature: | /s/ Bruno Rossi |
For Olink Proteomics SAS | Pour Olink Proteomics SAS | ||
M Oskar Hjelm | M Oskar Hjelm | ||
Signature: | /s/ Oskar Hjelm | Signature: | /s/ Oskar Hjelm |
12/19/2022 | 12/19/2022 |
11
Exhibit (e)(16)
OLINK HOLDING AB (publ)
AMENDED AND RESTATED 2021 INCENTIVE AWARD PLAN
2023 INTERNATIONAL RESTRICTED STOCK UNIT AWARD GRANT NOTICE
Olink Holding AB (publ), a Swedish public limited liability company (the “Company”), pursuant to its Amended and Restated 2021 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the holder listed below (the “Participant”), an award of restricted stock units (“Restricted Stock Units” or “RSUs”) in accordance with the percentage of the Participant’s base salary as notified to the Participant in the Equity section of the Company’s Bob HR system, at a per-unit price equal to the public price for one of the Company’s ADRs at market close on April 6, 2023. Each vested Restricted Stock Unit represents the right to receive, in accordance with the International Restricted Stock Unit Award Agreement attached hereto as Exhibit A and any additional terms and conditions, as set forth in Exhibit B, if applicable (Exhibits A and B together, the “Agreement”), such number of Shares (as defined in the Plan) or cash equal to the Fair Market Value of a Share upon vesting. This award of Restricted Stock Units is subject to all of the terms and conditions set forth herein and in the Agreement and the Plan, each of which are incorporated herein by reference, including all exhibits and attachments thereto. Unless otherwise defined herein, capitalized terms used in this International Restricted Stock Unit Award Grant Notice (the “Grant Notice”) and the Agreement shall have the same defined meanings as the terms defined in the Plan.
Vesting Commencement Date: | 7 April, 2023 |
Vesting Schedule: | The RSUs shall vest in equal installments on each of the first four anniversaries of the Vesting Commencement Date set forth above, provided the Participant has not experienced a Termination of Service on or prior to the applicable vesting date. |
Termination: | To the extent that the RSUs have not vested on the Participant’s Termination of Service, they shall terminate as of the applicable termination date. |
By the Participant’s electronic acceptance on the Olink Global Shares Equity Gateway platform (the “Global Shares Platform”), the Participant agrees to be bound by the terms and conditions of the Plan, the Agreement and this Grant Notice. The Participant has reviewed the Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the Agreement and the Plan. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, this Grant Notice or the Agreement. The Participant further agrees hereby that, as a condition to the receipt of Shares following settlement of the RSUs, the Participant may be required to execute such other agreement, as the Administrator may determine in its sole and absolute discretion. In addition, by electronically accepting on the Global Shares Platform, as applicable, the Participant also agrees that the Company, in its sole discretion, may satisfy any withholding obligations using any method permitted under Section 10.4 of the Plan.
1
Exhibit A
TO INTERNATIONAL RESTRICTED STOCK UNIT AWARD GRANT NOTICE
INTERNATIONAL RESTRICTED STOCK UNIT AWARD AGREEMENT
1.1 Pursuant to the International Restricted Stock Unit Award Grant Notice (the “Grant Notice”) to which this International Restricted Stock Unit Award Agreement (together with any additional terms and conditions, as set forth in Exhibit B, if applicable, the “Agreement”) is attached, Olink Holding AB (publ), a Swedish public limited liability company (the “Company”), has granted to the Participant the number of restricted stock units (“Restricted Stock Units” or “RSUs”) set forth in the Grant Notice under the Company’s Amended and Restated 2021 Incentive Award Plan, as amended from time to time (the “Plan”). Each Restricted Stock Unit represents the right to receive either (i) one American Depositary Share or American Depositary Receipt of the Company, representing an ordinary share of Common Stock of the Company (a “Share”) or (ii) cash equal to the Fair Market Value of one Share, upon vesting of such RSU.
ARTICLE 1.
GENERAL
1.1 Defined Terms. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and Grant Notice.
1.2 Incorporation of Terms of Plan. The RSUs are subject to the terms and conditions of the Plan, which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.
ARTICLE 2.
GRANT OF RESTRICTED STOCK UNITS
2.1 Grant of RSUs. Pursuant to the Grant Notice and upon the terms and conditions set forth in the Plan and this Agreement, effective as of [the Grant Date set forth in the Grant Notice, the Company hereby grants to the Participant an award of RSUs under the Plan in consideration of the Participant’s continued employment with or service to the Company or any Subsidiaries and for other good and valuable consideration.
2.2 Unsecured Obligation to RSUs. Unless and until the RSUs have vested in the manner set forth in Article 2 hereof, the Participant will have no right to receive Shares (or cash equal to the Fair Market Value of such Shares) under any such RSUs. Prior to actual payment of any vested RSUs, such RSUs will represent an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company.
2.3 Vesting Schedule. Subject to Section 2.5 hereof, the RSUs shall vest and become nonforfeitable with respect to the applicable portion thereof according to the vesting schedule set forth in the Grant Notice (rounding down to the nearest whole Share).
2.4 Consideration to the Company. In consideration of the grant of the award of RSUs pursuant hereto, the Participant agrees to render faithful and efficient services to the Company or any Subsidiary.
2
2.5 Forfeiture, Termination and Cancellation upon Termination of Service. Upon the Participant’s Termination of Service for any or no reason, all Restricted Stock Units which have not vested prior to or in connection with such Termination of Service shall thereupon automatically be forfeited, terminated and cancelled as of the applicable termination date without payment of any consideration by the Company, and the Participant, or the Participant’s beneficiary or personal representative, as the case may be, shall have no further rights hereunder. For the avoidance of doubt, providing service during only a portion of the vesting period prior to a vesting date shall not entitle the Participant to vest in a pro-rata portion of the unvested RSUs that would have vested as of such vesting date, nor will it entitle the Participant to any compensation for the lost vesting.
2.6 Issuance of Cash or Shares upon Settlement.
(a) As soon as administratively practicable following the vesting of any Restricted Stock Units pursuant to Section 2.3 hereof, but in no event later than thirty (30) days after such vesting date (for the avoidance of doubt, this deadline is intended to comply with the “short term deferral” exemption from Section 409A of the Code, to the extent applicable), the Company shall deliver to the Participant (or any Permitted Transferee), as determined by the Administrator in its sole discretion, either (i) a number of Shares equal to the number of RSUs subject to this Agreement that vest on the applicable vesting date or (ii) cash equal to the Fair Market Value of the Shares that vest on the applicable vesting date. Notwithstanding the foregoing, in the event Shares cannot be issued pursuant to the Plan, the Shares shall be issued pursuant to the preceding sentence as soon as administratively practicable after the Administrator determines that Shares can again be issued.
(b) As set forth in Section 10.4 of the Plan, the Company shall have the authority and the right to deduct or withhold, or to require the Participant to remit to the Company, an amount sufficient to satisfy all applicable foreign, federal, state and local taxes and/or social security, social insurance or national insurance contributions required by law to be withheld with respect to any taxable event arising in connection with the Restricted Stock Units. The Company shall not be obligated to deliver any Shares to the Participant or the Participant’s legal representative unless and until the Participant or the Participant’s legal representative shall have paid or otherwise satisfied in full the amount of all foreign, federal, state and local taxes and/or social security, social insurance or national insurance contributions applicable to the taxable income of the Participant (a “Tax Liability” being any liability for income tax, withholding tax, fringe benefit tax and any other employment related taxes or social security, social insurance or national insurance contributions payable by or on behalf of Participant in any jurisdiction) resulting from the grant or vesting of the Restricted Stock Units or the issuance of Shares.
(c) Participant agrees to indemnify and keep indemnified the Company, any Subsidiary and Participant’s employing company, if different, from and against any liability for or obligation to pay any portion of the Tax Liability, payable by the Company in respect of the Participant’s Tax Liability, that is attributable to (i) the vesting or settlement of, or any benefit derived by Participant from, the Restricted Stock Units, (ii) the acquisition by Participant of the Shares on settlement of the Restricted Stock Units or (iii) the disposal of any Shares.
(d) Participant hereby acknowledges that the Company (i) makes no representations or undertakings regarding the treatment of any Tax Liabilities in connection with any aspect of the Restricted Stock Units and (ii) does not commit to and is under no obligation to structure the terms of the grant or any aspect of any Award, including the Restricted Stock Units, to reduce or eliminate Participant’s liability for Tax Liabilities or achieve any particular tax result. Furthermore, if Participant becomes subject to tax in more than one jurisdiction between the date of grant of an Award, including the Restricted Stock Units, and the date of any relevant taxable event, Participant acknowledges that the Company may be required to withhold or account for Tax Liabilities in more than one jurisdiction.
3
2.7 Conditions to Delivery of Shares. The Shares deliverable hereunder may be treasury Shares or issued Shares which have then been reacquired by or held on behalf the Company. Such Shares shall be fully paid and nonassessable. The Company shall not be required to issue Shares deliverable hereunder prior to fulfillment of the conditions set forth in Section 10.6 of the Plan, including without limitation, the receipt by the Company of full payment of any applicable Tax Liability.
2.8 Rights as Stockholder. The holder of the RSUs shall not be, nor have any of the rights or privileges of, a stockholder of the Company, including, without limitation, voting rights and rights to dividends, in respect of the RSUs and any Shares underlying the RSUs and deliverable hereunder unless and until such Shares shall have been issued by the Company and held of record by such holder (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Article IX of the Plan.
ARTICLE 3.
OTHER PROVISIONS
3.1 Administration. The Administrator shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be final and binding upon the Participant, the Company and all other interested persons. No member of the Administrator or the Board shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the RSUs.
3.2 RSUs Not Transferable. The RSUs shall be subject to the restrictions on transferability set forth in Section 10.1 of the Plan.
3.3 Tax Consultation. The Participant represents that the Participant has consulted with any tax consultants the Participant deems advisable in connection with the RSUs and the issuance of Shares with respect thereto and that the Participant is not relying on the Company for any tax advice.
3.4 Binding Agreement. Subject to the limitation on the transferability of the RSUs contained herein, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
3.5 Adjustments Upon Specified Events. The Administrator may accelerate the vesting of the RSUs in such circumstances as it, in its sole discretion, may determine. The Participant acknowledges that the RSUs are subject to adjustment, modification and termination in certain events as provided in this Agreement and Article IX of the Plan.
3.6 Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company’s principal office, and any notice to be given to the Participant shall be addressed to the Participant at the Participant’s last address reflected on the Company’s records. By a notice given pursuant to this Section 3.6, either party may hereafter designate a different address for notices to be given to that party. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service (or any similar foreign entity).
3.7 Participant’s Representations. If the Shares issuable hereunder have not been registered under the Securities Act or any applicable state laws on an effective registration statement at the time of such issuance, the Participant shall, if required by the Company, concurrently with such issuance, make such written representations as are deemed necessary or appropriate by the Company and/or its counsel.
4
3.8 Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.
3.9 Governing Law. Governing Law and Dispute Resolution. The laws of Sweden shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. Any dispute, controversy or claim arising out of or in connection with this Agreement, or the breach, termination or invalidity thereof, shall be finally settled by arbitration administered by the Arbitration Institute of the Stockholm Chamber of Commerce (the “SCC”).
The Rules for Expedited Arbitrations shall apply, unless the SCC in its discretion determines, taking into account the complexity of the case, the amount in dispute and other circumstances, that the Arbitration Rules shall apply. In the latter case, the SCC shall also decide whether the Arbitral Tribunal shall be composed of one or three arbitrators. The seat of arbitration shall be Stockholm, Sweden. The language to be used in the arbitral proceedings shall be English.
3.10 Conformity to Securities Laws. The Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act and any other Applicable Law, including, without limitation, any rules or regulations of any securities exchange or automated quotation system on which the Shares are listed, quoted or traded. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the RSUs are granted, only in such a manner as to conform to Applicable Law. To the extent permitted by Applicable Law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such Applicable Law.
3.11 Amendment, Suspension and Termination. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the Board; provided, however, that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the RSUs in any material way without the prior written consent of the Participant.
3.12 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section 3.2 hereof, this Agreement shall be binding upon the Participant and his or her heirs, executors, administrators, successors and assigns.
3.13 Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if the Participant is subject to Section 16 of the Exchange Act, then the Plan, the RSUs and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.
3.14 Not a Contract of Service Relationship. Nothing in this Agreement or in the Plan shall confer upon the Participant any right to continue to serve as an employee or other Service Provider of the Company or any of its Subsidiaries or interfere with or restrict in any way with the right of the Company or any of its Subsidiaries, which rights are hereby expressly reserved, to discharge or to terminate for any reason whatsoever, with or without cause, the services of the Participant at any time (unless otherwise required by Applicable Law or any service agreement by and between the Participant and the Participant’s employer).
5
3.15 Entire Agreement. The Plan, the Grant Notice and this Agreement (including all Exhibits thereto, if any) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and the Participant with respect to the subject matter hereof.
3.16 Section 409A. The RSUs are not intended to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, “Section 409A”). However, notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any time the Administrator determines that the RSUs (or any portion thereof) may be subject to Section 409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate for the RSUs either to be exempt from the application of Section 409A or to comply with the requirements of Section 409A.
3.17 Limitation on Participant’s Rights. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. The Participant shall have only the rights of a general unsecured creditor of the Company and its Subsidiaries with respect to amounts credited and benefits payable, if any, with respect to the RSUs, and rights no greater than the right to receive the Shares as a general unsecured creditor with respect to RSUs, as and when payable hereunder.
3.18 Nature of Grant. By accepting the RSUs, the Participant acknowledges, understands and agrees that:
(a) the Plan is established voluntarily by the Company, is wholly discretionary in nature and may be modified, amended, suspended, or terminated by the Company at any time, to the extent permitted by the Plan;
(b) the grant of the RSUs is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of RSUs, or benefits in lieu of RSUs, even if RSUs have been granted in the past;
(c) all decisions with respect to future grants of RSUs or other grants, if any, will be at the sole discretion of the Company;
(d) the RSUs and the Participant’s participation in the Plan shall not create a right of employment or other service relationship with the Company;
(e) the RSUs and the Participant’s participation in the Plan shall not be interpreted as forming or amending an employment or service contract with the Company or the employing company (if different), and shall not interfere with the ability of the Company, the employing company (if different) or any Subsidiary, as applicable, to terminate the Participant’s employment or service relationship (if any);
(f) the Participant is voluntarily participating in the Plan;
(g) the RSUs and any Shares acquired under the Plan, and the income from and value of the same, are not intended to replace any pension rights or compensation;
6
(h) the RSUs and any Shares acquired under the Plan, and the income from and value of the same, are not part of normal or expected compensation for any purposes, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, holiday pay, pension or retirement or welfare benefits or similar payments;
(i) the future value of the Shares underlying the RSUs is unknown, indeterminable, and cannot be predicted with certainty;
(j) no claim or entitlement to compensation or damages shall arise from forfeiture of any portion of the RSUs resulting from the Participant’s Termination of Service (for any reason whatsoever and regardless of whether or not later found to be invalid or in breach of Applicable Laws in the jurisdiction where the Participant is providing service or the terms of the Participant’s employment or other service agreement, if any);
(k) unless otherwise agreed with the Company in writing, the RSUs and the Shares subject to the RSUs, and the income from and value of the same, are not granted as consideration for, or in connection with, the service the Participant may provide as a director of a Subsidiary;
(l) unless otherwise provided in the Plan or by the Company in its discretion, the RSUs and the benefits evidenced by this Agreement do not create any entitlement to have the RSUs or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; and
(m) neither the Company, the employing company (if different) nor any other Subsidiary shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the U.S. dollar that may affect the value of the RSUs or of any amounts due to the Participant pursuant to the vesting of the RSUs or the subsequent sale of any Shares acquired upon settlement of the RSUs.
3.19 Data Privacy. Without limiting any other provisions of this Agreement, Section 11.8 of the Plan is hereby incorporated into this Agreement as if first set forth herein.
(a) Data Collection and Usage. The Company collects, processes, transfers and uses personal data about the Participant that is necessary for the purpose of implementing, administering and managing the Plan. This personal data may include the Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any shares or directorships held in the Company, and details of all awards or other entitlements to Shares, granted, canceled, exercised, vested, unvested or outstanding in the Participant’s favor ("Data"), which the Company receives from the Participant or the Participant's employer (if different). If the Company offers the Participant an Award under the Plan, then the Company will collect Data for purposes of granting Awards and implementing, administering and managing the Plan and will process such Data in accordance with the Company’s then-current data privacy policies, which are made available to the Participant upon commencing employment and also available upon request. The legal basis, where required, for the processing of Data is the Participant’s consent.
7
(b) Stock Plan Administration Service Providers. The Company may transfer Data to an independent stock-plan administrator and other third parties based in Ireland, or elsewhere, which assists the Company with the implementation, administration and management of the Plan. In the future, the Company may select a different service provider and share Data with another company that serves in a similar manner. The Participant understands that the recipients of the Data may be located in Ireland or elsewhere, and that the recipients’ country (e.g., Ireland) may have different data privacy laws and protections than the Participant’s country. The Company’s service provider may open an account for the Participant to receive Shares pursuant to the Participant’s Award. The Participant will be asked to agree to separate terms and data processing practices with the service provider, which is a condition to the Participant’s ability to participate in the Plan. The Participant understands that the Participant may request a list with the names and addresses of any potential recipients of the Data by contacting the Participant’s local human resources representative. The Participant authorizes the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Participant’s participation in the Plan.
(c) Data Retention. The Company will use Data only as long as is necessary to implement, administer and manage the Participant’s participation in the Plan or as required to comply with legal or regulatory obligations, including under securities, exchange control, tax and employment laws. When the Company no longer needs the Participant’s Data, the Company will remove it from its systems. If the Company keeps the data longer, it would be to satisfy legal or regulatory obligations and the Company’s legal basis would be relevant laws or regulations.
(d) Consent; Voluntariness and Consequences of Denial or Withdrawal. Where permitted by Applicable Laws, consent is a requirement for participation in the Plan. In such cases, by accepting this Restricted Stock Unit, the Participant agrees with the data processing practices as described in this Agreement and grants such consent to the processing and transfer of Data as described in this Agreement and as necessary for the purpose of administering the Plan. The Participant’s participation in the Plan and the Participant’s grant of consent is purely voluntary. The Participant may deny or withdraw the Participant’s consent at any time; provided, that if the Participant does not consent, or if the Participant withdraws the Participant’s consent, the Participant cannot participate in the Plan unless required by Applicable Law. This would not affect the Participant’s salary or other compensation or the Participant's status as a Service Provider; the Participant would merely forfeit the opportunities associated with the Plan.
(e) Data Subject Rights. The Participant has a number of rights under data privacy laws in the Participant’s country. Depending on where the Participant is based, the Participant’s rights may include the right to (i) request access or copies of Data the Company processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing, (v) portability of Data, (vi) to lodge complaints with the competent tax authorities in the Participant’s country and/or (vii) a list with the names and addresses of any potential recipients of Data.
(f) GDPR Compliance. To the satisfaction and at the direction of the Company, all operations of the Plan, the RSUs and the Shares (at the time of grant and as necessary thereafter) shall include or be supported by appropriate agreements, notifications and arrangements in respect of Data and its use and processing under the Plan, in order to secure (i) the reasonable freedom of the Company or any Subsidiary, as appropriate, to operate the Plan and for connected purposes, and (ii) compliance with the data-protection requirements applicable from time to time, including, if applicable, and without limitation, Regulation EU 2016/679 of the European Parliament and of the Council of April 27, 2016.
3.20 Other Agreements. The Participant further agrees hereby that, as a condition to the grant of and/or the receipt of Shares following settlement of the RSUs, the Participant may be required to execute such other agreement, as the Administrator may determine in its sole and absolute discretion.
3.21 Language. The Participant acknowledges that the Participant is sufficiently proficient in English to understand the terms and conditions of this Agreement. Furthermore, if the Participant has received this Agreement, or any other document related to the Award and/or the Plan translated into a language other than English and if the meaning of the translated version is different from the English version, the English version will control.
8
3.22 Foreign Asset/Account Reporting Requirements. The Participant acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect the Participant’s ability to acquire or hold Shares acquired or received under the Plan or cash received from participating in the Plan in a brokerage account outside the Participant’s country. The Participant may also be required to repatriate sale proceeds or other funds received as a result of participating in the Plan to the Participant’s country through a designated bank or broker within a certain time after receipt. It is the Participant’s responsibility to be compliant with such regulations and the Participant should speak with the Participant’s personal advisor on this matter.
3.23 Insider Trading Restrictions/Market Abuse Laws. The Participant acknowledges that the Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, which may affect the Participant’s ability to directly or indirectly, accept, acquire, sell or attempt to sell or otherwise dispose of Shares or rights to the Shares, or rights linked to the value of Shares during such times as the Participant is considered to have “inside information” regarding the Company (as defined by the laws and/or regulations in applicable jurisdictions or the Participant’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders placed by the Participant before possessing the inside information. Furthermore, the Participant may be prohibited from (a) disclosing inside information to any third party, including fellow employees (other than on a “need to know” basis) and (b) “tipping” third parties or otherwise inducing them to buy or sell securities. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant acknowledges that it is the Participant’s responsibility to comply with any applicable restrictions, and the Participant is advised to speak to the Participant’s personal advisor on this matter.
3.24 Waiver. The Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by the Participant.
3.25 Appendix. Notwithstanding any provisions in this Agreement, the RSUs shall be subject to any additional terms and conditions set forth in the Appendix to this Agreement for the Participant’s country. Moreover, if the Participant relocates to one of the countries included in the Appendix, the additional terms and conditions for such country will apply to the Participant to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The Appendix constitutes part of this Agreement.
3.26 Imposition of Other Requirements. The Company reserves the right to impose other requirements on the RSUs and the Shares issuable thereunder, to the extent the Company determines it is necessary or advisable in order to comply with local laws or facilitate the administration of the Plan, and to require the Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
3.27 Severability. If any portion of the Grant Notice or this Agreement or any action taken under the Grant Notice or this Agreement, in any case is held illegal or invalid for any reason, the illegality or invalidity will not affect the remaining parts of the Grant Notice and/or this Agreement (as applicable), and the Grant Notice and/or this Agreement (as applicable) will be construed and enforced as if the illegal or invalid provisions had been excluded, and the illegal or invalid action will be null and void.
3.28 Electronic Delivery and Participation. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. The Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the company or a third party designated by the Company.
9
ARTICLE 4.
CONFIDENTIALITY
4.1 Confidentiality. Except with the express written consent of the Board, the Participant will not, either during the term of the Participant’s employment or service with the Company or anytime thereafter, directly or indirectly, use or disclose for the benefit of the Participant or any other person, firm or entity, any of the trade secrets or confidential information of the Company, whether or not said information was acquired, learned, obtained or developed by the Participant alone or in conjunction with others. For purposes of this Agreement, trade secrets shall mean that which is known only to the Company and those employees or other agents to whom it has been confided, and is by law the property of the Company, and shall include all information relating to design and manufacturing procedures, techniques, programs, business systems, processes, methods, and marketing studies. It is the intent hereof that the Participant shall not divulge or use any information which is unpublished or not otherwise readily available to the public or which is not general information in the business of the Company. In addition and notwithstanding anything to the contrary in this Agreement, pursuant to the federal U.S. Defend Trade Secrets Act of 2016, the Participant shall not be held civilly or criminally liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state or local governmental official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
10
EXHIBIT B
APPENDIX TO
INTERNATIONAL RESTRICTED STOCK UNIT AWARD AGREEMENT
ADDITIONAL TERMS & CONDITIONS FOR NON-U.S. PARTICIPANTS
Capitalized terms not specifically defined herein shall have the meanings specified in the Plan, Agreement and Grant Notice.
Terms and Conditions
This Appendix includes special and/or additional terms and conditions that govern the RSUs granted to the Participant under the Plan if the Participant resides and/or works in one of the countries listed below. These terms and conditions are in addition to or, if so indicated, in place of, the terms and conditions set forth in the Agreement. If the Participant is a citizen or resident of a country other than the one in which he or she is currently residing and/or working, transfers residency and/or employment to another country after the grant of the Award, or is considered resident of another country for local law purposes, the Administrator shall, in its discretion, determine to what extent the terms and conditions contained herein shall be applicable to the Participant.
Notifications
This Appendix also includes information regarding tax, securities law, exchange controls and certain other issues of which the Participant should be aware with respect to the Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of February 2022. Such laws are often complex and change frequently. As a result, the Company strongly recommends that the Participant not rely on the information in this Appendix as the only source of information relating to the consequences of the Participant’s participation in the Plan because the information may be out of date at the time that the RSUs vest or Shares acquired under the Plan are sold.
In addition, the information contained herein is general in nature and may not apply to the Participant’s particular situation and the Company is not in a position to assure the Participant of any particular result. Accordingly, the Participant should seek appropriate professional advice as to how the relevant laws in his or her country may apply to the Participant’s situation.
Finally, if the Participant is a citizen or resident of a country other than the one in which he or she is currently residing and/or working, transfers residency and/or employment to another country after the grant of the Award, or is considered a resident of another country for local law purposes, the information contained herein may not be applicable to the Participant in the same manner.
AUSTRIA
No country-specific provisions.
BELGIUM
No country-specific provisions.
CANADA
Terms and Conditions
Form of Settlement. Notwithstanding the Company’s discretion in Section 2.6(a) of the Agreement or any discretion under the Plan, the RSUs shall be settled in Shares only. In no event shall the RSUs be settled in cash.
Termination of Service. For purposes of the RSUs, the Participant’s Termination of Service (regardless of the reason of termination and whether or not later found to be invalid or in breach of employment or other laws or rules in the jurisdiction where the Participant is providing services or the terms of the Participant’s employment or service agreement, if any) will be effective as of the date that is the earliest of:
(1) the date when the Participant's engagement as a Service Provider is terminated, or
(2) the date that the Participant receives (or gives) notice of termination,
regardless of any notice period or period of pay in lieu of such notice or related payments or damages provided or required under applicable laws in the Participant’s jurisdiction (including, but not limited to statutory law, regulatory law and/or common law).
The Participant will not be entitled to any pro-rata vesting for that portion of time before the date on which his or her right to vest terminates, nor will the Participant be entitled to any compensation for lost vesting. Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, the Participant’s right to vest in the Award under the Plan, if any, will terminate effective as of the last day of the Participant’s minimum statutory notice period, but the Participant will not earn or be entitled to pro-rata vestings if the vesting date falls after the end of his or her statutory notice period, nor will the Participant be entitled to any compensation for lost vesting.
The following provisions will apply if the Participant is a resident of Quebec:
Data Privacy. This provision supplements the Data Privacy provisions in Section 3.19 of the Agreement:
The Participant hereby authorizes the Company, including the employing company or any Subsidiary and the Company’s representatives, including the broker(s) designated by the Company, to discuss with and obtain all relevant information from all personnel, professional or non-professional, involved with the administration and operation of the Plan. The Participant further authorizes the Company, employing company and/or any Subsidiary and any stock plan service provider, or such other broker(s) as designated by the Company, to disclose and discuss the Plan with their advisors. The Participant further authorizes the Company, employing company and/or any Subsidiary to record such information and to keep such information in the Participant’s employee file.
French Language Provision. The Participant hereby provides his or her consent to receive Plan information in English. Specifically, the Participant acknowledges as follows:
The parties acknowledge that it is their express wish that this Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.
Consentement Relatif à la Langue. Les parties reconnaissent avoir exigé la redaction en anglais de cette convention (“Agreement”), ainsi que de tous documents exécutés, avis donnés et procedures judiciaries intentées, directement ou indirectement, relativement à la présente convention.
Notifications
Securities Law Information. There may be securities law implications if the Participant sells the Shares acquired under the Plan through a broker other than a broker appointed under the Plan or if the sale does not take place through the facilities of a stock exchange outside of Canada.
DENMARK
Terms and Conditions
Danish Stock Option Act. Notwithstanding any provisions in the Agreement to the contrary, the treatment of the RSUs upon the Participant’s Termination of Service shall be governed by the Danish Act on the Use of Rights to Purchase or Subscribe for Shares etc. in Employment Relationships (the “Stock Option Act”), as in effect at the time of the Participant’s Termination of Service (as determined by the Administrator, in its discretion, in consultation with legal counsel). The Participant acknowledges having received an “Employer Information Statement” in Danish, which is being provided to comply with the Stock Option Act.
FRANCE
Terms and Conditions
Language Acknowledgement. By accepting the Agreement providing for the terms and conditions of the Participant's grant, the Participant confirms having read and understood the documents relating to this grant (the Plan and the Agreement) which were provided in English. The Participant accepts the terms of those documents accordingly.
Consentement Relatif à l'Utilisation de l'Anglais. En acceptant les droits sur des actions assujetties à des restrictions, le Participant confirme avoir lu et compris le Contrat, y compris l'Avis d'Attribution et le Plan, y compris tous leurs termes et conditions, qui ont été transmis en langue anglaise. Le Participant accepte les dispositions de ces documents en connaissance de cause.
GERMANY
No country-specific provisions.
JAPAN
No country-specific provisions.
NETHERLANDS
No country-specific provisions.
SINGAPORE
Terms and Conditions
Restriction on Sale. Shares acquired under the Plan cannot be sold or otherwise offered for sale in Singapore earlier than six months after the date of grant, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”), or pursuant to, and in accordance with the conditions of, any other applicable provisions of the SFA.
Notifications
Securities Law Information. The grant of the RSUs is being made pursuant to the “Qualifying Person” exemption under section 273(1)(f) of the SFA under which it is exempt from the prospectus and registration requirements and is not made with a view to the underlying Shares being subsequently offered for sale to any other party. The Plan has not been, and will not be, lodged or registered as a prospectus with the Monetary Authority of Singapore.
SPAIN
Terms and Conditions
Nature of Grant. The following provision supplements Section 3.18 of the Agreement:
In accepting the Award, the Participant consents to participation in the Plan and acknowledges that the Participant has received a copy of the Plan.
Further, the Participant understands that the Company has unilaterally, gratuitously and discretionally decided to offer participation in the Plan to individuals who may be Service Providers throughout the world. The decision is a limited decision that is entered into upon certain express assumptions and conditions. Consequently, the Participant understands that participation in the Plan is granted on the assumption and condition that participation in the Plan and any Shares acquired under the Plan shall not become a part of any employment contract (either with the Company or any Subsidiary or Affiliate) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever. In addition, the Participant understands that this grant would not be made but for the assumptions and conditions referred to above; thus, the Participant acknowledges and freely accepts that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, then any rights granted under the Plan shall be null and void.
The Participant also understands and agrees that any portion of the RSUs that is unvested will be automatically forfeited, without entitlement to any amount of indemnification, in the event of the Participant's Termination of Service for any reason, including, but not limited to, resignation, disciplinary dismissal adjudged to be with cause, disciplinary dismissal adjudged or recognized to be without cause, individual or collective dismissal on objective grounds, whether adjudged or recognized to be with or without cause, material modification of the terms of employment under Article 41 of the Workers’ Statute, relocation under Article 40 of the Workers’ Statute, Article 50 of the Workers’ Statute, unilateral withdrawal by the Service Recipient and under Article 10.3 of the Royal Decree 1382/1985.
Notifications
Securities Law Information. The Participant’s participation in the Plan and any Shares issued thereunder do not qualify under Spanish regulations as securities. No “offer of securities to the public,” as defined under Spanish law, has taken place or will take place in the Spanish territory. Neither the Plan nor the Agreement has been nor will it be registered with the Comisión Nacional del Mercado de Valores, and does not constitute a public offering prospectus.
Exchange Control Information. The Participant must declare the acquisition, ownership and sale of Shares acquired under the Plan. Generally, the declaration must be made in January for Shares owned as of December 31 of the prior year on a Form D-6; however, if the value of Shares acquired or sold exceeds €1,502,530, the declaration must also be filed within one month of the acquisition or sale, as applicable.
In addition, the Participant may be required to declare electronically to the Bank of Spain any securities accounts (including brokerage accounts) held abroad, any foreign instruments (including Shares) and any transactions with non-Spanish residents (including the payment of any Shares made to the Participant by the Company) depending on the value of the transactions during the relevant year or the balances in such accounts and the value of such instruments as of December 31 of the relevant year.
Foreign Asset/Account Reporting Information. To the extent that the Participant holds assets or rights outside of Spain (e.g., Shares or cash held in a brokerage or bank account) with a value in excess of €50,000 per asset type as of December 31 (or at any time during the year in which the asset is sold), the Participant will be required to report information on such assets or rights on the Participant’s tax return (tax form 720) for such year. After such assets or rights are initially reported, the reporting obligation will apply for subsequent years only if the value of any previously-reported assets or rights increases by more than €20,000, or if the ownership of such assets or rights is transferred or relinquished during the year. The report must be completed by March 31.
SWEDEN
No country-specific provisions.
UNITED KINGDOM
Terms and Conditions
Tax Obligations. This provision supplements Section 2.6 of the Agreement:
Without limitation to Section 2.6 of the Agreement, the Participant hereby agrees that he or she is liable for all Tax Liability and hereby covenants to pay all such Tax Liability, as and when requested by the Company or the Participant's employer or by Her Majesty’s Revenue and Customs (“HMRC”) (or any other tax or relevant authority). The Participant also hereby agrees to indemnify and keep indemnified the Company and the Participant's employer against any Tax Liability that they are required to pay or withhold, or have paid or will pay, to HMRC (or any other tax or relevant authority) on the Participant’s behalf.
Notwithstanding the foregoing, if the Participant is an executive officer or director (as within the meaning of Section 13(k) of the U.S. Exchange Act, as amended from time to time), the Participant understands that the Participant may not be able to indemnify the Company or employing company for the amount of income tax not collected from or paid by the Participant, as it may be considered a loan. In the event that the Participant is an executive officer or director and income tax is not collected from the Participant within ninety (90) days after the end of the tax year in which the taxable event occurs, the amount of any uncollected income tax may constitute an additional benefit to the Participant on which additional income tax and national insurance contributions may be payable. The Participant is responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Participant's employer for the value of any NICs due on this additional benefit, which the Company or the employing company may recover from the Participant.
Exhibit (e)(17)
OLINK HOLDING AB (publ)
2021 INCENTIVE AWARD PLAN
2023 INTERNATIONAL STOCK OPTION GRANT NOTICE
Olink Holding AB (publ), a Swedish public limited liability company (the “Company”), pursuant to its 2021 Incentive Award Plan, as may be amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”), an option (“Option”) to purchase such number of Shares (as defined in the Plan) as set forth below. The Option is subject to all of the terms and conditions set forth herein, as well as in the Plan and the International Stock Option Agreement attached hereto as Exhibit A (the “Stock Option Agreement”) and any additional terms and conditions, as set forth in Exhibit B (together with the Stock Option Agreement, the “Agreement”) each of which are incorporated herein by reference, including all exhibits or attachments thereto. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and the Stock Option Agreement.
Participant: | |
Grant Date: | 17 April 2023 |
Vesting Commencement Date: | 7 April 2023 |
Exercise Price per Share: | $22.79 |
Total Exercise Price: | |
Total Number of ordinary shares of Common Stock of the Company: | |
Expiration Date: | 7 April 2028 |
Vesting Schedule: | The Option shall vest in equal installments on each of the first four anniversaries of the Vesting Commencement Date, provided Participant has not experienced a Termination of Service on or prior to the applicable vesting date. |
Type of Option: X Incentive Stock Option ¨ Nonqualified Stock Option
By his or her signature and the Company’s signature below, Participant agrees to be bound by the terms and conditions of the Plan, the Stock Option Agreement, and this Grant Notice. Participant has reviewed the Stock Option Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the Stock Option Agreement and the Plan. Participant further agrees hereby that, as a condition to the receipt of the Shares following exercise of the Option, Participant may be required to execute a lock-up or other agreement, as the Administrator may determine in its sole and absolute discretion. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, this Grant Notice or the Stock Option Agreement. In addition, by signing below, Participant also agrees that the Company, in its sole discretion, may satisfy any withholding obligations using any method permitted under Section 10.4 of the Plan.
OLINK HOLDING AB (publ): | PARTICIPANT: | |||
By: | By: | |||
Print Name: | Print Name: | |||
Title: | ||||
Address: | Address: |
A-1-1
EXHIBIT A TO U.S. STOCK OPTION GRANT NOTICE
INTERNATIONAL STOCK OPTION AGREEMENT
Pursuant to the International Stock Option Grant Notice (the “Grant Notice”) to which this International Stock Option Agreement and any additional terms and conditions, as set forth in Exhibit B (together with the International Stock Option Agreement, the “Agreement”) is attached, Olink Holding AB (publ), a Swedish public limited liability company (the “Company”), has granted to Participant an Option under the Company’s 2021 Incentive Award Plan, as may be amended from time to time (the “Plan”), to purchase the number of Shares indicated in the Grant Notice.
ARTICLE 1.
GENERAL
1.1 Defined Terms. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice.
1.2 Incorporation of Terms of Plan. The Option is subject to the terms and conditions of the Plan which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.
ARTICLE 2.
GRANT OF OPTION
2.1 Grant of Option. In consideration of Participant’s past and/or continued employment with or service to the Company or any Subsidiary and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the “Grant Date”), the Company irrevocably grants to Participant the Option to purchase any part or all of an aggregate of the number of Shares set forth in the Grant Notice, upon the terms and conditions set forth in the Plan and this Agreement, subject to adjustments as provided in Article IX of the Plan.
2.2 Exercise Price. The exercise price of the Shares subject to the Option shall be as set forth in the Grant Notice; provided, however, that the price per share of the Shares subject to the Option shall not be less than 100% of the Fair Market Value of a Share on the Grant Date. Notwithstanding the foregoing, if the Option is designated as an Incentive Stock Option and Participant is a Greater Than 10% Stockholder as of the Grant Date, the exercise price per share of the Shares subject to the Option shall not be less than 110% of the Fair Market Value of a Share on the Grant Date.
2.3 Consideration to the Company. In consideration of the grant of the Option by the Company, Participant agrees to render faithful and efficient services to the Company or any Subsidiary. Nothing in the Plan or this Agreement shall confer upon Participant any right to continue in the employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant.
A-1-2
ARTICLE 3.
PERIOD OF EXERCISABILITY
3.1 Commencement of Exercisability.
(a) Subject to Sections 3.2, 3.3, 5.11 and 5.17 hereof, the Option shall become vested and exercisable in such amounts and at such times as are set forth in the Grant Notice.
(b) No portion of the Option which has not become vested and exercisable at the date of Participant’s Termination of Service shall thereafter become vested and exercisable, except as may be otherwise provided by the Administrator or as set forth in a written agreement between the Company and Participant. Upon Participant’s Termination of Service by the Company for Cause, the Option (whether vested or unvested) shall terminate and cease to be exercisable upon such termination. For the avoidance of doubt, providing service during only a portion of the vesting period prior to a vesting date shall not entitle Participant to vest in a pro-rata portion of the unvested Option that would have vested as of such vesting date nor will it entitle Participant to any compensation for the lost vesting.
(c) Notwithstanding Section 3.1(a) hereof and the Grant Notice, but subject to Section 3.1(b) hereof, in the event of a Change in Control the Option shall be treated pursuant to Sections 9.2 and 9.3 of the Plan.
3.2 Duration of Exercisability. Each portion of the Option which becomes vested and exercisable pursuant to the vesting schedule set forth in the Grant Notice shall remain vested and exercisable until it becomes unexercisable under Section 3.3 hereof.
3.3 Expiration of Option. The Option may not be exercised to any extent by anyone after the first to occur of the following events:
(a) The Expiration Date set forth in the Grant Notice, which shall in no event be more than ten (10) years from the Grant Date;
(b) If the Option is designated as an Incentive Stock Option and Participant, at the time the Option was granted, was a Greater Than 10% Stockholder, the expiration of five (5) years from the Grant Date;
(c) The expiration of three (3) months from the date of Participant’s Termination of Service, unless such termination occurs by reason of Participant’s death or Disability;
(d) The expiration of one (1) year from the date of Participant’s Termination of Service by reason of Participant’s death or Disability; or
(e) Participant’s Termination of Service by the Company for Cause.
3.4 Special Tax Consequences. Participant acknowledges that, to the extent that the aggregate Fair Market Value (determined as of the time the Option is granted) of all Shares with respect to which Incentive Stock Options, including the Option (if applicable), are exercisable for the first time by Participant in any calendar year exceeds $100,000, the Option and such other options shall be Nonqualified Stock Options to the extent necessary to comply with the limitations imposed by Section 422(d) of the Code. Participant further acknowledges that the rule set forth in the preceding sentence shall be applied by taking the Option and other “incentive stock options” into account in the order in which they were granted, as determined under Section 422(d) of the Code and the Treasury Regulations thereunder. Participant also acknowledges that an Incentive Stock Option exercised more than three (3) months after Participant’s Termination of Service, other than by reason of death or Disability, will be taxed as a Nonqualified Stock Option.
A-1-3
3.5 Tax Indemnity.
(a) Participant agrees to indemnify and keep indemnified the Company, any Subsidiary and Participant’s employing company, if different, from and against any liability for or obligation to pay any portion of the Tax Liability, payable by the Company in respect of Participant’s Tax Liability (a “Tax Liability” being any liability for income tax, withholding tax, fringe benefit tax and any other employment related taxes or social security, social insurance or national insurance contributions in any jurisdiction) that is attributable to (i) the grant or exercise of, or any benefit derived by Participant from, the Option, (ii) the acquisition by Participant of the Shares on exercise of the Option or (iii) the disposal of any Shares.
(b) The Option cannot be exercised until Participant has made such arrangements as the Company may require for the satisfaction of any Tax Liability that may arise in connection with the exercise of the Option and/or the acquisition of the Shares by Participant. The Company shall not be required to issue, allot or transfer Shares until Participant has satisfied this obligation.
(c) Participant hereby acknowledges that the Company (i) makes no representations or undertakings regarding the treatment of any Tax Liabilities in connection with any aspect of the Option and (ii) does not commit to and is under no obligation to structure the terms of the grant or any aspect of any Award, including the Option, to reduce or eliminate Participant’s liability for Tax Liabilities or achieve any particular tax result. Furthermore, if Participant becomes subject to tax in more than one jurisdiction between the date of grant of an Award, including the Option, and the date of any relevant taxable event, Participant acknowledges that the Company may be required to withhold or account for Tax Liabilities in more than one jurisdiction.
ARTICLE 4.
EXERCISE OF OPTION
4.1 Person Eligible to Exercise. Except as provided in Section 5.3 hereof, during the lifetime of Participant, only Participant may exercise the Option or any portion thereof, unless it has been disposed of pursuant to a domestic relations order. After the death of Participant, any exercisable portion of the Option may, prior to the time when the Option becomes unexercisable under Section 3.3 hereof, be exercised by the deceased Participant’s personal representative or by any person empowered to do so under the deceased Participant’s will or under the then-Applicable Laws of descent and distribution.
4.2 Partial Exercise. Any exercisable portion of the Option or the entire Option, if then wholly exercisable, may be exercised in whole or in part at any time prior to the time when the Option or portion thereof becomes unexercisable under Section 3.3 hereof. However, the Option shall not be exercisable with respect to fractional Shares.
4.3 Manner of Exercise. The Option, or any exercisable portion thereof, may be exercised solely by delivery to the Secretary of the Company (or any third party administrator or other person or entity designated by the Company; for the avoidance of doubt, delivery shall include electronic delivery), during regular business hours, of all of the following prior to the time when the Option or such portion thereof becomes unexercisable under Section 3.3 hereof:
(a) An exercise notice in a form specified by the Administrator, stating that the Option or portion thereof is thereby exercised, such notice complying with all applicable rules established by the Administrator. The notice shall be signed by Participant or other person then entitled to exercise the Option or such portion of the Option;
A-1-4
(b) The receipt by the Company of full payment for the Shares with respect to which the Option or portion thereof is exercised, including payment of any applicable Tax Liability, which shall be made by deduction from other compensation payable to Participant or in such other form of consideration permitted under Section 4.4 hereof that is acceptable to the Company;
(c) Any other written representations or documents as may be required in the Administrator’s sole discretion to evidence compliance with the Securities Act, the Exchange Act or any other Applicable Law, rule or regulation; and
(d) In the event the Option or portion thereof shall be exercised pursuant to Section 4.1 hereof by any person or persons other than Participant, appropriate proof of the right of such person or persons to exercise the Option.
Notwithstanding any of the foregoing, the Company shall have the right to specify all conditions of the manner of exercise, which conditions may vary by country and which may be subject to change from time to time.
4.4 Method of Payment. Payment of the exercise price shall be by any of the following, or a combination thereof, at the election of Participant:
(a) Cash or check;
(b) With the consent of the Administrator and to the extent permitted by Applicable Law, surrender of Shares (including, without limitation, Shares otherwise issuable upon exercise of the Option) held for such period of time as may be required by the Administrator in order to avoid adverse accounting consequences and having a Fair Market Value on the date of delivery equal to the aggregate exercise price of the Option or exercised portion thereof; or
(c) Other legal consideration acceptable to the Administrator (including, without limitation, if there is a public market for Shares at the time the Tax Liabilities are satisfied, through the delivery of a notice that Participant has placed a market sell order with a broker with respect to Shares then issuable upon exercise of the Option, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the Option exercise price; provided that payment of such proceeds is then made to the Company at such time as may be required by the Company, but in any event not later than the settlement of such sale).
4.5 Conditions to Issuance of Shares. The Shares deliverable upon the exercise of the Option, or any portion thereof, may be treasury shares or Shares which have then been reacquired by or held on behalf of the Company. Such Shares shall be fully paid and nonassessable. The Company shall not be required to issue or deliver any Shares purchased upon the exercise of the Option or portion thereof prior to fulfillment of all of the conditions in Section 10.6 of the Plan and the following conditions, including without limitation, the receipt by the Company of full payment for such Shares, including payment of any applicable Tax Liability.
4.6 Rights as Stockholder. The holder of the Option shall not be, nor have any of the rights or privileges of, a stockholder of the Company, including, without limitation, voting rights and rights to dividends, in respect of any Shares purchasable upon the exercise of any part of the Option unless and until such Shares shall have been issued by the Company, held of record by such holder (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), and, to the extent applicable, Participant has executed the Company’s stockholders agreement or registration rights agreement, as applicable. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Article IX of the Plan.
A-1-5
ARTICLE 5.
OTHER PROVISIONS
5.1 Administration. The Administrator shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be final and binding upon Participant, the Company and all other interested persons. No member of the Committee or the Board shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the Option.
5.2 Whole Shares. The Option may only be exercised for whole Shares.
5.3 Option Not Transferable. Subject to Section 4.1 hereof, the Option may not be sold, pledged, assigned or transferred in any manner other than by will or the laws of descent and distribution or, subject to the consent of the Administrator, pursuant to a domestic relations order, unless and until the Option has been exercised and the Shares underlying the Option have been issued, and all restrictions applicable to such Shares have lapsed. The Option shall be subject to the restrictions on transferability set forth in Section 10.1 of the Plan.
5.4 Tax Consultation. Participant represents that Participant has consulted with any tax consultants Participant deems advisable in connection with the purchase or disposition of such Shares and that Participant is not relying on the Company for any tax advice.
5.5 Binding Agreement. Subject to the limitation on the transferability of the Option contained herein, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
5.6 Adjustments Upon Specified Events. The Administrator may accelerate the vesting of the Option in such circumstances as it, in its sole discretion, may determine. Participant acknowledges that the Option is subject to adjustment, modification and termination in certain events as provided in this Agreement and Article IX of the Plan.
5.7 Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company’s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant’s last address reflected on the Company’s records. By a notice given pursuant to this Section 5.7, either party may hereafter designate a different address for notices to be given to that party. Any notice which is required to be given to Participant shall, if Participant is then deceased, be given to the person entitled to exercise his or her Option pursuant to Section 4.1 hereof by written notice under this Section 5.7. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service (or any similar foreign entity).
5.8 Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.
5.9 Governing Law and Dispute Resolution. The laws of Sweden shall govern the interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. Any dispute, controversy or claim arising out of or in connection with this Agreement, or the breach, termination or invalidity thereof, shall be finally settled by arbitration administered by the Arbitration Institute of the Stockholm Chamber of Commerce (the “SCC”).
A-1-6
The Rules for Expedited Arbitrations shall apply, unless the SCC in its discretion determines, taking into account the complexity of the case, the amount in dispute and other circumstances, that the Arbitration Rules shall apply. In the latter case, the SCC shall also decide whether the Arbitral Tribunal shall be composed of one or three arbitrators. The seat of arbitration shall be Stockholm, Sweden. The language to be used in the arbitral proceedings shall be English.
5.10 Conformity to Securities Laws. Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act, and any other Applicable Law, including, without limitation, any rules or regulations of any securities exchange or automated quotation system on which the Shares are listed, quoted or traded. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Option is granted and may be exercised, only in such a manner as to conform to such Applicable Law. To the extent permitted by Applicable Law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such Applicable Law.
5.11 Amendment, Suspension and Termination. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the Board; provided, however, that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the Option in any material way without the prior written consent of Participant.
5.12 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section 5.3 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns.
5.13 Notification of Disposition. If the Option is designated as an Incentive Stock Option, Participant shall give prompt notice to the Company of any disposition or other transfer of any Shares acquired under this Agreement if such disposition or transfer is made (i) within two (2) years from the Grant Date with respect to such Shares or (ii) within one (1) year after the transfer of such Shares to Participant. Such notice shall specify the date of such disposition or other transfer and the amount realized, in cash, other property, assumption of indebtedness or other consideration, by Participant in such disposition or other transfer.
5.14 Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Plan, the Option and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.
5.15 Not a Contract of Service Relationship. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any of its Subsidiaries or interfere with or restrict in any way with the right of the Company or any of its Subsidiaries, which rights are hereby expressly reserved, to discharge or to terminate for any reason whatsoever, with or without cause, the services of Participant at any time (unless otherwise required by Applicable Law or any service agreement by and between Participant and Participant’s employer).
A-1-7
5.16 Entire Agreement. The Plan, the Grant Notice and this Agreement constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof.
5.17 Section 409A. The Option is not intended to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, “Section 409A”). However, notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any time the Administrator determines that the Option (or any portion thereof) may be subject to Section 409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate either for the Option to be exempt from the application of Section 409A or to comply with the requirements of Section 409A.
5.18 Limitation on Participant’s Rights. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the Option, and rights no greater than the right to receive the Shares as a general unsecured creditor with respect to options, as and when exercised pursuant to the terms hereof.
5.19 Nature of Grant. By accepting the grant of the Option, Participant acknowledges, understands and agrees that:
(a) the Plan is established voluntarily by the Company, is wholly discretionary in nature and may be modified, amended, suspended, or terminated by the Company at any time, to the extent permitted by the Plan;
(b) the grant of the Option is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of Options, or benefits in lieu of the Option, even if Options have been granted in the past;
(c) all decisions with respect to future grants of Options or other grants, if any, will be at the sole discretion of the Company;
(d) the Option and Participant’s participation in the Plan shall not create a right of employment or other service relationship with the Company;
(e) the Option and Participant’s participation in the Plan shall not be interpreted as forming or amending an employment or service contract with the Company or the employing company (if different), and shall not interfere with the ability of the Company, the employing company (if different) or any Subsidiary, as applicable, to terminate Participant’s employment or service relationship (if any);
(f) Participant is voluntarily participating in the Plan;
(g) the Option and any Shares acquired under the Plan, and the income from and value of the same, are not intended to replace any pension rights or compensation;
(h) the Option and any Shares acquired under the Plan, and the income from and value of the same, are not part of normal or expected compensation for any purposes, including but not limited to, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, holiday pay, pension or retirement or welfare benefits or similar payments;
A-1-8
(i) the future value of the Shares underlying the Option is unknown, indeterminable, and cannot be predicted with certainty;
(j) if the underlying Shares do not increase in value, the Option will have no value;
(k) no claim or entitlement to compensation or damages shall arise from forfeiture of any portion of the Option resulting from Participant’s Termination of Service (for any reason whatsoever and regardless of whether or not later found to be invalid or in breach of Applicable Laws in the jurisdiction where Participant is providing service or the terms of Participant’s employment or other service agreement, if any);
(l) unless otherwise agreed with the Company in writing, the Option and the Shares subject to the Option, and the income from and value of the same, are not granted as consideration for, or in connection with, the service Participant may provide as a director of a Subsidiary;
(m) unless otherwise provided in the Plan or by the Company in its discretion, the Option and the benefits evidenced by this Agreement do not create any entitlement to have the Option or any such benefits transferred to, or assumed by, another company nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting the Shares; and
(n) neither the Company, the employing company (if different) nor any other Subsidiary shall be liable for any foreign exchange rate fluctuation between Participant’s local currency and the U.S. dollar that may affect the value of the Option or of any amounts due to Participant pursuant to the vesting of the Option or the subsequent sale of any Shares acquired upon settlement of the Option.
5.20 Data Privacy. Without limiting any other provisions of this Agreement, Section 11.8 of the Plan is hereby incorporated into this Agreement as if first set forth herein.
(a) Data Collection and Usage. The Company collects, processes, transfers and uses personal data about Participant that is necessary for the purpose of implementing, administering and managing the Plan. This personal data may include Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any shares or directorships held in the Company, and details of all awards or other entitlements to Shares, granted, canceled, exercised, vested, unvested or outstanding in Participant’s favor (“Data”), which the Company receives from Participant or Participant's employer (if different). If the Company offers Participant an Award under the Plan, then the Company will collect Data for purposes of granting Awards and implementing, administering and managing the Plan and will process such Data in accordance with the Company’s then-current data privacy policies, which are made available to Participant upon commencing employment and also available upon request. The legal basis, where required, for the processing of Data is Participant’s consent.
(b) Stock Plan Administration Service Providers. The Company may transfer Data to an independent stock-plan administrator and other third parties based in the United States, Sweden, Ireland or elsewhere, which assists the Company with the implementation, administration and management of the Plan. In the future, the Company may select a different service provider and share Data with another company that serves in a similar manner. Participant understands that the recipients of the Data may be located in the United States, Sweden, Ireland or elsewhere, and that the recipients’ country (e.g., the United States, Sweden, Ireland or elsewhere) may have different data privacy laws and protections than Participant’s country. The Company’s service provider may open an account for Participant in connection with the Option. Participant will be asked to agree to separate terms and data processing practices with the service provider, which is a condition to Participant’s ability to participate in the Plan. Participant understands that Participant may request a list with the names and addresses of any potential recipients of the Data by contacting Participant’s local human resources representative. Participant authorizes the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing Participant’s participation in the Plan.
A-1-9
(c) Data Retention. The Company will use Data only as long as is necessary to implement, administer and manage Participant’s participation in the Plan or as required to comply with legal or regulatory obligations, including under securities, exchange control, tax and employment laws. When the Company no longer needs Participant’s Data, the Company will remove it from its systems. If the Company keeps the data longer, it would be to satisfy legal or regulatory obligations and the Company’s legal basis would be relevant laws or regulations.
(d) Consent; Voluntariness and Consequences of Denial or Withdrawal. Where permitted by Applicable Laws, consent is a requirement for participation in the Plan. In such cases, by accepting the Option, Participant agrees with the data processing practices as described in this Agreement and grants such consent to the processing and transfer of Data as described in this Agreement and as necessary for the purpose of administering the Plan. Participant’s participation in the Plan and Participant’s grant of consent is purely voluntary. Participant may deny or withdraw Participant’s consent at any time; provided, that if Participant does not consent, or if Participant withdraws Participant’s consent, Participant cannot participate in the Plan unless required by Applicable Law. This would not affect Participant’s salary or other compensation or Participant's status as a Service Provider; Participant would merely forfeit the opportunities associated with the Plan.
(e) Data Subject Rights. Participant has a number of rights under data privacy laws in Participant’s country. Depending on where Participant is based, Participant’s rights may include the right to (i) request access or copies of Data the Company processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing, (v) portability of Data, (vi) to lodge complaints with the competent tax authorities in Participant’s country and/or (vii) a list with the names and addresses of any potential recipients of Data.
(f) GDPR Compliance. To the satisfaction and at the direction of the Company, all operations of the Plan, the Option and the underlying Shares (at the time of grant and as necessary thereafter) shall include or be supported by appropriate agreements, notifications and arrangements in respect of Data and its use and processing under the Plan, in order to secure (i) the reasonable freedom of the Company or any Subsidiary, as appropriate, to operate the Plan and for connected purposes, and (ii) compliance with the data-protection requirements applicable from time to time, including, if applicable, and without limitation, Regulation EU 2016/679 of the European Parliament and of the Council of April 27, 2016.
5.21 Other Agreements. Participant further agrees hereby that, as a condition to the grant of and/or the receipt of the Shares following exercise of the Option, Participant may be required to execute lock-up or other agreement, as the Administrator may determine in its sole and absolute discretion.
5.22 Language. Participant acknowledges that Participant is sufficiently proficient in English to understand the terms and conditions of this Agreement. Furthermore, if Participant has received this Agreement, or any other document related to the Option and/or the Plan translated into a language other than English and if the meaning of the translated version is different from the English version, the English version will control.
A-1-10
5.23 Foreign Asset/Account Reporting Requirements. Participant acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect Participant’s ability to acquire or hold Shares acquired upon exercise of the Option or cash received from participating in the Plan in a brokerage account outside Participant’s country. Participant may also be required to repatriate sale proceeds or other funds received as a result of participating in the Plan to Participant’s country through a designated bank or broker within a certain time after receipt. It is Participant’s responsibility to be compliant with such regulations and Participant should speak with Participant’s personal advisor on this matter.
5.24 Insider Trading Restrictions/Market Abuse Laws. Participant acknowledges that Participant may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, which may affect Participant’s ability to directly or indirectly, accept, acquire, sell or attempt to sell or otherwise dispose of Shares or rights to the Shares, or rights linked to the value of Shares during such times as Participant is considered to have “inside information” regarding the Company (as defined by the laws and/or regulations in applicable jurisdictions or Participant’s country). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders placed by Participant before possessing the inside information. Furthermore, Participant may be prohibited from (a) disclosing inside information to any third party, including fellow employees (other than on a “need to know” basis) and (b) “tipping” third parties or otherwise inducing them to buy or sell securities. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. Participant acknowledges that it is Participant’s responsibility to comply with any applicable restrictions, and Participant is advised to speak to Participant’s personal advisor on this matter.
5.25 Waiver. Participant acknowledges that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by Participant.
5.26 Appendix. Notwithstanding any provisions in this Agreement, the Option shall be subject to any additional terms and conditions set forth in the Appendix to this Stock Option Agreement for Participant’s country. Moreover, if Participant relocates to one of the countries included in the Appendix, the additional terms and conditions for such country will apply to Participant to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The Appendix constitutes part of this Agreement.
5.27 Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Option and the Shares purchased upon exercise of the Option, to the extent the Company determines it is necessary or advisable in order to comply with local laws or facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
5.28 Severability. If any portion of the Grant Notice or this Agreement or any action taken under the Grant Notice or this Agreement, in any case is held illegal or invalid for any reason, the illegality or invalidity will not affect the remaining parts of the Grant Notice and/or this Agreement (as applicable), and the Grant Notice and/or this Agreement (as applicable) will be construed and enforced as if the illegal or invalid provisions had been excluded, and the illegal or invalid action will be null and void.
5.29 Electronic Delivery and Participation. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. Participant hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an on-line or electronic system established and maintained by the company or a third party designated by the Company.
A-1-11
ARTICLE 6.
TRADE SECRETS
6.1 Confidentiality. Except with the express written consent of the Board, Participant will not, either during the term of Participant’s employment or service with the Company or anytime thereafter, directly or indirectly, use or disclose for the benefit of Participant or any other person, firm or entity, any of the trade secrets of the Company, whether or not said information was acquired, learned, obtained or developed by Participant alone or in conjunction with others. For purposes of this Agreement, trade secrets shall mean that which is known only to the Company and those employees or other agents to whom it has been confided, and is by law the property of the Company, and shall include all information relating to design and manufacturing procedures, techniques, programs, business systems, processes, methods, and marketing studies. It is the intent hereof that Participant shall not divulge or use any such information which is unpublished or not otherwise readily available to the public or which is not general information in the business of the Company. In addition and notwithstanding anything to the contrary in this Agreement, pursuant to the federal U.S. Defend Trade Secrets Act of 2016, Participant shall not be held civilly or criminally liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state or local governmental official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.
A-1-12
EXHIBIT B
APPENDIX TO
INTERNATIONAL STOCK OPTION AGREEMENT
COUNTRY SPECIFIC TERMS & CONDITIONS
Capitalized terms not specifically defined herein shall have the meanings specified in the Plan, Grant Notice and Stock Option Agreement.
Terms and Conditions
This Appendix includes special and/or additional country specific terms and conditions that govern the Option granted to Participant under the Plan if Participant resides and/or works in one of the countries listed below. These terms and conditions are in addition to or, if so indicated, in place of, the terms and conditions set forth in the Agreement. If Participant is a citizen or resident of a country other than the one in which he or she is currently residing and/or working, transfers residency and/or employment to another country after the grant of the Option, or is considered resident of another country for local law purposes, the Administrator shall, in its discretion, determine to what extent the terms and conditions contained herein shall be applicable to Participant.
Notifications
This Appendix also includes information regarding tax, securities law, exchange controls and certain other issues of which Participant should be aware with respect to Participant’s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of May 2023. Such laws are often complex and change frequently. As a result, the Company strongly recommends that Participant not rely on the information in this Appendix as the only source of information relating to the consequences of Participant’s participation in the Plan because the information may be out of date at the time that the Option vests or is exercised or Shares acquired under the Plan are sold.
In addition, the information contained herein is general in nature and may not apply to Participant’s particular situation and the Company is not in a position to assure Participant of any particular result. Accordingly, Participant should seek appropriate professional advice as to how the relevant laws in his or her country may apply to Participant’s situation.
Finally, if Participant is a citizen or resident of a country other than the one in which he or she is currently residing and/or working, transfers residency and/or employment to another country after the grant of the Option, or is considered a resident of another country for local law purposes, the information contained herein may not be applicable to Participant in the same manner.
A-1-13
SWEDEN
Terms and Conditions
Tax Withholding. The following provision supplements Section 3.5 of the Stock Option Agreement:
Without limiting the Company’s authority to satisfy its withholding obligations for any Tax Liability as set forth herein, by accepting the Option, Participant authorizes the Company to sell Shares otherwise deliverable to Participant upon exercise of the Option to satisfy such Tax Liability, regardless of whether the Company and/or any Subsidiary has an obligation to withhold such Tax Liability.
NORWAY
No country-specific provisions.
A-1-14
Exhibit (e)(18)
OLINK HOLDING AB (publ)
2021 INCENTIVE AWARD PLAN
2023 U.S. STOCK OPTION GRANT NOTICE
Olink Holding AB (publ), a Swedish public limited liability company (the “Company”), pursuant to its 2021 Incentive Award Plan, as may be amended from time to time (the “Plan”), hereby grants to the holder listed below (“Participant”), an option (“Option”) to purchase such number of Shares (as defined in the Plan) as set forth below. The Option is subject to all of the terms and conditions set forth herein, as well as in the Plan and the U.S. Stock Option Agreement attached hereto as Exhibit A (the “Stock Option Agreement”), each of which are incorporated herein by reference, including all exhibits or attachments thereto. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and the Stock Option Agreement.
Participant: | |
Grant Date: | 17 April 2023 |
Vesting Commencement Date: | 7 April 2023 |
Exercise Price per Share: | $22.79 |
Total Exercise Price: | |
Total Number of ordinary shares of Common Stock of the Company: | |
Expiration Date: | 7 April 2028 |
Vesting Schedule: | The Option shall vest in equal installments on each of the first four anniversaries of the Vesting Commencement Date, provided Participant has not experienced a Termination of Service on or prior to the applicable vesting date. |
Type of Option: X Incentive Stock Option ¨ Nonqualified Stock Option
By his or her signature and the Company’s signature below, Participant agrees to be bound by the terms and conditions of the Plan, the Stock Option Agreement, and this Grant Notice. Participant has reviewed the Stock Option Agreement, the Plan and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and fully understands all provisions of this Grant Notice, the Stock Option Agreement and the Plan. Participant further agrees hereby that, as a condition to the receipt of the Shares following exercise of the Option, Participant may be required to execute a lock-up or other agreement, as the Administrator may determine in its sole and absolute discretion. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under the Plan, this Grant Notice or the Stock Option Agreement. In addition, by signing below, Participant also agrees that the Company, in its sole discretion, may satisfy any withholding obligations using any method permitted under Section 10.4 of the Plan.
OLINK HOLDING AB (publ): | PARTICIPANT: | |||
By: | By: | |||
Print Name: | Print Name: | |||
Title: | ||||
Address: | Address: |
A-1-1
EXHIBIT A TO U.S. STOCK OPTION GRANT NOTICE
U.S. STOCK OPTION AGREEMENT
Pursuant to the Stock Option Grant Notice (the “Grant Notice”) to which this U.S. Stock Option Agreement (this “Agreement”) is attached, Olink Holding AB (publ), a Swedish public limited liability company (the “Company”), has granted to Participant an Option under the Company’s 2021 Incentive Award Plan, as may be amended from time to time (the “Plan”), to purchase the number of Shares indicated in the Grant Notice.
ARTICLE 1.
GENERAL
1.1 Defined Terms. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice.
1.2 Incorporation of Terms of Plan. The Option is subject to the terms and conditions of the Plan which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control.
ARTICLE 2.
GRANT OF OPTION
2.1 Grant of Option. In consideration of Participant’s past and/or continued employment with or service to the Company or any Subsidiary and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the “Grant Date”), the Company irrevocably grants to Participant the Option to purchase any part or all of an aggregate of the number of Shares set forth in the Grant Notice, upon the terms and conditions set forth in the Plan and this Agreement, subject to adjustments as provided in Article IX of the Plan.
2.2 Exercise Price. The exercise price of the Shares subject to the Option shall be as set forth in the Grant Notice; provided, however, that the price per share of the Shares subject to the Option shall not be less than 100% of the Fair Market Value of a Share on the Grant Date. Notwithstanding the foregoing, if the Option is designated as an Incentive Stock Option and Participant is a Greater Than 10% Stockholder as of the Grant Date, the exercise price per share of the Shares subject to the Option shall not be less than 110% of the Fair Market Value of a Share on the Grant Date.
2.3 Consideration to the Company. In consideration of the grant of the Option by the Company, Participant agrees to render faithful and efficient services to the Company or any Subsidiary. Nothing in the Plan or this Agreement shall confer upon Participant any right to continue in the employ or service of the Company or any Subsidiary or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise in a written agreement between the Company or a Subsidiary and Participant.
A-1-2
ARTICLE 3.
PERIOD OF EXERCISABILITY
3.1 Commencement of Exercisability.
(a) Subject to Sections 3.2, 3.3, 5.11 and 5.17 hereof, the Option shall become vested and exercisable in such amounts and at such times as are set forth in the Grant Notice.
(b) No portion of the Option which has not become vested and exercisable at the date of Participant’s Termination of Service shall thereafter become vested and exercisable, except as may be otherwise provided by the Administrator or as set forth in a written agreement between the Company and Participant. Upon Participant’s Termination of Service by the Company for Cause, the Option (whether vested or unvested) shall terminate and cease to be exercisable upon such termination. For the avoidance of doubt, providing service during only a portion of the vesting period prior to a vesting date shall not entitle Participant to vest in a pro-rata portion of the unvested Option that would have vested as of such vesting date nor will it entitle Participant to any compensation for the lost vesting.
(c) Notwithstanding Section 3.1(a) hereof and the Grant Notice, but subject to Section 3.1(b) hereof, in the event of a Change in Control the Option shall be treated pursuant to Sections 9.2 and 9.3 of the Plan.
3.2 Duration of Exercisability. Each portion of the Option which becomes vested and exercisable pursuant to the vesting schedule set forth in the Grant Notice shall remain vested and exercisable until it becomes unexercisable under Section 3.3 hereof.
3.3 Expiration of Option. The Option may not be exercised to any extent by anyone after the first to occur of the following events:
(a) The Expiration Date set forth in the Grant Notice, which shall in no event be more than ten (10) years from the Grant Date;
(b) If the Option is designated as an Incentive Stock Option and Participant, at the time the Option was granted, was a Greater Than 10% Stockholder, the expiration of five (5) years from the Grant Date;
(c) The expiration of three (3) months from the date of Participant’s Termination of Service, unless such termination occurs by reason of Participant’s death or Disability;
(d) The expiration of one (1) year from the date of Participant’s Termination of Service by reason of Participant’s death or Disability; or
(e) Participant’s Termination of Service by the Company for Cause.
3.4 Special Tax Consequences. Participant acknowledges that, to the extent that the aggregate Fair Market Value (determined as of the time the Option is granted) of all Shares with respect to which Incentive Stock Options, including the Option (if applicable), are exercisable for the first time by Participant in any calendar year exceeds $100,000, the Option and such other options shall be Nonqualified Stock Options to the extent necessary to comply with the limitations imposed by Section 422(d) of the Code. Participant further acknowledges that the rule set forth in the preceding sentence shall be applied by taking the Option and other “incentive stock options” into account in the order in which they were granted, as determined under Section 422(d) of the Code and the Treasury Regulations thereunder. Participant also acknowledges that an Incentive Stock Option exercised more than three (3) months after Participant’s Termination of Service, other than by reason of death or Disability, will be taxed as a Nonqualified Stock Option.
A-1-3
3.5 Tax Indemnity.
(a) Participant agrees to indemnify and keep indemnified the Company, any Subsidiary and Participant’s employing company, if different, from and against any liability for or obligation to pay any portion of the Tax Liability, payable by the Company in respect of Participant’s Tax Liability (a “Tax Liability” being any liability for income tax, withholding tax, fringe benefit tax and any other employment related taxes or social security, social insurance or national insurance contributions in any jurisdiction) that is attributable to (i) the grant or exercise of, or any benefit derived by Participant from, the Option, (ii) the acquisition by Participant of the Shares on exercise of the Option or (iii) the disposal of any Shares.
(b) The Option cannot be exercised until Participant has made such arrangements as the Company may require for the satisfaction of any Tax Liability that may arise in connection with the exercise of the Option and/or the acquisition of the Shares by Participant. The Company shall not be required to issue, allot or transfer Shares until Participant has satisfied this obligation.
(c) Participant hereby acknowledges that the Company (i) makes no representations or undertakings regarding the treatment of any Tax Liabilities in connection with any aspect of the Option and (ii) does not commit to and is under no obligation to structure the terms of the grant or any aspect of any Award, including the Option, to reduce or eliminate Participant’s liability for Tax Liabilities or achieve any particular tax result. Furthermore, if Participant becomes subject to tax in more than one jurisdiction between the date of grant of an Award, including the Option, and the date of any relevant taxable event, Participant acknowledges that the Company may be required to withhold or account for Tax Liabilities in more than one jurisdiction.
ARTICLE 4.
EXERCISE OF OPTION
4.1 Person Eligible to Exercise. Except as provided in Section 5.3 hereof, during the lifetime of Participant, only Participant may exercise the Option or any portion thereof, unless it has been disposed of pursuant to a domestic relations order. After the death of Participant, any exercisable portion of the Option may, prior to the time when the Option becomes unexercisable under Section 3.3 hereof, be exercised by the deceased Participant’s personal representative or by any person empowered to do so under the deceased Participant’s will or under the then-Applicable Laws of descent and distribution.
4.2 Partial Exercise. Any exercisable portion of the Option or the entire Option, if then wholly exercisable, may be exercised in whole or in part at any time prior to the time when the Option or portion thereof becomes unexercisable under Section 3.3 hereof. However, the Option shall not be exercisable with respect to fractional Shares. Furthermore, the Option shall only be exercisable during the quarterly open trading windows, as designated by the Company.
4.3 Manner of Exercise. The Option, or any exercisable portion thereof, may be exercised solely by delivery to the Secretary of the Company (or any third party administrator or other person or entity designated by the Company; for the avoidance of doubt, delivery shall include electronic delivery), during regular business hours, of all of the following prior to the time when the Option or such portion thereof becomes unexercisable under Section 3.3 hereof:
(a) An exercise notice in a form specified by the Administrator, stating that the Option or portion thereof is thereby exercised, such notice complying with all applicable rules established by the Administrator. The notice shall be signed by Participant or other person then entitled to exercise the Option or such portion of the Option;
A-1-4
(b) The receipt by the Company of full payment for the Shares with respect to which the Option or portion thereof is exercised, including payment of any applicable Tax Liability, which shall be made by deduction from other compensation payable to Participant or in such other form of consideration permitted under Section 4.4 hereof that is acceptable to the Company;
(c) Any other written representations or documents as may be required in the Administrator’s sole discretion to evidence compliance with the Securities Act, the Exchange Act or any other Applicable Law, rule or regulation; and
(d) In the event the Option or portion thereof shall be exercised pursuant to Section 4.1 hereof by any person or persons other than Participant, appropriate proof of the right of such person or persons to exercise the Option.
Notwithstanding any of the foregoing, the Company shall have the right to specify all conditions of the manner of exercise, which conditions may vary by country and which may be subject to change from time to time.
4.4 Method of Payment. Payment of the exercise price shall be by any of the following, or a combination thereof, at the election of Participant:
(a) Cash or check;
(b) With the consent of the Administrator and to the extent permitted by Applicable Law, surrender of Shares (including, without limitation, Shares otherwise issuable upon exercise of the Option) held for such period of time as may be required by the Administrator in order to avoid adverse accounting consequences and having a Fair Market Value on the date of delivery equal to the aggregate exercise price of the Option or exercised portion thereof; or
(c) Other legal consideration acceptable to the Administrator (including, without limitation, if there is a public market for Shares at the time the Tax Liabilities are satisfied, through the delivery of a notice that Participant has placed a market sell order with a broker with respect to Shares then issuable upon exercise of the Option, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the Option exercise price; provided that payment of such proceeds is then made to the Company at such time as may be required by the Company, but in any event not later than the settlement of such sale).
4.5 Conditions to Issuance of Shares. The Shares deliverable upon the exercise of the Option, or any portion thereof, may be treasury shares or Shares which have then been reacquired by or held on behalf of the Company. Such Shares shall be fully paid and nonassessable. The Company shall not be required to issue or deliver any Shares purchased upon the exercise of the Option or portion thereof prior to fulfillment of all of the conditions in Section 10.6 of the Plan and the following conditions, including without limitation, the receipt by the Company of full payment for such Shares, including payment of any applicable Tax Liability.
4.6 Rights as Stockholder. The holder of the Option shall not be, nor have any of the rights or privileges of, a stockholder of the Company, including, without limitation, voting rights and rights to dividends, in respect of any Shares purchasable upon the exercise of any part of the Option unless and until such Shares shall have been issued by the Company, held of record by such holder (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), and, to the extent applicable, Participant has executed the Company’s stockholders agreement or registration rights agreement, as applicable. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Article IX of the Plan.
A-1-5
ARTICLE 5.
OTHER PROVISIONS
5.1 Administration. The Administrator shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be final and binding upon Participant, the Company and all other interested persons. No member of the Committee or the Board shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the Option.
5.2 Whole Shares. The Option may only be exercised for whole Shares.
5.3 Option Not Transferable. Subject to Section 4.1 hereof, the Option may not be sold, pledged, assigned or transferred in any manner other than by will or the laws of descent and distribution or, subject to the consent of the Administrator, pursuant to a domestic relations order, unless and until the Option has been exercised and the Shares underlying the Option have been issued, and all restrictions applicable to such Shares have lapsed. The Option shall be subject to the restrictions on transferability set forth in Section 10.1 of the Plan.
5.4 Tax Consultation. Participant represents that Participant has consulted with any tax consultants Participant deems advisable in connection with the purchase or disposition of such Shares and that Participant is not relying on the Company for any tax advice.
5.5 Binding Agreement. Subject to the limitation on the transferability of the Option contained herein, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
5.6 Adjustments Upon Specified Events. The Administrator may accelerate the vesting of the Option in such circumstances as it, in its sole discretion, may determine. Participant acknowledges that the Option is subject to adjustment, modification and termination in certain events as provided in this Agreement and Article IX of the Plan.
5.7 Notices. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company’s principal office, and any notice to be given to Participant shall be addressed to Participant at Participant’s last address reflected on the Company’s records. By a notice given pursuant to this Section 5.7, either party may hereafter designate a different address for notices to be given to that party. Any notice which is required to be given to Participant shall, if Participant is then deceased, be given to the person entitled to exercise his or her Option pursuant to Section 4.1 hereof by written notice under this Section 5.7. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service (or any similar foreign entity).
5.8 Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement.
5.9 Governing Law and Dispute Resolution. This Agreement shall be governed by and construed under the laws of the State of Delaware regardless of the law that might be applied under principles of conflicts of laws. The venue of any litigation arising from this Agreement or any disputes relating to Participant’s employment shall be in the United States District Court for the District of Delaware, or a state district court of competent jurisdiction in New Castle County, Delaware. Participant consents to personal jurisdiction of the United States District Court for the District of Delaware, or a state district court of competent jurisdiction in New Castle County, Delaware for any dispute relating to or arising out of this Agreement or Participant’s employment, and Participant agrees that Participant shall not challenge personal or subject matter jurisdiction in such courts.
A-1-6
5.10 Conformity to Securities Laws. Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act, and any other Applicable Law, including, without limitation, any rules or regulations of any securities exchange or automated quotation system on which the Shares are listed, quoted or traded. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Option is granted and may be exercised, only in such a manner as to conform to such Applicable Law. To the extent permitted by Applicable Law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such Applicable Law.
5.11 Amendment, Suspension and Termination. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the Board; provided, however, that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the Option in any material way without the prior written consent of Participant. If any provision of this Agreement is determined by any court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken from this Agreement and the remainder of this Agreement shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Agreement.
5.12 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section 5.3 hereof, this Agreement shall be binding upon Participant and his or her heirs, executors, administrators, successors and assigns.
5.13 Notification of Disposition. If the Option is designated as an Incentive Stock Option, Participant shall give prompt notice to the Company of any disposition or other transfer of any Shares acquired under this Agreement if such disposition or transfer is made (i) within two (2) years from the Grant Date with respect to such Shares or (ii) within one (1) year after the transfer of such Shares to Participant. Such notice shall specify the date of such disposition or other transfer and the amount realized, in cash, other property, assumption of indebtedness or other consideration, by Participant in such disposition or other transfer.
5.14 Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if Participant is subject to Section 16 of the Exchange Act, the Plan, the Option and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.
5.15 Not a Contract of Service Relationship. Nothing in this Agreement or in the Plan shall confer upon Participant any right to continue to serve as an employee or other service provider of the Company or any of its Subsidiaries or interfere with or restrict in any way with the right of the Company or any of its Subsidiaries, which rights are hereby expressly reserved, to discharge or to terminate for any reason whatsoever, with or without cause, the services of Participant at any time (unless otherwise required by Applicable Law or any service agreement by and between Participant and Participant’s employer).
A-1-7
5.16 Entire Agreement. The Plan, the Grant Notice and this Agreement constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and Participant with respect to the subject matter hereof.
5.17 Section 409A. The Option is not intended to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other guidance that may be issued after the date hereof, “Section 409A”). However, notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any time the Administrator determines that the Option (or any portion thereof) may be subject to Section 409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other person for failure to do so) to adopt such amendments to the Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines are necessary or appropriate either for the Option to be exempt from the application of Section 409A or to comply with the requirements of Section 409A.
5.18 Limitation on Participant’s Rights. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the Option, and rights no greater than the right to receive the Shares as a general unsecured creditor with respect to options, as and when exercised pursuant to the terms hereof.
5.19 Data Privacy.
(a) Data Collection and Usage. The Company collects, processes, transfers and uses personal data about Participant that is necessary for the purpose of implementing, administering and managing the Plan. This personal data may include Participant’s name, home address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any shares or directorships held in the Company, and details of all awards or other entitlements to Shares, granted, canceled, exercised, vested, unvested or outstanding in Participant’s favor ("Data"), which the Company receives from Participant or Participant's employer (if different). If the Company offers Participant an Award under the Plan, then the Company will collect Data for purposes of granting Awards and implementing, administering and managing the Plan and will process such Data in accordance with the Company’s then-current data privacy policies, which are made available to Participant upon commencing employment and also available upon request. The legal basis, where required, for the processing of Data is Participant’s consent.
(b) Stock Plan Administration Service Providers. The Company may transfer Data to an independent stock-plan administrator and other third parties based in the United States, Sweden, Ireland, or elsewhere, which assists the Company with the implementation, administration and management of the Plan. In the future, the Company may select a different service provider and share Data with another company that serves in a similar manner. Participant understands that the recipients of the Data may be located in the United States, Sweden, Ireland or elsewhere, and that the recipients’ country (e.g., the United States, Sweden, Ireland or elsewhere) may have different data privacy laws and protections than Participant’s country. The Company’s service provider may open an account for Participant to receive Shares pursuant to Participant’s Award. Participant will be asked to agree to separate terms and data processing practices with the service provider, which is a condition to Participant’s ability to participate in the Plan. Participant understands that Participant may request a list with the names and addresses of any potential recipients of the Data by contacting Participant’s local human resources representative. The Participant authorizes the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing Participant’s participation in the Plan.
A-1-8
(c) Data Retention. The Company will use Data only as long as is necessary to implement, administer and manage Participant’s participation in the Plan or as required to comply with legal or regulatory obligations, including under securities, exchange control, tax and employment laws. When the Company no longer needs Participant’s Data, the Company will remove it from its systems. If the Company keeps the data longer, it would be to satisfy legal or regulatory obligations and the Company’s legal basis would be relevant laws or regulations.
(d) Consent; Voluntariness and Consequences of Denial or Withdrawal. Where permitted by Applicable Laws, consent is a requirement for participation in the Plan. In such cases, by accepting this Restricted Stock Unit, Participant agrees with the data processing practices as described in this Agreement and grants such consent to the processing and transfer of Data as described in this Agreement and as necessary for the purpose of administering the Plan. Participant’s participation in the Plan and Participant’s grant of consent is purely voluntary. Participant may deny or withdraw Participant’s consent at any time; provided, that if Participant does not consent, or if Participant withdraws Participant’s consent, Participant cannot participate in the Plan unless required by Applicable Law. This would not affect Participant’s salary or other compensation or Participant's status as a Service Provider; Participant would merely forfeit the opportunities associated with the Plan.
(e) Data Subject Rights. Participant has a number of rights under data privacy laws in Participant’s country. Depending on where Participant is based, Participant’s rights may include the right to (i) request access or copies of Data the Company processes, (ii) rectification of incorrect Data, (iii) deletion of Data, (iv) restrictions on processing, (v) portability of Data, (vi) to lodge complaints with the competent tax authorities in Participant’s country and/or (vii) a list with the names and addresses of any potential recipients of Data.
(f) GDPR Compliance. To the satisfaction and at the direction of the Company, all operations of the Plan and the Shares (at the time of grant and as necessary thereafter) shall include or be supported by appropriate agreements, notifications and arrangements in respect of Data and its use and processing under the Plan, in order to secure (i) the reasonable freedom of the Company or any Subsidiary, as appropriate, to operate the Plan and for connected purposes, and (ii) compliance with the data-protection requirements applicable from time to time, including, if applicable, and without limitation, Regulation EU 2016/679 of the European Parliament and of the Council of April 27, 2016.
5.20 Foreign Asset/Account Reporting Requirements. Participant acknowledges that there may be certain foreign asset and/or account reporting requirements which may affect Participant’s ability to acquire or hold Shares acquired or received under the Plan or cash received from participating in the Plan in a brokerage account outside Participant’s country. Participant may also be required to repatriate sale proceeds or other funds received as a result of participating in the Plan to Participant’s country through a designated bank or broker within a certain time after receipt. It is Participant’s responsibility to be compliant with such regulations and Participant should speak with Participant’s personal advisor on this matter.
A-1-9
5.21 Other Agreements. Participant further agrees hereby that, as a condition to the grant of and/or the receipt of the Shares following exercise of the Option, Participant may be required to execute lock-up or other agreement, as the Administrator may determine in its sole and absolute discretion.
5.22 Internationally Mobile Participants. If Participant relocates outside the United States during the life of the Option, the special provisions for such country shall apply to Participant, to the extent the Company determines that the application of such provisions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan. The Company reserves the right to impose other requirements on the Option and the Shares purchased upon exercise of the Option, to the extent the Company determines it is necessary or advisable in order to comply with local laws or facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
ARTICLE 6.
NON-COMPETITION; NON-SOLICITATION; TRADE SECRETS
6.1 Non-Competition. Participant covenants and agrees that Participant will not at any time during the term of Participant’s employment or service with the Company or its Subsidiaries (collectively, for purposes of this Article 6, the “Company”) and for a period of twelve (12) months following Participant’s Termination of Service for whatever reason (the “Non-Compete Period”), compete with the businesses of the Company by engaging, directly or indirectly, in the Covered Business (as defined in Section 6.5 below) within the Covered Area (as defined in Section 6.5 below), without the written consent of the Board.
6.2 Non-Solicitation of Customers. During the Non-Compete Period, Participant agrees not to (i) solicit, directly or indirectly, for the benefit of Participant or any other person, firm or entity, any person, firm or entity that was a customer (or affiliate thereof) of the Company during the twelve (12) month period ending on the date of Participant’s Termination of Service (“Customers”) for the purpose of providing any products or services included in the Covered Business, (ii) induce or attempt to induce any supplier (or affiliate thereof) of the Company during the twelve (12) month period ending on the date of Participant’s Termination of Service (“Supplier”) to refrain from or cease doing business with the Company, or (iii) interfere with, disrupt or attempt to disrupt the relationship, contractual or otherwise, between the Company and any Customers or Suppliers.
6.3 Non-Solicitation of Service Providers. During the Non-Compete Period, Participant agrees not to (i) induce, encourage or otherwise solicit any employee or independent contractor who provided services to the Company during the twelve (12) month period prior to any date of determination to terminate such person’s employment or other relationship with the Company or (ii) assist any other person, firm or entity in hiring any such employee or independent contractor.
6.4 Confidentiality. Except with the express written consent of the Board, Participant will not, either during the term of Participant’s employment or service with the Company or anytime thereafter, directly or indirectly, use or disclose for the benefit of Participant or any other person, firm or entity, any of the trade secrets of the Company, whether or not said information was acquired, learned, obtained or developed by Participant alone or in conjunction with others. For purposes of this Agreement, trade secrets shall mean that which is known only to the Company and those employees or other agents to whom it has been confided, and is by law the property of the Company, and shall include all information relating to design and manufacturing procedures, techniques, programs, business systems, processes, methods, and marketing studies. It is the intent hereof that Participant shall not divulge or use any such information which is unpublished or not otherwise readily available to the public or which is not general information in the business of the Company. In addition and notwithstanding anything to the contrary in this Agreement, pursuant to the federal Defend Trade Secrets Act of 2016, Participant shall not be held civilly or criminally liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state or local governmental official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. No section in this Agreement is intended to or shall limit, prevent, impede or interfere in any way with Participant's right, without prior notice to the Company, to provide information to the government, participate in investigations, testify in proceedings regarding the Company’s past or future conduct, or engage in any activities protected under whistleblower statutes.
A-1-10
6.5 Definitions.
a. “Covered Business” means any business in which the Company or its Subsidiaries is actively engaged, or actively contemplating engaging in, during the term of Participant’s employment or service with the Company or applicable Subsidiary, or, with respect to periods following termination of such employment, at the date of Participant’s Termination of Service with the Company or applicable Subsidiary, or twelve (12) months prior to the date of such termination, including, without limitation, the Company’s business, which is connected with but not limited to the development and manufacturing of multiplex immunoassay panels, related instruments and the provision of services related thereto.
b. The phrase “engaging, directly or indirectly” means engaging or having an interest in, directly or indirectly, as owner, partner, participant of a joint venture, trustee, proprietor, shareholder, member, manager, director, officer, employee, independent contractor, capital investor, lender, consultant, advisor or similar capacity, or by lending his or its name or reputation to be used in connection with, or otherwise participating in or making available his or its skill, knowledge or experience to be used in connection with, the operation, management or control of a division, group, or other portion of a business or enterprise engaged in any aspect of the Covered Business.
c. The phrase “within the Covered Area” is defined to include those various states within, and territories of, the United States and in each of the countries where the Company or its Subsidiaries is performing or has at any time performed the Covered Business.
A-1-11